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Summary 
 
Chronic pain is a debilitating symptom of a wide range of conditions. These conditions are 
both highly prevalent and create adverse consequences for individuals and society. Whilst 
understanding of chronic pain conditions has improved, in a number of cases the mechanisms 
of chronic pain are not fully understood and no cure is available. It is appreciated that chronic 
pain is not only unpleasant in itself, but can also lead to a reorganisation of the nervous 
system resulting in further suffering. These factors present a justification for further 
investigation into the mechanisms and effects of chronic pain to enable progress towards 
more effective treatments. 
 
Neuroimaging techniques have helped our understanding the mechanisms and effects of 
chronic pain. Techniques have been developed to examine the structure, chemistry and 
activity of the brain. This thesis describes investigations that used neuroimaging to examine 
the effects of chronic pain on the human brain.  
 
A distinction has been drawn between chronic widespread pain (CWP) and chronic localised 
pain (CLP). Historically, the latter was seen as a condition of the peripheral components of 
the pain system. More recently, however, an understanding has been gained that central 
mechanisms may also be a factor in these conditions. The purpose of my investigations was 
to examine differences and similarities in the effects of two CWP and CLP conditions on the 
human brain. Fibromyalgia (FM) and Knee Osteoarthritis (OA) were chosen as 
representatives of these classes of condition. The effects on neurochemistry, brain structure 
and coordinated brain activity in these conditions were compared using magnetic resonance 
spectroscopy (MRS), voxel-based morphometry (VBM) and resting state functional 
connectivity (rs-FC). 
 
Using MRS I observed a reduction in N-Acetylaspartic acid (NAA) in the thalamus of OA 
patients when compared to FM. Using VBM I observed that grey matter volume (GMV) was 
reduced in the left brainstem and posterior cingulate cortex in FM patients when compared to 
OA. GMV was reduced in the left precentral, middle frontal and supramarginal gyri in OA 
when compared to FM. Using rs-FC I observed an increase in functional connectivity in the 
default mode network of FM patients when compared to OA. I observed increased functional 
connectivity within the default mode network (DMN) in both pain conditions compared to 
healthy controls. I also observed increased functional connectivity between the precuneus and 
regions in both the DMN and executive attention networks. 
 
Consideration is given to these findings in the context of previous relevant research. The 
implications of the results are related the patients’ own experience of their condition and links 
to clinical measures are also discussed. The findings provide further evidence for the neural 
basis of elements of patients’ experience of their condition and further understanding of the 
differences between the wider presentations of these conditions. The findings are drawn 
together to demonstrate where the effects of CWP and CLP overlap and where their effects 
contrast. Consideration is given to the mechanisms at work in these conditions that suggest 
differing effects on the components of the pain system and also to demonstrate where 
prolonged abnormal peripheral input may be a factor driving adaptation in CLP. 
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CHAPTER 1 - General Introduction 
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Introduction 
Pain and its avoidance has been a theme of a wide range of human activities since the 
evolution of our species. With the rare exception of those experiencing congenital analgesia, 
every human will experience pain during their lives. Whilst we are fortunate to live in an age 
where there is widespread access to mechanisms and treatments to manage and control pain, 
there are clinical conditions that demonstrate that our knowledge and mastery of pain is 
incomplete. The existence of chronic pain conditions that show limited response to medical 
intervention not only demonstrates the limits of our knowledge of pain, but also provides a 
pressing motivation for pain research given the adverse effects that these conditions have on 
the lives of their sufferers. 
 
The purpose of this thesis is to describe and discuss a series of studies that examine the 
effects that two contrasting chronic pain conditions have on the human brain. The studies 
were conducted using three neuroimaging techniques to observe the effects of pain on the 
brains of chronic pain patients. 
 
In this chapter I will consider the purpose of pain, the development of our understanding of 
the mechanisms of pain and examine research into the consequences of prolonged pain. I will 
contrast chronic localised pain and chronic widespread pain and consider why these 
conditions may differ in their effects on the human nervous system. I will then consider the 
use of neuroimaging for the study of pain in living humans. I will then examine how different 
neuroimaging techniques may be used to generate converging evidence to the nature of the 
effects of pain on the nervous system. 
 
In the following chapters I describe three studies that were undertaken to use neuroimaging 
techniques to examine chronic localised and widespread pain. In each case comparisons are 
made both between groups of participants experiencing chronic localised or widespread pain 
conditions and between chronic pain patients and healthy control participants. Admission to 
the patient groups was based on prior diagnoses. To provide further insight into the nature of 
the patients’ experience of their condition each patient was required to complete a series of 
questionnaires. The questionnaires were intended to capture the impact of the patients’ 
condition on their mental health, to provide better understanding of patients’ experience of 
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their pain and to provide further evidence of the distinction between the conditions. The use 
the questionnaires is described in detail in the following chapters. 
 
In Chapter 2 I describe the use of magnetic resonance spectroscopy to examine differences in 
levels of neurochemicals in areas of the brain associated with the processing and 
representation of pain. 
 
Chapter 3 describes a study made to determine whether differences could be observed in the 
grey matter volumes of regions within the brains of chronic pain patients and those of healthy 
controls. The study used voxel-based morphometry to warp participants’ brain images to a 
standard template to enable comparisons to be made between the levels of grey matter present 
across the areas of the brain. 
 
Chapter 4 describes a study using functional connectivity to examine the correlation between 
levels of activity in areas of interest across the brain in both chronic pain conditions and 
healthy controls. This study examined the effects of chronic pain on activity within 
previously identified anticorrelated brain networks: the executive attention network 
associated with externally directed cognition and the default mode network associated with 
self-reflection and rest. 
 
Chapter 5 summarises the results of the studies and discusses their implications for our 
knowledge of the nature of chronic pain. I consider the differences and similarities observed 
in the effects of chronic localised and widespread pain on the human brain. I also consider the 
implications of the observed differences in regard to the recommendation of further research 
and for the development of targeted therapies for the alleviation, or at least management, of 
these conditions. 
Pain and its purpose 
In common with many species, humans have evolved a complex nervous system that 
continuously samples elements of the state of both the external world and the internal 
environment. From the principles of evolutionary theory, the primary force driving adaption 
is that which increases the chances of an individual surviving long enough to reproduce. It is 
clear that a signalling system capable of accurate representation of the threats and 
18 
 
opportunities in the external world is highly advantageous in ensuring continued survival. For 
this system to be effective, however, the avoidance of threats and use of opportunities needs 
to be considered in the context of the overall state of the organism to enable an effective 
survival strategy. The elements of the nervous system that have developed to register and 
represent the internal states of the organism are essential for the formation of a coherent 
representation of the organism’s overall status and current needs. From this representation, a 
plan may be formed for the implementation of behaviours that will service the organism’s 
current needs. These elements enable the “homeostatic” management of the organism’s state 
(e.g. sweating in response to heat, shivering in response to cold), motivate behaviours to 
restore an optimal state and, within humans, develop the representations that underpin a sense 
of self (Damasio, 2003). In addition to the detection of an excess or a scarcity of survival-
relevant substances within the internal environment, the internally-oriented nervous system 
has also evolved the capability to monitor the integrity of the components of the organism 
and signal when their integrity is compromised (Craig, 2003). The ability to monitor the 
integrity of an organism’s own components and motivate a behavioural response to damage is 
of obvious survival value. Pain is the description given to the subjective experience that 
accompanies the activation of the elements of the nervous system that respond to damage. 
The most widely accepted definition of pain is “an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of such 
damage”. (IASP Task Force on Taxonomy, 1994). The evolutionary purpose of pain is 
plausibly explained in terms of motivating behaviours to avoid bodily damage, to rest and 
protect damaged components and thus prevent further damage (Millan, 1999) and, within our 
own species, to motivate help-seeking behaviours (Thorstensson, Gooberman-Hill, Adamson, 
Williams, & Dieppe, 2009). Within this view the purpose of pain can be seen as an extension 
of the more basic homeostatic mechanisms of the nervous system in that it serves to motivate 
behaviours that seek to restore an individual to an optimal state. If an element of the evolved 
purpose of pain is to facilitate appropriate behaviours then it is understandable why pain is an 
unpleasant experience that, under normal circumstances, is difficult to ignore (Ecclestone & 
Crombez, 1999). It has been proposed that evolutionary purpose of pain is best served by the 
promotion of behaviours that minimise the risk of damage and enable bodily repair once 
damage has occurred (Wall, McMahon, & Koltzenburg, 2006). Within this thesis I will 
consider conditions where pain persists beyond the stage where these behaviours have been 
established and where the persistence of pain may have a transformative effect of the nervous 
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system of the sufferer. To enable this consideration I will first look at research into the causes 
and underlying mechanisms of the pain system. 
The causes and mechanisms of pain 
Early theories about the causes of pain ranged from the imbalance of the vital humours, the 
actions of gods or demons, or the effects of negative emotions (as reviewed in Doleys, 2014). 
An idea of a system for conveying information about bodily damage from the periphery to 
the brain and for instigating compensatory behaviours was suggested by both Galen and 
Avicenna. Whilst elements within these theories find counterparts in the modern descriptions 
of the mechanisms of pain, a richer understanding of these mechanisms could not be 
developed before several discoveries had been made. The modern understanding of the 
mechanisms of pain grew from the 19th century studies of the nervous system, such as those 
performed by Schiff and von Frey (Perl, 2007); the discovery of the neuron and synaptic 
inter-cellular communication (Ramón y Cajal, 1911); and the description of nociceptors by 
Sherrington (1906). These elements combined to provide an understanding of a system 
comprising multiple specialised elements that could communicate with each other via 
electrochemical means to convey information about noxious stimuli from the periphery to the 
brain. Whilst the presence or absence of receptors with the specific purpose of detecting and 
signalling pain was the subject of intense debate throughout the 20th century (see Moayedi & 
Davis, 2012), the role of specific classes of pain receptors and those played by classes of 
afferent fibres came to be better understood. This led to an understanding of the key elements 
of the pain system outside the brain in that the importance of nociceptors, Aδ and C afferent 
fibres, the neurons of the dorsal horn laminae and the ascending spinal tracts came to be 
appreciated (Wall et al., 2006). I will briefly summarise the contemporary view of the 
anatomy and neurobiology of pain using peripheral nociceptive pain for illustration: the 
reader is referred to reviews by Besson, Brooks and Tracey, and Millan for further detail 
(Besson, 1999; Brooks & Tracey, 2005; Millan, 1999). Pain most commonly entails the 
transmission of information from nociceptors located in the periphery to the CNS to enable 
an appropriate response to be made to actual or potential tissue damage. Nociception takes 
place at receptors on primary afferent fibres (PAFs), located within skin, muscle and joints. 
Different classes of PAF exist, which are either specialised to be responsive to a particular 
type of noxious stimulus (e.g. mechanical or thermal) or polymodal. The most important 
types of PAF for the transmission of pain-related information are the thin, unmyelinated Aδ 
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fibres and the thicker myelinated C fibres. These fibres use a range of neurotransmitters, 
excitatory amino acids, neuropeptides and other substances to transmit information onwards. 
The PAFs project to neurons within the laminae of the dorsal horn (DH) of the spine. Within 
the DH are located interneurons, which integrate sensory information and play a role in 
modulating nociceptive signals, including inhibiting the release of neurotransmitters from Aδ 
and C fibres. Also within the DH are projection neurons, which carry pain information to 
supraspinal targets via mono- or polysynaptic pathways. Three major pathways from the DH 
to supraspinal targets are the spinothalamic (STT), spinomesencephalic (SMT) and 
spinorecticular tracts (SRT), which project to primarily contralateral targets (Almeida, 
Roizenblatt, & Tufik, 2004). The SMT projects to the pons and superior colliculus, which in 
turn pass pain-related signals to the basal ganglia. The SRT projects to the reticular formation 
and thence to the thalamus. The STT projects to a number of nuclei within the ventral, 
ventromedial and medial thalamus. The thalamic nuclei targeted by the STT have onward 
projections to cortical areas associated with sensory processing (postcentral gyrus), pain 
specific processing (insula), cognition (pre-frontal cortex) and affect (cingulate gyrus). These 
areas have been proposed as being components of the ‘pain neuromatrix’ i.e. brain areas 
whose combined action generate the overall representation of a patient’s pain (Melzack, 
2001). 
 
With increased knowledge of the anatomy and neurobiology of the pain system, the 
limitations of available descriptions of the system’s operation gained greater prominence.  
 An appreciation of the existence of distinct classes of pain and the diversity of responses to 
similar noxious stimuli (e.g. Beecher, 1946) led researchers to seek an improved model for 
interpreting the pain system. It was clear to Melzack and co-workers that the emotional state 
and the sufferer’s attitude towards their pain could have a direct influence on the level of pain 
subjectively experienced. They proposed the Gate Control Theory (Melzack & Wall, 1965) 
which suggested that the level and type of pain experienced was influenced not only by input 
from the periphery, but could be modulated by control mechanisms descending from the 
brain. This led to a view of the pain system not merely as a passive reflector of reality, but as 
a complex system that could be influenced by an array of additional factors (e.g. a person’s 
emotional state or psychological perception of pain). Other observations such as from cases 
where pain persisted after its original cause had been addressed or ‘phantom pain’ perceived 
to be present in a limb after amputation (e.g. Flor et al., 1995), led researchers to an 
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understanding that the response of the pain system was not necessarily optimal in all cases. 
Additionally, it was observed that exposure to pain could lead to alterations in the pain 
system’s operation: the development of tolerance or hypersensitivity in response to pain 
could be considered adaptive (or maladaptive) responses to persisting pain conditions (e.g. 
Costigan, Scholz, & Woolf, 2010; Dar, Ariely, & Frenk, 1995). The initial view of adaptation 
within the pain system centred on alterations to peripheral components (Wall et al., 2006). 
Further research, however, uncovered distinctive forms of maladaptive response in persistent 
pain entailing a more fundamental reorganisation of the system’s core components (Nielsen 
& Henriksson, 2007), with a suggestion of the ‘central sensitisation’ of the pain system. 
Central sensitisation occurs within the CNS at both DH neurons and supraspinal sites and 
consists of an increase in both membrane excitability and level of synaptic activity in 
response to noxious stimuli (Latremoliere & Woolf, 2009; Staud, 2002; Suzuki, Rygh, & 
Dickenson, 2004). Central sensitisation causes the recruitment of additional inputs to 
nociceptive pathways to lower the threshold at which stimuli are perceived as noxious or to 
amplify the effect of noxious stimuli, and persists after the original noxious stimulus has been 
withdrawn (Woolf, 2012). The growing appreciation of plasticity within the human pain 
system taken with the increasing understanding of the human nervous system has led to 
several theories concerning the effects of prolonged pain on this system. The investigation of 
central reorganisation of the human pain system in response to persistent pain is the primary 
focus of this thesis. I will now examine what is meant by chronic pain and contrast chronic 
widespread and chronic localised pain conditions. 
Chronic pain 
Chronic pain has been defined by the International Association for the Study of Pain as pain 
that persists past the healing phase after injury, and is clinically determined as pain that has 
lasted longer than 12 weeks (Merskey & Bogduk, 1994). In practice, however, the use of this 
definition varies according to the condition creating the pain. For example, back pain often 
takes 6 months to be classed as chronic; while in post-herpetic neuralgia 3 months of 
continuous pain is the time at which the condition is typically deemed as chronic. Apkarian, 
Baliki and Geha (2009) proposed that the use of one definition of chronic pain does not give 
a full, correct explanation, and thus, for each specific type of chronic pain a specifically 
related definition must be given based on the peripheral and central mechanisms that underlie 
the development of each condition. Within the clinical and scientific literature two main 
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dimensions of pain emerge: one defined by site of injury (e.g. back, head, viscera) and the 
other by the cause of the discomfiture experienced (e.g. neuropathic, arthritic, cancer, 
myofascial, diabetic). Clinically, symptoms can result from the presence of a number of pain-
creating conditions that can make it difficult to assess the relative contribution of each 
condition to the overall pain experienced. An example of this situation is given by chronic 
low back pain where levels of joint degeneration, muscle, and nerve injuries differ from 
subject to subject. In some cases of lower back pain, clinical investigation reveals no joint 
abnormalities or injury to muscle or nerves. The wide variety in the results of clinical 
investigation in lower back pain greatly adds to the challenge of understanding the 
contribution of each component and the interaction between them (Apkarian et al., 2009). 
The effect of chronic pain on the lives of sufferers can be profound and these conditions are 
highly prevalent. As an example, lower back pain is a very common condition that can arise 
due to a wide range of mechanical or non-mechanical factors. Mechanical causes are present 
in the overwhelming majority of lower back pain cases (Deyo & Weinstein, 2001). 
Disruption of the components of the spinal system gives the possibility that lower back pain 
may be accompanied by numbness, loss of reflex and weakness (Chien & Bajwa, 2008). It 
has been estimated that lower back pain is one of the most common health problems in 
medical practice and is experienced by 70-85% of mature people (Frymoyer, 1988). In the 
UK chronic low back pain is the most common factor for worker absence and accounts for 
12.5% of all days lost (Maniadakis & Gray, 2000).  
Other examples of chronic pain conditions include temporomandibular joint pain syndrome 
(Moss & Garrett, 1984), chronic neuropathic pain (Woolf & Mannion, 1999), irritable bowel 
syndrome (Whitehead, Engel, & Schuster, 1980) and complex regional pain syndrome 
(Birklein, 2005). 
As illustrated by these examples, chronic pain can result from a wide range of conditions. It is 
evident that there are different causes and expressions of chronic pain. One of the primary 
distinctions drawn between classes of chronic pain is derived from the extent, across the body, 
of the experienced pain. This distinction classifies chronic pain as localised, if limited to a 
single region of the body or widespread if the pain is more extensive. It is the purpose of this 
thesis to consider the similarities and differences in the effects on the human brain of chronic 
widespread and localised pain. For this purpose I have selected fibromyalgia (FM) as an 
example of chronic widespread pain and osteoarthritis of the knee (OA) as an example of 
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chronic localised pain. These conditions have been selected due to their high prevalence, the 
high level of disruption entailed for patients, and level of demand that these conditions create 
on the resources of global health care systems. I will now look in detail at these conditions. 
Fibromyalgia 
FM is a chronic, painful, noninflammatory syndrome that has an adverse effect on the 
musculoskeletal system (Wolfe et al., 1990). This condition affects 2.7% of the world’s 
population (Queiroz, 2013) with women being 11 times more likely to suffer FM than men 
(Clauw & Crofford, 2003). FM results in a greatly impaired quality of life for the patient and 
also entails economic consequences for society (Annemans et al., 2008). Despite its 
prevalence and adverse impact, the aetiology and pathophysiology of the disease is unclear.  
The diagnosis of FM includes two specific criteria recommended by the American College of 
Rheumatology: 1) a record of widespread pain for at least three months; 2) pain in 11 of 18 
specific anatomical sites or tender points on digital palpation with an estimated strength of 40 
N or 4 kg (Wolfe et al., 1990) . Other symptoms associated with FM include nonrestorative 
sleep, fatigue, anxiety, morning stiffness, cognitive disturbances, headache, paraesthesia, 
depression and symptoms associated with autonomic dysfunction (Crofford & Clauw, 2002; 
Solano et al., 2009;Yunus, Masi, & Aldag, 1989). As an example, nonrestorative sleep is 
common in FM: approximately about 75% of patients experience issues such as early middle 
or late insomnia, hypersomnia and frequent awakening. FM patients commonly experience 
more insomnia-related symptoms than either rheumatoid arthritis patients or healthy controls 
(Belt, Kronholm, & Kauppi, 2009).  
It was noted (Wolfe, Ross, Anderson, Russell, & Hebert, 1995) that FM is often comorbid 
with affective disorders and functional somatic syndromes (FSSs) such as irritable bowel 
syndrome, irritable bladder and post-traumatic stress disorder. In addition to comorbidity, 
commonalities between FM and the other FSSs have been noted, though the overlap between 
the patients’ experience of these conditions is far from complete (Kanaan, Lepine, & Wessely, 
2007). A report made by Yunus (2007) proposed the unifying concept of ‘central sensitivity 
syndrome’ to account for the commonalities seen between FM and other FSS conditions. This 
proposal suggested an underlying mechanism of neuroendocrine deviations, which interact 
with psychological and other factors to generate the symptoms experienced, however, the 
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concept of a central sensitivity syndrome has not been universally accepted and this term has 
become uncommon in more recent literature 
The similarities observed in FSSs may imply a common genetic mechanism. It has been 
identified in numerous FSSs that central sensitisation entails increased excitability of the 
central nervous system through diverse synaptic and neurotransmitter/neurochemical 
activations (Woolf, 2012). Recent research has proposed a role for polymorphisms of genes 
in the catecholaminergic systems in creating a predisposition to FM (Ablin, Cohen, & 
Buskila, 2006; Buskila, Sarzi-Puttini, & Ablin, 2007) and in shaping the patient’s experience 
of the condition. 
  
Significant progress has been made in understanding the mechanisms of underlying altered 
pain processing in FM (Ablin, Neumann, & Buskila, 2008). Buskila and Press (2001) 
suggested that this relates to atypical sensory processing in the CNS coupled with 
dysfunction of skeletal muscle nociception and the hypothalamic–pituitary–adrenal (HPA) 
axis. Adler and Geenen (2005) reported that FM patients have widespread anomaly in pain 
perception, particularly a reduction in pain threshold and tolerance to pressure, cold, and heat. 
Changes in the HPA axis have been verified in FM patients (Crofford et al., 1994). 
Additionally, alterations in the operation of the autonomic nervous system have often been 
described in FM. Various groups of researchers have suggested systematic hyperactivity in 
FM (Martinez-Lavin, 2007). Unusual sympathovagal balance in male FM patients with 
sympathetic hyperactivity and concurrently decreased parasympathetic activity has been 
reported recently (Cohen et al., 2001). Elevated sympathetic and lowered parasympathetic 
tones in women with FM were described as a basal autonomic state; and autonomic 
dysregulation may have insinuations related with the symptomatology, physical and 
psychological sides of health (Cohen et al., 2000). The observations of altered states 
associated with FM has led to a search for biomarkers for the diagnosis for the condition that 
would aid in understanding the disease’s activity. It has been noted, however, as per 
Dadabhoy, Crofford, Spaeth, Russell and Clauw (2008) that many candidate biomarkers for 
FM have been rejected due to either a lack of specificity to FM or a reliance on subjective 
evaluation.  
 
From the 1990s it has become evident that FM is not a homogeneous condition (Wolfe et al., 
1996). Whilst there also are often chronic widespread pain and increased tenderness, other 
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symptoms are not present in all patients. It was demonstrated by Turk and colleagues that 
subgrouping by cluster analyses of the Multidimensional Pain Inventory in different chronic 
pain groups may be relevant to FM patients. They investigated three FM subgroups, which 
they described as dysfunctional, interpersonally distressed or adaptive copers. All subgroups 
undertook a standardised treatment program with the authors making the conclusion that 
applying treatment according to psychological needs increases treatment effectiveness (Turk, 
Okifuji, Sinclair, & Starz, 1998; Turk, Okifuji, Sinclair, & Starz, 1996). Subsequently, 
Thieme and colleagues (Thieme, Spies, Sinha, Turk, & Flor, 2005) subdivided FM patients 
into the three aforementioned categories according to their results on the Multidimensional 
Pain Inventory and applied hierarchical regression analyses to recognize predictors of pain 
behaviours for all subgroups. Their conclusions supported the heterogeneity of FM both in 
terms of the factors underlying a diagnosis of the condition and in the behaviours that result. 
Their research implies a challenge for gaining an understanding of the mechanisms that result 
in FM, but also supports the suggestion that FM treatment is most effective when it takes into 
account the patient’s experience of their condition. 
 
To conclude, while FM affects many people, its aetiology is currently unknown. The 
possibility remains that the term ‘fibromyalgia’ is currently used to refer to a number of 
different conditions, which contributes to the poor level of current understanding of FM 
(Apkarian et al., 2009). 
Osteoarthritis 
Arthritis is the name given to a wide range of conditions that cause damage in one or more 
joints. Arthritis can result from a wide range of causes including autoimmune disorders, 
infection or physical damage to the affected site. Osteoarthritis (OA) is the most common 
form of arthritis. OA arises from either damage or accumulated wear to a joint, which results 
in the breakdown of cartilage and damage to bone. OA of the knee has been identified an 
important cause of pain and disability in elderly people (Jordan, 2003) and the fourth most 
common health problem in females (Murray & Lopez, 1997). The economic impact of OA is 
significant in terms of resultant disability and the cost of remedial surgery (Brooks, 2002). No 
cure is currently available for OA and therefore treatment objectives concentrate on 
maximising function and quality of life and minimising the pain experienced (Fries, 
Weinberger, Lorig, Jacobs, & Goldberg, 2000). Modern treatment regimens include 
26 
 
physiotherapy, exercise, diet management, alteration of mechanics with orthotic devices, 
analgesics, anti-inflammatories and management based on the pathophysiological 
mechanisms of pain (Woolf et al., 2004). However, despite the adoption of a wider basis for 
the treatment of OA, this is not sufficient to prevent a total replacement of the affected joint 
being required in some cases (Jordan, 2003). 
Historically, OA patients were considered to be suffering from a peripheral disease with pain 
resulting solely from damage to joints. This is certainly the case for a subgroup of OA 
patients who experience a complete disappearance of their symptoms after replacement of the 
affected joints (March et al., 1999). However, from the 20th century an appreciation was 
gained that OA presented greater complexities. A discorrelation between the radiographic 
severity of OA and pain experienced was noted in some cases (McAlindon, Cooper, Kirwan, 
& Dieppe, 1993). It was also noted that the high occurrence of referred pain, hyperalgesia and 
alterations in skin sensitivity away from the damaged joint could not be explained solely 
through a peripheral model of pain (Farrell, Gibson, McMeeken, & Helme, 2000; Hendiani et 
al., 2003; Imamura et al., 2008; Khan, McLoughlin, Giannakas, Hutchinson, & Andrew, 
2004; Khan & Woolson, 1998; Ordeberg, 2004). An understanding has developed of the 
contributions of peripheral and central sensitisation to the pain experienced in OA (Jordan, 
2003). It is also now known that regular and intensive nociceptive sensory information from 
painful structures generates considerable neurochemical and metabolic alterations (Siddall & 
Cousins, 2004). Neurologic reorganisation in OA was found within spinal cord segments (in 
animal models), which entailed an increased excitability of dorsal horn neurons that generates 
pain hypersensitivity in a segmental distribution (Bird et al., 2006; Schadrack et al., 1999). 
This demonstrated central sensitisation as a factor within OA and may offer some explanation 
for the range of sensations experienced by some OA patients. 
 
There have been a number of studies examining the involvement of central pain modulation 
in OA (Farrell et al., 2000; Jordan, 2003; Kosek & Ordeberg, 2000). Bajaj, Bajaj, Graven-
Nielsen, & Arendt-Nielsen (2001) illustrated deep hyperalgesia in the tibialis anterior muscle 
of subjects with knee OA. Creamer and colleagues displayed pain relief in the contralateral 
non-injected knee resulted from the injection of anaesthetic into another knee (Creamer, 
Hunt, & Dieppe, 1996). These studies both proposed a role for the central nervous system in 
the expression of chronic pain in patients with knee OA. More recently Imamura et al. (2008) 
demonstrated a generalised state of hyperalgesia in patients with knee OA in superficial and 
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deep structures. They similarly proposed that maintenance of the chronic pain depends on the 
involvement of the peripheral and central nervous system. This sensitisation phenomenon is 
not specific to knee OA, as Farrell and colleges showed similar cutaneous and deep 
hyperalgesia in the forearm of patients with thumb-base OA (Farrell et al., 2000). Taken 
together, these studies suggest that as pain develops from acute to chronic a concomitant 
increase in central sensitisation is also present in some cases of OA. 
Thus, despite the differences in patients’ experience of chronic widespread pain (FM) and 
chronic localised pain (OA) there may be some underlying common factors since the effects 
of central sensitisation has been observed in both conditions. I will now consider 
neuroimaging of pain and the modern view of neuroimaging progress in the understanding of 
fibromyalgia and osteoarthritis.  
Neuroimaging of Pain 
From the last quarter of the 20th century research into human pain has been greatly assisted 
by the availability of neuroimaging techniques that allow the living brains of pain patients to 
be noninvasively studied. A substantial contribution to our knowledge of pain has been made 
through the use of neuroimaging. 
 
Neuroimaging is a set of techniques that enables the type, structure and extent of living brain 
tissue to be analysed based on its response to varying magnetic fields. Over several decades 
research into neuroimaging methods have enabled the generation of images of the brain’s 
structure, the level of neurochemicals present within brain regions, and the level of 
coordinated activity between brain regions. The availability of neuroimaging techniques has 
been valuable in enabling the investigation of the areas of the brain that are involved in the 
processing of pain signals, in the representation of pain, and that play a role in the descending 
pain modulation pathways.  
 
In the past two decades, numerous functional neuroimaging studies have identified a set of 
brain regions in which increased activity is associated with the presence of clinical or 
experimental pain. This group of regions has been referred to as the pain neuromatrix 
(Melzack, 1990). The inclusion of regions within the neuromatrix has been the subject of 
debate, but the current consensus identifies the following regions as playing a role in this 
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system: primary (S1) and secondary (S2) somatosensory cortex, anterior cingulate cortex 
(ACC), anterior and posterior insula, prefrontal cortex (PFC), thalamus and periaqueductal 
grey (PAG) (Apkarian et al., 2009; Derbyshire, 2000). The exact function performed by each 
of these areas in the pain neuromatrix is not yet fully understood, but a division into lateral 
(comprising S1, S2, thalamus and posterior insula) and medial (comprising ACC, PFC, 
anterior insula and PAG) systems has been proposed (Tracey, 2008). The lateral pain system 
is believed to be instrumental in the representation of the physical aspects of pain i.e. the 
location and characteristics of the noxious stimulus and the effects on the body. The medial 
system is proposed to be involved in the evaluative and affective responses to pain and the 
direction of attention to painful stimuli and, in the case of the PAG, modulating the effects of 
pain via the descending pathways (Xie, Huo, & Tang, 2009). 
 
Research using functional magnetic resonance imaging (fMRI) and positron emission 
tomography (PET) has suggested that the anterior cingulate cortex (ACC) is particularly 
important in the processing of pain. It has been shown that the ACC is the brain area most 
regularly activated after the application of a painful stimulus (LaGraize & Fuchs, 2007).  
 
As illustrated in Figure 1., the ACC comprises regions that differ in cytoarchitecture, 
connectivity and function (as reviewed in Bush, Luu, & Posner, 2000 and  Vogt, 2005). A 
key distinction has been drawn between dorsal-caudal (dACC) and ventral-rostral (vACC) 
areas of the ACC. Functional and structural connectivity has been noted between dACC and 
lateral prefrontal cortex, parietal cortex, premotor cortex, motor and supplementary motor 
areas. In contrast, connections have been mapped between vACC and amygdala, PAG, 
nucleus accumbens, AntIns, hippocampus and hypothalamus. Imaging studies have shown 
that dACC plays a role in the modulation of cognition and attention, response selection and 
error detection. The vACC shows greater involvement in assessing the salience of emotional 
stimuli and the regulation of emotional responses (Mohanty et al., 2007; Whalen, Bush, 
McNally, & Wilhelm, 1998). The relevance of the vACC in emotional processing of pain has 
been demonstrated by a number of studies that demonstrated increased activity in this area 
particularly with increased attention to noxious stimuli or increased perceived unpleasantness 
(Kulkarni et al., 2005; Rainville, Duncan, Price, Carrier, & Bushnell, 1997; Vogt, Derbyshire, 
& Jones, 1996). Lesioning this area has been shown, in humans and animals, to eliminate the 
emotional element of pain sensation (that is, the subjective distress associated with the 
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presence of pain), yet leaving the sensory-discriminative component intact (Ballantine, 
Cassidy, Flanagan, & Marino, 1967; Fuchs, Balinsky, & Melzack, 1996; Johansen, Fields, & 
Manning, 2001; LaGraize, Borzan, Peng, & Fuchs, 2006). 
 
Figure 1. Sagittal view of the left medial surface of human brain. The dorsal-caudal anterior 
cingulate cortex is indicated by the red boundary lines. The ventral-rostral anterior cingulate 
cortex is indicated by the blue boundary lines. 
 
Research in the field of fMRI in humans illustrated that many analgesic procedures, including 
opioid analgesia, placebo and hypnotic analgesia, thalamic and motor cortex stimulation-
induced analgesia, and cognitive modulation of pain are related with enhanced activation in 
the vACC  (Casey, 1999; Davis, Taylor, Crawley, Wood, & Mikulis, 1997; deCharms et al., 
2005; Faymonville et al., 2003; Petrovic & Ingvar, 2002). These findings support the idea 
that vACC holds an important position in the modulation of pain. 
  
Investigating the neural effects of chronic pain 
Whilst we now have a better understanding of which brain regions are involved in the 
processing of pain, we have limited knowledge of the effects of prolonged pain on the 
structure and function of these regions. It is well understood that the brain is able to learn and 
adapt to changing circumstances through the reorganisation of synaptic connections between 
neurons (Pascual-Leone, Amedi, Fregni, & Merabet, 2005). This adaption can be achieved 
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through the establishment of new synapses, the removal of existing synapses or adjustments 
to the strength of the link between neurons. Neuroimaging studies have provided evidence of 
these mechanisms in action in response to either training or repeated presentation of stimuli 
(Recanzone, Merzenich, Jenkins, Grajski, & Dinse, 1992) or as a consequence of a change in 
sensory input. An example of the latter case is the reorganisation of the somatosensory map 
in response to limb amputation observed by Flor et al. (1995). The possible consequences of 
the prolonged application of a stimulus are the development of tolerance (Hammer, Egilmez, 
& Emmett-Oglesby, 1997), sensitivity (Karni & Sagi, 1991) and neuronal damage through 
excitotoxicity (Mayer, Mao, Holt, & Price, 1999). Given that chronic pain conditions can 
entail the prolonged presentation of sensory input, adaptation via one or more of these 
mechanisms is possible. The effects of chronic pain on the human nervous systems have been 
studied using a range of neuroimaging techniques. I will examine previous research using 
three of these techniques in detail in the coming chapters, however, I will provide examples 
of the findings of neuroimaging studies of pain here (several comprehensive reviews of 
neuroimaging studies of pain are available e.g. Apkarian, Bushnell, Treede, & Zubieta, 2005; 
Tracey, 2008). fMRI studies have shown that cortical reorganisation can be observed in 
chronic back pain and phantom pain patients (Flor, Braun, Elbert, & Birbaumer, 1997; 
MacIver, Lloyd, Kelly, Roberts, & Nurmikko, 2008; Tsao, Galea, & Hodges, 2008). Brain 
atrophy (i.e. a decrease in grey matter volume) has been observed in the of patients with a 
range of chronic pain conditions (Apkarian et al., 2004; Schmidt-Wilcke et al., 2005). 
Additionally, neurochemical changes in the brains of chronic pain patients have been 
observed (Grachev, Fredrickson, & Apkarian, 2000).  
 
In this thesis I will describe studies that were conducted using three neuroimaging 
techniques: magnetic resonance spectroscopy (MRS), voxel-based morphometry (VBM) and 
resting state functional connectivity (FC). These techniques and their contributions to our 
knowledge of the mechanisms of chronic pain will be presented in detail in the relevant 
chapters. Each of these techniques examines a different aspect of brain composition that may 
be useful in generating converging evidence about chronic pain. MRS provides information 
about the levels of neurochemicals present in different regions of the brain. Of relevance to 
the examination of the effects of chronic pain on the brain, n-acetylaspartic acid (NAA) has 
been identified as a neurometabolite that is indicative of neuronal integrity, density and 
metabolism (Rae, 2014). Additionally, levels of the excitatory neurotransmitter Glutamate 
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have been found to increase in response to painful stimuli (Gussew et al., 2009; Mullins, 
Rowland, Jung, & Sibbitt, 2005) and may therefore provide information about differing 
mechanisms of action between pain conditions. VBM provides a method of mapping the 
brains of multiple participants to a standard template to enable an examination to be 
performed to the relative sizes of regions in the brain. FC examines the correlation in the 
activity of groups of neurons across regions of the brain. A strong correlation between the 
activity of neurons in regions distributed across the brain is taken to indicate their 
participation in functional networks i.e. collections of brain regions that contribute to a 
common task or purpose. These techniques were selected to give an opportunity to examine 
multiple aspects of the effects of chronic widespread and localised pain on the human 
nervous system and thus generate further understanding of these conditions.  
 
I will now look at previous neuroimaging research that has been conducted into two examples 
of chronic pain conditions (FM and OA) and consider what this research can tell us about the 
mechanisms at work. 
 
Neuroimaging studies of fibromyalgia 
The effects of FM on the human brain have been studied using neuroimaging techniques for a 
number of years (Gracely & Ambrose, 2011). Early investigations used SPECT and PET to 
examine alterations in activity levels in the areas of the brain relevant to pain processing.  
 
Studies using SPECT to assess regional cerebral blood flow (rCBF) revealed alterations in 
the function of both cortical and subcortical pain processing areas in FM. Using a chemical 
tracer to highlight rCBF, reduced activity levels were observed in the thalamus and caudate 
nucleus in FM patients (Bradley et al., 1999;  Mountz et al., 1995).  
 
PET has been used to investigate neurochemical alterations to the brains of FM patients 
through the application of chemical tracers that selectively bind to receptors of interest. 
Through observing the interaction of the action of the chemical tracer with areas of interest in 
participants’ brains an assessment can be made of the patients’ binding potential for relevant 
substances. Wood et al. (Wood et al., 2007) used [11C]-raclopride to examine binding at 
D2/D3 dopamine receptors during the application of a painful stimulus. In normal 
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participants the release of endogenous dopamine (in response to the painful stimulus) reduced 
binding of [11C]-raclopride at the D2/D3 receptors. FM patients demonstrated disruption to 
the dopamine system in the basal ganglia this response was not observed. Harris et al. (Harris 
et al., 2007) conducted a similar study using the application of [11C]-carfentanil during PET 
to examine binding at the μ-opioid receptor. μ-opioid receptor binding potentials were shown 
to be reduced in FM patients compared to controls in several brain areas considered to be 
significant in pain processing and regulation, namely, the nucleus accumbens, dorsal 
cingulate, and amygdala). μ-opioid receptors have been identified as the primary sites of 
action of several endogenous opioid peptides (Zadina, Hackler, Ge, & Kastin, 1997) and are 
the target of several analgesic opioid drugs (Trescot, Andrea M., Datta, Sukdeb, Lee, Marion, 
& Hansen, Hans, 2008). The action of endogenous opioids on these receptors has been 
associated with a reduction in the reported sensory and affective aspects of experienced pain 
(Zubieta et al., 2001). Given the role of μ-opioid receptors in regulating the noxious 
experience of pain it is reasonable to suggest that a decrease in the presence of these receptors 
in FM may be accompanied with a decrease in the efficacy of endogenous opioids and may 
account for the reduced effectiveness of exogenous opiates in the treatment of FM (Harris et 
al., 2007). 
  
Later studies observed the effects of FM on the intrinsic connectivity of the brain at rest. 
Using resting-state functional connectivity techniques (FC), researchers have shown an 
increased correlation of activity between areas of the insular cortex and areas of the cingulate 
cortex in FM patients (Ichesco et al., 2014). 
 
In addition to alterations in brain activity, alterations to the structure of the brain have been 
noted in FM patients in studies using VBM. It was observed that reductions in grey matter 
volume were present in pain-relevant cortical and subcortical structures including the 
amygdala, cingulate cortex, hippocampus and the parahippocampal gyrus (Luerding, 
Weigand, Bogdahn, & Schmidt-Wilcke, 2008). It was further observed that FM patients 
suffered increased levels of age-related grey matter reduction in comparison to healthy 
controls (Kuchinad et al., 2007). 
 
Diffusion tensor imaging has been used to observe the effects of FM on white matter 
connectivity throughout the brain and has demonstrated a reduction in the level of 
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connectivity (as reflected by fractional anisotropy) between the thalamus and other areas 
(Sundgren et al., 2007). 
 
As illustrated in Table 1, several studies have used MRS to investigate changes to 
neurochemistry associated with FM. The majority of these studies have examined either the 
effects of FM on NAA or Glu/Glx, with some also including m-Ins, Cho and Cr. The studies 
have unsurprisingly focussed on areas of the brain known to be involved in the processing of 
either the sensory or emotional aspects of pain such as the insula, amygdala, basal ganglia, 
postcentral gyri and cingulate cortex. Also included in the studies are the hippocampus, 
thalamus and prefrontal cortex. Emerging from these studies is a view that an increase of Glu 
or Glx in pain relevant areas is related to the presence of FM and is proportional to clinical 
measures of the pain relating to the condition (for instance, as recorded in the Visual Analog 
Scale) (Feraco et al., 2011). As an example, Harris et al. (2008) observed that alterations in 
the ratio of Glutamate to Creatine in the posterior insula correlated with FM patients 
experience of clinical pain (after both sham and verum applications of a non-pharmacologic 
intervention). They further observed a negative correlation between the alteration of the 
Glu/Cr ratio in this patient group and their threshold to experimentally applied pain. As noted 
previously, an increase in the level of the excitatory transmitter Glu has been observed after 
the application of acute painful stimuli: these findings suggest a similar response to chronic 
clinical pain. 
 
Several studies observed a decrease in the measured level of NAA in the hippocampi of FM 
patients, and a negative correlation between decreased hippocampal NAA and clinical pain. 
These findings can be viewed in the context of converging evidence of hippocampal 
vulnerability to the effects of a range of chronic conditions including pain and depression and 
evidenced in abnormalities in metabolite levels or connectivity between the hippocampus and 
cortical areas (Fasick, Spengler, Samankan, Nader, & Ignatowski, 2015; Mutso et al., 2014). 
Given the association between NAA and neuronal viability it is not surprising to note that a 
reduction in NAA is associated with adverse consequences of FM since it can be taken to 
indicate dysfunction within vulnerable structures. 
 
The effects of FM on levels of other brain metabolites are less clear. A small number of 
studies have examined the effects of FM on m-Ins, Cho and Cr, but is difficult to build a 
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consensus view. FM has been associated with both an increase and decrease of hippocampal 
Cho (Emad et al., 2008; Fayed et al., 2010). An increase in m-Ins in amygdala and thalamus 
has been reported in FM (Valdés et al., 2010), which contrasts with a decrease observed in m-
Ins in FM in hippocampus and sensorimotor cortex (Fayed et al., 2010). Further studies are 
required to determine if m-Ins can provide significant insights into the effects of FM on 
neurochemistry. 
 
The differences observed in levels of NAA and Glu/Glx suggest that MRS may be able to 
provide a biomarker for FM to assist in the diagnosis and treatment of the condition.  
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Study Metabolites Brain Areas Experimental 
Techniques 
Groups Partici-
pants 
Measures Results 
Petrou et al 
(2008) 
NAA, Cho, 
Cr, 
NAA/Cr, 
Cho/Cr, 
NAA/Cho 
DLPFC,             
Basal ganglia, 
Supraventricular 
white matter, 
Insula 
H-MRS,               
Pre- and post-
contrast 
enhanced MR 
imaging,          
Pressure pain 
threshold 
FM 
HC 
21 
27 
Visual analog scale 
(VAS),     Ctr. for 
Epidemiological Studies 
Depression Scale (CES-
D), Spielberger Trait 
Personality Inventory 
Anxiety Qs, 
Catastrophizing 
Component of the Coping 
Strategies Qs 
Cho/Cr variability in the right DLPFC 
was significantly different in the 2 
groups 
A significant correlation between 
Cho/Cr in the DLPFC and clinical 
pain in FM 
Evoked pain threshold significantly 
correlated with NAA/Cho in the left 
insula and left basal ganglia in FM 
Emad et al 
(2008) 
NAA, Cho, 
Cr, 
NAA/Cho, 
NAA/Cr, 
Cho/Cr 
Hippocampi H-MRS FM 
HC 
15 
10 
FM Impact Qs (FIQ),             
Visual analogue scale 
(VAS),  The Mini Mental 
State Examination 
(MMSE),             The 
Hamilton Depression 
Scale, The structured 
sleep interview 
NAA decrease of in hippocampi in 
FM 
Cho increase in R hippocampus in 
FM 
NAA/Cho and NAA/Cr decrease in 
hippocampi in FM 
Correlations between language score 
and R Cho and R Cr levels. 
Harris et al 
(2008) 
Glu AntIns, PosIns H-MRS, FMRI, 
Painful pressure 
FM 10 Experimental pressure- 
evoked pain thresholds,                    
Short form McGill Pain 
Questionnaire (SF-MPQ) 
Changes in Glu/Cr in PosIns 
negatively correlated to experimental 
pain threshold 
Elevated Glu/Cr in FM pre-treatment 
correlates with clinical pain 
Harris et al 
(2009) 
Glu, Glx 
 
Right AntIns, 
Right PosIns 
H-MRS, 
Pressure pain 
test 
FM 
HC 
19 
14 
Gracely Box Scale (GBS) 
Qs 
 
FM patients: elevated Glu, Glx in 
PosIns 
Glu and Glx levels negatively 
correlated with pressure pain 
thresholds 
Wood et al 
(2009) 
NAA, 
NAA-Cr 
Hippocampi H-MRS FM 
HC 
16 
8 
FM Impact Qs (FIQ) 
 
NAA/Cr decrease in R hippocampus 
in FM 
Negative correlation between scores 
on the FIQ and NAA/Cr in R 
hippocampus 
Valdes et al 
(2010) 
 
Glx, NAA, 
Cr, Cho, M-
Ins 
Amygdala, 
Thalami, PFC 
H-MRS FM 
HC 
 
28 
24 
Visual analog scale 
(VAS), Health 
Assessment Qs (HAQ), 
FM Impact Qs (FIQ), 
Hospital Anxiety and 
Depression Scale (HADS) 
Glx increase and higher Glx/Cr ratio 
in the R amygdala in FM  
M-Ins increase in R amygdala and R 
thalamus in FM patients associated 
with higher levels of pain, fatigue and 
depression 
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Fayed et al 
(2010) 
 
 
Glx, NAA, 
Cr, Cho, M-
Ins 
Somatosensory 
cortices, 
Thalamus, 
Hippocampi, 
Posterior 
cingulate gyrus 
 
H-MRS, MRI, 
Diffusion tensor 
imaging (DTI), 
Diffusion-
weighted 
images (DWI) 
FM 
HC 
 
 
10 
10 
 
 
Pain Catastrophizing 
Scale (PCS)                                 
Hospital Anxiety and 
Depression Scale (HADS)           
Pain Visual Analogue 
Scale (PVAS)                                      
Pain threshold                      
Mini-Mental State Exam 
(MMSE)                                     
FM Impact Qs (FIQ) 
Glx increase and higher Glx/Cr ratio 
in the posterior cingulate gurus in FM 
M-Ins decrease in in hippocampi in 
FM 
M-Ins/Cr decrease in the L sensory-
motor area and the L hippocampus in 
FM
Cho and NAA/NAAG decrease in L 
hippocampus in FM 
Feraco et al 
(2011) 
Glu, Glx, 
Cr, M-Ins 
VLPFC, 
Thalamus 
H-MRS 
 
FM 
HC 
 
12 
12 
Pain Visual Analogue 
Scale (PVAS)                                       
FM Impact Questionnaire 
(FIQ) 
Glx/Cr and Glu/Cr increase in 
VLPFC in FM
Correlation Glu/Cr in L thalamus and 
PVAS 
 
 
Table 1. Magnetic Resonance Spectroscopy studies of Fibromyalgia. 
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A significant amount of research has used neuroimaging techniques to investigate central 
sensitisation in FM (as reviewed in Cagnie et al., 2014). A key theme to emerge from this 
research is increased activity in the brains of FM patients, as observed using fMRI, in 
response to experimentally applied pain. As demonstrated in Gracely, Petzke, Wolf and 
Clauw (2002) and by Cook et al. (2004), it has been noted that whilst the application of 
experimental pain to FM patients evoke activity in the same brain regions as in healthy 
controls, the levels of activation were higher in FM patients.  
 
Functional neuroimaging techniques have also been used to investigate the cognitive and 
affective components of FM. It was demonstrated that pain catastrophising was correlated 
with enhanced activity, as assessed by fMRI, in some brain areas related to anticipation of 
pain (medial frontal cortex, cerebellum), attention to pain (dorsal anterior cingulate cortex, 
dorsolateral prefrontal cortex) and emotional aspects of pain (Gracely et al., 2004). 
Additionally, FM patients showed increased activity in the PFC, posterior parietal cortex and 
PAG (Burgmer et al., 2011) during pain anticipation and catastrophisation. This observation 
reflects the cognitive and evaluative aspects of FM and also the effects of continuing pain on 
the descending pain modulation pathways. FMRI has been used to demonstrate alterations in 
brain perfusion in FM, as well as abnormalities in pain-stimulated perfusion (Foerster et al., 
2011; Staud, 2002). 
  
These findings suggest that FM is associated with a diverse range of alterations to both 
structure, function and chemistry within the brain, though further research is required to 
untangle causal relationships between the condition and these observations. 
 
Neuroimaging studies of osteoarthritis 
As with FM, the effects of OA on the brain have been investigated using several 
neuroimaging techniques (as reviewed in Harvey, Taylor and Wise, 2012), though fewer 
studies have been made of OA using these methods. The lower number of neuroimaging 
studies of OA may reflect the consensus that peripheral factors are of greater importance in 
this condition. 
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Studies of the effects of OA on brain structure have used VBM to reveal grey matter 
reduction in the thalamus, anterior insula, hippocampus and somatosensory cortex (Baliki, 
Schnitzer, Bauer, & Apkarian, 2011), though Gwilym et al. (Gwilym, Filippini, Douaud, 
Carr, & Tracey, 2010) and Rodriguez-Raecke et al. (Rodriguez-Raecke, Niemeier, Ihle, 
Ruether, & May, 2009), also using VBM, noted that this reduction was eliminated in the 
months following replacement of the affected joint.  
 
Neurochemical alterations of the thalamus have also been observed in OA. Shigemura et al. 
(2012) used MRS to observe that a decreased ratio of NAA to Creatine was present in the 
thalamus contralateral to joint damage in OA. Given that NAA is taken to be a marker of 
overall neuronal viability (Grachev, Thomas, & Ramachandran, 2002) it is perhaps not 
surprising that reversible thalamic atrophy may be accompanied by decreased relative levels 
of NAA. 
 
Most studies that have used fMRI to investigate OA have examined the effects of applied 
experimental pain on OA patients. From these studies the application of acute pain to OA 
patients activates similar brain areas to those activated in healthy controls. Similarly to FM 
patients, levels of activation in these areas are somewhat increased in OA patients compared 
to HC. (Baliki, Geha, Jabakhanji, et al., 2008) and, in the case of the ACC, show differing 
extents of activation (Buffington, Hanlon, & McKeown, 2005).  
 
The pain produced spontaneously in OA has been shown to activate areas associated with 
cognition, evaluation and affect. This has been achieved both by observing the resting brain 
via fMRI (Howard et al., 2012) and by using fMRI and PET to contrast activations produced 
spontaneously by OA with those produced by experimental procedures (Kulkarni et al., 2007; 
Parks et al., 2011). 
 
Finally, abnormal activity in the brainstem especially the PAG has been noted in OA 
(Gwilym et al., 2009). It has been suggested that this represents an impairment of the 
descending pain modulation pathways in OA, which adds to the evidence for central 
mechanisms playing a role in the ongoing experience of the condition. 
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Differences and Similarities of OA and FM 
As previously stated, the purpose of this thesis is to present three neuroimaging studies that 
compare and contrast the effects of OA and FM on the human brain. I shall take the research 
described above as a starting point from which to develop the hypotheses to be investigated 
using MRS, VBM and FC.  
 
The most obvious difference between FM and OA is the extent of painful areas across the 
bodies of patients. Whilst noting cases of referred pain and hyperalgesia, the areas of pain 
associated with OA are generally localised to the damaged joints. In contrast, FM pain is 
widely spread across patients’ bodies, thus justifying the selection of these conditions as 
examples of CLP and CWP.  
 
OA is associated, in most cases, with objectively observable joint damage and has a well-
understood aetiology, whereas FM presents with no obvious signs of injury and its causes and 
mechanisms of progression are not yet known. OA is more common in women than men, but 
the ratio is much smaller than that for FM, which is much more common in women. The 
symptoms of OA are commonly restricted to physical impairments, whereas FM has been 
associated with impairments of mood, cognition and attention.  
 
Taken together, these factors suggest sharply contrasting conditions whose similarities may 
be limited to the prolonged experience of pain and the effects that this continued experience 
may have on the brain. The factors described above suggest a contrast between a widespread 
disorder of the central nervous system and a condition that is maintained by peripheral 
nociception resulting from physical damage. The observation of elements of central 
sensitisation and resultant hyperalgesia in OA, however, support the suggestion that OA 
cannot be explained purely with reference to peripheral mechanisms. Examining the results 
of neuroimaging investigations also suggests a more complex relationship between the 
conditions. 
 
Both OA and FM have been associated with grey matter volume reductions. The reductions 
in OA are in areas more associated with the lateral or somatosensory pain system (thalamus, 
insula, hippocampus, somatosensory cortex); the reductions in FM are associated with 
structures more associated with the affective and evaluative aspects of pain (amygdala, 
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cingulate cortex), though FM also showed GMV reduction in the hippocampus. Whilst it has 
been observed that thalamic GMV reduction in OA is reversible with treatment, no such 
observation has been made about FM. It is unclear if this is due to the peculiarities of the 
thalamus or whether different GMV reducing mechanisms are present in the conditions. 
Brainstem shape and volume alterations (across the pons and PAG) have been noted in FM to 
a greater degree than OA.  
 
Both conditions show increased activity in pain processing brain areas (in patients relative to 
healthy controls) and both conditions show increased activity in areas associated with 
emotional processing of pain, though this has been much more pronounced in FM. 
 
FM shows alterations in levels of glutamate in some pain processing regions, whilst OA 
shows reduced levels of NAA in the thalamus. Neurochemical disruption was observed to be 
more widespread in FM than OA with alterations to the neurochemistry of the nucleus 
accumbens, dorsal cingulate and amygdala being observed. Both conditions showed 
alteration to the functioning of the PAG, but a raised level of activity in FM contrasted with 
disrupted functioning in OA.  
 
Considering the findings of this research suggests that FM would be expected to present more 
widespread differences than OA when compared with healthy controls in our studies. As such, 
one would expect to see FM presenting more marked differences in brain areas associated 
with cognition, emotion and attention than OA. The differences in the effects on the PAG of 
the conditions suggest that differences may be detected between the conditions in the areas 
influencing the behaviour of the descending pain modulation pathways. If the increased 
activity of the PAG in FM acts to limit ascending pain signals then it is possible that the 
maladaptive effects of continued pain stimulation would be lessened in the somatosensory 
pain system in FM when compared to OA. 
 
Implications and Hypotheses 
As noted, three neuroimaging techniques will be used to generate converging evidence for the 
similarities and differences between the effects of OA and FM on the human brain. The 
techniques are MRS, VBM and FC, which examine neurochemistry, neuroanatomy and 
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neuronal activity respectively. I will describe the techniques and generate specific hypotheses 
in detail in the following chapters, but will now suggest broad hypotheses based on current 
knowledge of OA and FM and the opportunities afforded by MRS, VBM and FC. The 
research described above has suggested some differences (and commonalities) between the 
conditions of interest that may be uncovered through use of my selected techniques. My 
primary hypothesis is that CLP and CWP have different effects on the human brain and that 
these differences will be observable by MRS, VBM and FC.  
 
Previous research has proposed two component systems within the overall pain 
representation and processing system. Given the more pronounced cognitive and emotional 
components of the experience of FM and I would hypothesise that greater differences would 
be observed between FM and HC in the medial cognitive-emotional pain system. Given the 
disruption of movement and proprioception associated with OA I hypothesise that greater 
differences would be observed between OA and HC in the lateral somatosensory pain system.  
 
One of the themes to emerge from prior research into FM and OA is that whilst OA is 
influenced by central mechanisms their influence is more restricted than in FM. An example 
of this being the detection of neurochemical changes in a wider range of areas in FM when 
compared with OA: neurochemical changes were detected only in the thalamus in OA, but in 
a range of areas in FM. I hypothesise that my MRS investigation will reveal greater 
neurochemical differences in terms of brain regions and neurochemical levels in FM 
compared to OA and compared to HC. 
 
Previous research has revealed greater cognitive impairment in FM than in OA. Using FC we 
are able to observe the level of cohesion of network activity in the resting brain of each 
participant. Since FM patients experience greater cognitive and attentional issues I 
hypothesise that greater dissimilarity will be observed between FM and HC than between OA 
and HC in the brain networks examined. 
Prior research has noted GMV reductions in patients with chronic pain conditions. I 
hypothesise that the differences in the effects of OA on the lateral somatosensory pain system 
and FM on the medial cognitive-emotional pain system will result in observable differences 
in GMV reductions in the brain regions comprising these systems in the relevant patient 
groups. 
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 Through the use of the selected techniques I will generate evidence that will provide greater 
understanding of the effects of CLP and CWP. By bringing together results from three 
neuroimaging techniques it is intended that this research will facilitate the development of 
better-targeted treatments for these conditions. 
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CHAPTER 2 - Is chronic widespread pain (fibromyalgia) 
expressed differently from chronic local pain (osteoarthritis of the 
knee)? A Magnetic Resonance Spectroscopy study 
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Introduction 
Pain has been defined as “an unpleasant sensory or emotional experience associated with 
actual or potential tissue damage” (Merskey & Bogduk, 1994). The experience of pain is 
subjective and is familiar to most people, but it can be debilitating when it becomes a chronic 
condition. For clinical purposes chronic pain is characterised as pain which persists longer 
than 12 weeks, usually existing after the healing phase of the injury that first caused the pain, 
but it may also develop without any obvious injury process (Merskey & Bogduk, 1994). 
Chronic pain can have different localisation in the body depending on the aetiology, being 
either localised or widespread. 
  
Fibromyalgia (FM) and osteoarthritis (OA) are two common causes of chronic 
musculoskeletal pain with differing bodily representation. FM is a condition characterised by 
widespread pain, poor sleep and fatigue with no obvious peripheral pathological cause. In 
contrast, OA is a degenerative joint disease with obvious cartilage breakdown and bony 
deformity leading to dysfunction and pain in the affected area. OA is a common condition in 
the elderly, whereas FM can affect younger adults (Neumann & Buskila, 2003; Y. Zhang & 
Jordan, 2008). These diseases have a financial impact on society through public spending on 
treatment and time lost from work.  
 
Interest has grown in the use of Magnetic Resonance Spectroscopy (MRS) to study the 
role of neurochemistry in chronic pain. A combination of improved technology and an 
increased appreciation of the value of neurochemical data in understanding physiological 
processes have made MRS an important technique in the investigation of the living brain. 
It shows great potential for the investigation of the biochemical processes associated with 
the sensation of pain (Grachev, Ramachandran, Thomas, Szeverenyi, & Fredrickson, 
2003; Gussew, Rzanny, Güllmar, Scholle, & Reichenbach, 2011). 
 
While MRS has been used widely to investigate FM (Emad et al., 2008; Fayed et al., 
2010; Harris et al., 2009; Valdés et al., 2010; Wood, Ledbetter, Glabus, Broadwell, & 
Patterson, 2009), I am only aware of one in vivo MRS study of OA (Shigemura et al., 
2012). Recently MRS has been used to examine possible neurochemical differences in 
two chronic pain conditions with different aetiologies (neuropathic versus non-
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neuropathic) (Gustin et al., 2011). Gustin et al. used MRS to compare the effects of 
trigeminal neuropathic pain (TNP) with temporomandibular disorder (TMD) on patients’ 
brains. Given the suggestion that TNP is maintained by mechanisms that alter brain 
anatomy, whereas TMD is driven by peripheral mechanisms, Gustin et al. hypothesised 
that TNP would also lead to observable changes in neurochemistry. A reduced ratio of 
NAA to Cr was observed in the Thalamus of TNP patients compared to healthy controls 
and to TMD patients. Furthermore, a negative correlation was observed between this ratio 
and TNP patients’ recorded pain scores. These findings lend support to the suggestion that 
MRS is a viable method for observing differences in neurochemistry associated with the 
central mechanisms of chronic pain conditions and provide motivation for the use of MRS 
to investigate differences between FM and OA. 
 
Using FM as a model of chronic widespread pain (CWP) and knee OA as a model of 
chronic localised pain (CLP), this study set out to compare the neurochemical profiles of 
these two conditions, using pain-free participants as controls. Since these pain conditions 
have different bodily representations, I hypothesized that there would be differences in 
central expression between CWP and CLP. In particular, I would expect to see significant 
differences in N-acetyl aspartate (NAA) and Glutamate (Glu) levels between the groups. 
NAA is widely believed to be a marker of neuronal density and viability (Govindaraju, 
Young, & Maudsley, 2000; Simmons, Frondoza, & Coyle, 1991), therefore I expected to 
observe a decrease in NAA level in CLP. Glu is a major excitatory neurotransmitter that 
has previously been found to increase in response to an acute painful stimulus (Gussew et 
al., 2009; Mullins et al., 2005). Increased levels of Glu may therefore be suggestive of an 
increase in excitatory activity consequently I predicted a Glu elevation in CWP. 
 
The first aim of the study was to investigate whether statistical differences could be observed 
in the level of neurometabolites in four brain regions between CWP group (FM) and CLP 
group (OA) compared to healthy controls group (HC). The second aim was to examine 
neurometabolite differences between FM and OA groups whilst controlling for the effects of 
age. As noted, the typical age of onset differs between the two diseases therefore I anticipated 
a difference between the mean age of my patient groups: controlling for age differences 
would therefore protect the internal validity of my study. The third aim was to explore the 
relationships between the levels of neurometabolites and clinical measures, such as pain 
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rating scores (PRS), depression scores (DS), anxiety scores (AS), and pain duration (PD) 
between the groups.  
Methods and participants 
Participants 
Consideration was given to the participant group sizes that would give a sufficiently high 
probability of detecting differences in metabolite levels between the groups. A review of 8 
previous MRS studies of chronic pain (7 FM, 1 OA) revealed that a mean group size of 16 
participants. These studies had made a comparison between metabolite levels in a single 
patient group and healthy controls and therefore had a mean total participant group size of 32. 
I examined the sample size that would be needed in such experiments to achieve an 80% 
power level, using the tool G*Power 3 (Faul, Erdfelder, Lang, & Buchner, 2007). This 
analysis showed that to achieve 80% power in detecting a large effect size (Cohen’s d = 0.8) 
a total group of 42 participants would be required, hence the experiments, whilst successful, 
could be considered somewhat underpowered. It was my intention to make a 3-way 
comparison between two groups of chronic pain patients and a group of healthy controls, 
therefore I used G*Power to determine what group sizes would be required to achieve a 
power level similar to previous experiments using an ANOVA. G*Power revealed that to 
achieve 80% power in detecting a large effect size (Cohen’s f = 0.4) three groups of 22 
participants would be required and therefore I aimed to recruit a total of 66 participants. For 
the purposes of this study it was possible to recruit 50 participants, therefore achieving a 
power of approximately 70%. 
 
All participants were females aged 31-65. There were 17 participants with FM (mean +/- SD 
age 47.88 +/- 8.15 years), 17 participants with OA of the knee (mean +/- SD age 61.65 +/- 
3.06 years), and 16 HC (mean +/- SD age 44.25 +/- 11.32 years) for this study. Demographic 
information for the FM, OA and HC participants is given in Tables 2, 3 and 4, respectively. 
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 Subject Age Pain 
duration 
(years) 
Pain 
Rating 
Score 
HADS 
Anxiety 
Score  
HADS 
Depression 
Score 
2 43 14 5 17 13 
3 51 30 3.5 1 6 
6 36 3 6 8 9 
8 42 18 6.5 0 2 
10 50 7 5 7 9 
13 41 2 2 20 9 
17 65 14 8 0 7 
18 46 10 8 8 10 
22 51 20 6 15 12 
25 55 2 7 7 6 
27 34 5 6 9 16 
28 55 12 7.5 14 17 
29 61 24 3 12 15 
30 46 13 8 16 18 
31 49 4 2 12 16 
38 45 2 4 18 13 
53 
Mean 
±SD 
44 
47.88 
8.15            
22 
11.88 
8.66 
7 
5.56 
2.04              
15 
10.53 
6.26 
17 
11.47 
4.69 
 
Table 2: Demographics of fibromyalgia subjects 
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 Subject Age Pain 
duration 
(years) 
Site Pain 
Rating 
Score 
HADS 
Anxiety 
Score  
HADS 
Depression 
Score 
19 65 2 Left 2 1 6 
20 63 40 Both 6 14 14 
23 58 5 Left 6 7 8 
24 64 3 Left 5 8 6 
26 58 8 Both 7 13 10 
32 62 3 Right 7 5 7 
33 65 5 Left 5 9 17 
34 62 4 Both 7 13 13 
37 58 6 Right 9 13 11 
45 64 3 Right 8 6 14 
46 55 11 Both 6 14 15 
47 65 5 Both 5 5 7 
48 65 4 Right 7 2 8 
49 62 5 Both 1 12 13 
50 61 5 Right 4 8 6 
51 62 44 Left 4 7 8 
52 59 5 Both 3 3 9 
Mean 
±SD 
61.65 
3.06 
9.29 
12.50 
N/A 
N/A 
5.41 
2.12 
8.24 
4.31 
10.12 
3.57 
 
Table 3: Demographics of osteoarthritis subjects 
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 Subject Age HADS 
Anxiety Score 
HADS  
Depression Score 
1 
4 
5 
7 
9 
11 
12 
14 
15 
16 
35 
36 
39 
40 
41 
42 
Mean 
±SD 
31 
46 
62 
46 
47 
32 
36 
56 
35 
65 
34 
34 
60 
47 
36 
41 
44.25 
±11.32 
0 
5 
1 
0 
0 
6 
4 
3 
0 
3 
1 
2 
7 
3 
1 
2 
2.38 
±2.22 
2 
5 
3 
1 
0 
2 
10 
0 
0 
1 
0 
0 
6 
4 
0 
5 
2.44 
±2.90 
 
Table 4: Demographics of healthy controls 
 
FM participants were classified using the American College of Rheumatology criteria (Wolfe 
et al., 1990) for the classification of FM, such that each subject fulfilled the following 
criteria:  
1) widespread pain in all four quadrants of the body for at least 3 months; 
2) tenderness or pain to touch in at least 11 out of 18 specific anatomical sites described as 
tender points. 
 
FM participants were recruited from a district general hospital fibromyalgia clinic in North 
Wales. FM participants were excluded if they had knee OA. Participants with knee OA were 
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recruited from the pre-operative arthroplasty clinic at Ysbyty Gwynedd, Bangor. Participants 
with rheumatoid arthritis and OA of other joints were excluded, as was anyone who also had 
a diagnosis of co-morbid FM. HC participants without chronic pain were recruited using the 
Bangor University’s School of Psychology’s community participant panel and local 
advertisements. All participants were asked to refrain from using analgesic medication on the 
day of the scan until after scanning was completed. Normal contraindications for MRI were 
also used as exclusion criteria (e.g. pacemakers, metal implants, claustrophobia). 
 
This study was approved by the Ethics Committee from the School of Psychology, Bangor 
University and North West Wales Research Ethics Committee (reference 10/WNo01/16). 
Research activities took place in Bangor Imaging Centre, Bangor University. All participants 
provided informed consent. 
 
Methods 
MRS procedures 
All participants underwent the same MRS protocol. MRS scanning was conducted using a 3 
Tesla Phillips Achieva MRI system (Philips Health Care, Eindhoven, Netherlands). MRS was 
used to measure the levels of six neurometabolites in four different brain regions previously 
found to be implicated in chronic pain (Emad et al., 2008; Fayed et al., 2010; Grachev et al., 
2000; Grachev et al., 2002; Gussew et al., 2011; Harris et al., 2009; Valdés et al., 2010; 
Wood, Ledbetter, et al., 2009). The neurochemicals investigated were N-acetyl aspartate 
(NAA), Choline (Cho), Creatine (Cr), Glutamate (Glu), Glutamine (Gln), Glu + Gln (Glx) 
and Myo-Inositol (m-Ins) within the anterior cingulate cortex (ACC), anterior insula (AntIns), 
posterior insula (PosIns), and the thalamus (Thal). 
 
A high-resolution T1-weighted scan was used for localisation for the MRS scans. The T1 
weighted image was acquired as 5 echo MP-RAGE sequence (TE = 3.5, 5.1, 6.8, 8.5, 10.2 ms, 
TR = 12 ms, TI = 1150 ms, 3D acquisition, FOV = 240 mm X 220 mm X 130 mm, voxel 
dimensions = 0.7 X 0.7 X 0.7 mm3). Single voxel proton MRS (PRESS-TE=40 ms, TR=2000 
ms, 196 averages) was localised to the ACC (2 x 2 x 2 cm3), AntIns (1.5 x 1.5 x 2.5 cm3), 
PosIns (1.5 x 1.5 x 2.5 cm3), and the Thal (1.5 x 1.5 x 2.5 cm3) based on anatomical 
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landmarks identified on the T1 weighted image. Each examination lasted approximately one 
hour. Figures 2 and 3 show the selected voxel locations and MRS spectra respectively. 
 
 
 
 
Figure 2: Voxel locations for magnetic resonance spectroscopy (MRS) of the anterior 
cingulate cortex (ACC), Anterior Insula, Posterior Insula, and the Thalamus 
 
 
 
 
 
 
 
 
 
 
52 
 
  
ACC - anterior cingulate cortex 
AntIns - anterior insula 
PosIns - posterior insula 
 
Figure 3: Representative MRS spectra from each of the four regions from one participant in 
the study, demonstrating typical signal quality 
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Questionnaires 
Participants completed the Pain Rating Scale (PRS) and the Hospital Anxiety and Depression 
Scale (HADS). The questionnaires were completed by the participants immediately prior to 
scanning. 
  
The Pain Rating Scale enables the level of pain on the day of scanning to be measured by 
assessing the intensity of the pain, how distressing it is, and how much it interferes with 
normal everyday activities (Jensen & Karoly, 2001). For this paper I focused solely on the 
intensity of pain on the day of scanning (PRS of 0-10).  
 
The HADS is an uncomplicated and reliable instrument to assess both depression and anxiety 
in hospital practice and community settings, and provides a score of 0-21 for each measure. 
Participants complete a questionnaire by responding to statements applicable to generalised 
anxiety or depression (Snaith, 2003). Patients’ responses are recorded as Anxiety Score (AS) 
and Depression Score (DS). 
 
Pain Duration 
Pain duration (PD) was collected from medical notes and participant interviews. It was 
considered from the first report by patient. 
Data Analysis 
The MRS data was transferred from the scanner in the form of Philips SDAT and SPAR files 
for analysis using LC-Model software (Provencher, 1993). LC-Model has a high level of 
acceptance within the MRS field as an appropriate fitting technique and normalizes the area 
under each fitted metabolite peak against the area of the unsuppressed water peak for the 
region, allowing metabolite concentrations to be calculated for NAA, Glu, Gln, Cho, and Cr 
and up to 14 other metabolites (Provencher, 1993). In addition, the use of LC-Model for 
spectral quantification provides a high level of reproducibility in clinical populations 
(Mullins et al., 2003). The default LC-Model setup contains an estimated correction for 
relaxation and assumed water concentration effects. However, these may not truly reflect the 
water content or relaxation properties of the tissues present in the voxels. To address these 
concerns the high-resolution T1 weighted images for each subject were segmented into grey 
54 
 
matter (GM), white matter (WM), and cerebrospinal fluid (CSF) using Statistical Parametric 
Mapping toolbox (SPM), so tissue content within the MRS voxels could be assessed 
(Gasparovic et al., 2006). Voxel registration was then performed using custom-made scripts 
developed in MATLAB, which can be accessed at http://biu.bangor.ac.uk/projects.php.en. 
The scripts generated a mask for each voxel location by combining location information from 
the Philips SPAR file with orientation and location information contained within the T1 
image. The application of this mask to the GM, WM and CSF images enabled the calculation 
of partial volume within the region of interest by establishing the percentage of each tissue 
type within the relevant voxels. These percentages were used to correct metabolite 
concentrations referenced to water, for partial volume and relaxation effects as described by 
Gasparovic et al, (Gasparovic et al., 2006) using equation [1]: 
 
 
 
   [1] 
 
Where [M] is the concentration of the metabolite; SM_obs and SH2O_obs are the signals from the 
metabolite of interest and the unsuppressed water; fGM, fWM, and fCSF are the fractional 
volume of GM, WM and CSF in the voxel respectively. RH2O_GM, RH2O_WM, RH2O_CSF, and RM 
refer to correction factors for T1 and T2 relaxation effects on GM, WM, CSF, metabolite 
signal and assumed water content for each tissue type (43300 mM for GM, 35880 mM for 
WM, 53883 mM for CSF, and assuming 55550 mM water in pure water). Relaxation effects 
are calculated as RM = exp[-TE/T2M](1-exp[-TR/T1M]) where T1 for GM, WM and CSF was 
estimated from the literature at 1500 ms, 1000 ms, and 4000 ms respectively, while T2 was at 
63 ms, 50 ms, and 200 ms respectively (Dieringer et al., 2014; Ganji et al., 2012; Prescot, Shi, 
Choi, & Renshaw, 2014; Träber, Block, Lamerichs, Gieseke, & Schild, 2004). T1 and T2 
values for metabolites were likewise an average of estimates from the literature assuming 
mostly GM content of the voxels: NAA (T1=1403, T2=272); Cho (T1=1182, T2=217); Cr 
(T1=1320, T2=217); m-Ins (T1=1100, T2 = 200); with Glu and Gln signals assumed to have 
the same relaxation times (T1=1220, T2=185) (Choi & Frahm, 1999; Choi et al., 2006; 
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Träber et al., 2004; Tsai et al., 2007; Walaszek, Schubert, Mekle, & Ittermann, 2012; 
Zaaraoui et al., 2007).  
 
For further description of the method for correction the reader is again directed to Gasparovic 
et al. (Gasparovic et al., 2006). This equation therefore gives a calculated concentration in 
units of mM/kg water, and all results are reported as such. However, due to the assumptions 
regarding water content, these may be thought of as institutional units and therefore would be 
different if other assumptions regarding water content and relaxation were used. 
Statistics 
Each region of interest was analysed individually using SPSS 20 software (IBM, Armonk, 
NY, 2012). A one-way between-groups analysis of variance (ANOVA) was conducted to 
explore if there were any statistical differences in the levels of neurometabolites in four brain 
regions between three groups. Post-hoc comparisons using the Tukey HSD test were then 
performed to determine the level of significance and direction of potential differences in OA 
and FM groups compared to HC group. Likewise, ANOVAs with the Tukey HSD test were 
conducted to explore if there were any statistical differences in age between groups.   
 
Furthermore, due to reports in the literature about changes in neurometabolite levels being 
associated with aging (Chang, Ernst, Poland, & Jenden, 1996; Christiansen, Toft, Larsson, 
Stubgaard, & Henriksen, 1993; Haga, Khor, Farrall, & Wardlaw, 2009; Saunders, Howe, van 
den Boogaart, Griffiths, & Brown, 1999), a one-way between-groups analysis of covariance 
(ANCOVA) was conducted to control for age in the levels of neurometabolites between the 
groups. The independent variables were groups, and the dependent variables were the levels 
of neurometabolites. Age was used as the covariate in this analysis.  
In addition, the relationships between the levels of neurometabolites and clinical measures 
(PRS, DS, AS, and PD) were investigated using Pearson product-moment correlation 
coefficient. 
Results 
A summary of the participants’ characteristics are presented in Table 5 and include subjects’ 
age, PD in years, PRS, AS, and DS. Mean PD, PRS, AS, and DS did not show any significant 
differences between the patient groups (an independent sample t-test). There was a 
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statistically significant difference in age for the three groups: F (2, 47) = 21.1, p = .00, η2 
= .47 as revealed using a one-way between-groups ANOVA. The Tukey HSD test indicated 
that the mean age for OA group (M = 61.65, SD = 3.06) was significantly different at the p 
< .01 levels from FM group (M = 47.88, SD = 8.15) and HC group (M = 44.25, SD = 11.32). 
There was no significant difference in the mean age between FM and HC groups. 
 
 
Subject 
Group 
Age Pain 
duration 
(years) 
Pain 
Rating 
Score 
HADS 
Anxiety 
Score 
HADS 
Depression 
Score 
FM 47.88 
±8.15  
11.88 
±8.66 
5.56 
±2.04  
10.53 
±6.26 
11.47 
±4.69 
OA 61.65 
±3.06 
9.29 
±12.50 
5.41 
±2.12 
8.24 
±4.31 
10.12 
±3.57 
HC 44.25 
±11.32 
N/A N/A 2.38 
±2.22 
2.44 
±2.90 
 
FM – fibromyalgia subjects 
OA – knee osteoarthritis subjects 
HC – healthy controls 
 
Table 5: Summary of demographic and clinical characteristics of participants (Mean / ±SD). For full 
detail see tables 2, 3 and 4.) 
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As shown in Table 6, the acquired MRS data was of a satisfactory quality for further 
processing as expressed in the signal to noise ratios achieved.  
 
Brain Groups S:N ratio Tissue segmentation 
regions  
 
Mean (SD) GM  
Mean (SD) 
WM  
Mean (SD) 
CSF  
Mean (SD) 
ACC FM 24.12 (3.66) 0.68 (0.09) 0.16 (0.08) 0.17 (0.11) 
 OA 22.06 (3.38) 0.73 (0.03) 0.13 (0.03) 0.14 (0.04) 
 HC 
 
22.19 (4.76) 0.70 (0.08) 0.12 (0.03) 0.18 (0.09) 
AntIns FM 17.19 (3.64) 0.67 (0.06) 0.16 (0.08) 0.17 (0.08) 
 OA 17.53 (2.43) 0.66 (0.05) 0.16 (0.07) 0.18 (0.06) 
 HC 
 
19.00 (2.63) 0.66 (0.06) 0.20 (0.08) 0.13 (0.04) 
PosIns FM 17.31 (2.65) 0.60 (0.07) 0.30 (0.07) 0.10 (0.04) 
 OA 16.59 (1.70) 0.58 (0.05) 0.29 (0.06) 0.13 (0.04) 
 HC 
 
19.69 (3.38) 0.61 (0.06) 0.27 (0.07) 0.12 (0.06) 
Thal FM 16.18 (2.74) 0.48 (0.03) 0.48 (0.03) 0.04 (0.06) 
 OA 15.24 (2.08) 0.49 (0.01) 0.49 (0.01) 0.03 (0.03) 
 HC 16.93 (2.19) 0.49 (0.01) 0.49 (0.01) 0.03 (0.02) 
 
ACC – anterior cingulate cortex, AntIns – anterior insula, PosIns – posterior insula, Thal – 
thalamus; FM – fibromyalgia subjects, OA – knee osteoarthritis subjects, HC – healthy 
controls; GM – grey matter, WM – white matter, CSF – cerebrospinal fluid 
 
Table 6. Signal to noise (S:N) ratio and tissue segmentation values 
 
I was able to derive good fits of the raw data as assessed by the Cramer-Rao Lower Bound 
(CRLB - an estimate of goodness of fit) from LC-Model. As shown in Table 7, CRLB for 
most metabolites was on average less than 10% (e.g. average CRLB for Glu was 7.7% in the 
ACC, 9% in the AntIns and PosIns, and 9.9% in the Thal, while Cr was < 3% in all regions), 
well below the cut-off of 20% as generally used in the literature (Choi & Frahm, 1999; Choi 
et al., 2006; Träber et al., 2004; Tsai et al., 2007; Walaszek et al., 2012; Zaaraoui et al., 2007). 
Gln, a small peak that is difficult to fit, was the only exception, with an average CRLB of 
22%. Rather than to exclude data, I decided to extend my cut-off for Gln to 30%, and 
maintain awareness that there may be more variability in these measures than in other 
metabolites. I will discuss the implications of my CRLB analysis and use of cut-offs below. 
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Brain 
regions 
Groups Gln %SD Glu %SD Ins %SD NAA %SD Cho %SD Cr %SD Glu+Gln  
ACC FM 21.94 
(6.25) 
7.47 
(1.18) 
6.12 
(0.86) 
3.35  
(0.70) 
3.00  
(0.00) 
2.06 
(0.24) 
7.18 
(1.02) 
 
 OA 21.41 
(4.56) 
8.06 
(1.52) 
6.18 
(0.95) 
3.41  
(0.80) 
2.88 
(0.33) 
2.06 
(0.24) 
7.53 
(1.42) 
 
 HC 23.38 
(8.19) 
 
7.88 
(1.54) 
6.44 
(0.96) 
3.81  
(0.98) 
3.25 
(0.58) 
2.12 
(0.34) 
7.63 
(1.41) 
AntIns FM 29.25 
(10.50) 
9.13 
(1.15) 
8.31 
(1.78) 
3.25  
(0.68) 
3.88 
(0.62) 
2.94 
(0.44) 
8.75 
(1.57) 
 
 OA 28.94 
(10.90) 
9.29 
(0.77) 
7.35 
(0.79) 
3.29  
(0.47) 
3.47 
(0.52) 
2.53 
(0.52) 
8.82 
(0.88) 
 
 HC 25.94 
(9.57) 
 
8.69 
(1.08) 
7.44 
(1.26) 
3.25  
(0.58) 
3.69 
(0.60) 
2.56 
(0.51) 
8.31 
(1.02) 
PosIns FM 25.25 
(4.20) 
9.25 
(1.18) 
8.38 
(1.67) 
3.19  
(0.40) 
4.13 
(0.34) 
2.81 
(0.40) 
8.75 
(1.00) 
 
 OA 28.53 
(8.60) 
9.53 
(1.01) 
7.94 
(1.30) 
3.06  
(0.24) 
4.00  
(0.50) 
2.47 
(0.52) 
9.06 
(1.09) 
 
 HC 27.00 
(14.82) 
 
8.19 
(1.38) 
7.38 
(1.15) 
2.56  
(0.51) 
3.63 
(0.50) 
2.31 
(0.48) 
7.88 
(1.26) 
Thal FM 33.12 
(13.79) 
9.35 
(1.66) 
9.94 
(2.38) 
3.88  
(0.99) 
3.35 
(0.49) 
2.71 
(0.47) 
8.88 
(1.22) 
 
 OA 35.77 
(15.77) 
10.71 
(1.57) 
10.18 
(1.94) 
4.06  
(1.14) 
3.53 
(0.62) 
2.71 
(0.59) 
10.35 
(1.73) 
 
 HC 28.07 
(8.00) 
9.80 
(0.94) 
9.73 
(1.62) 
3.47  
(0.74) 
3.33 
(0.49) 
2.47 
(0.52) 
9.07 
(0.96) 
 
ACC – anterior cingulate cortex, AntIns – anterior insula, PosIns – posterior insula, Thal 
– thalamus; FM – fibromyalgia subjects, OA – knee osteoarthritis subjects, HC – healthy 
controls; Gln – Glutamine, Glu – Glutamate, Ins – Inositol, NAA – N-acetyl aspartate, 
Cho – Choline, Cr – Creatine  
 
Table 7. Cramer-Rao Lower Bound (CRLB) percentages 
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Figure 2 shows typical MRS spectra from all regions demonstrating the signal to noise and 
line shape acquired. 
   
Neurometabolite levels across all brain regions are shown in Table 8, with significant results 
in bold, as discovered using one-way between-groups ANOVA. There were statistically 
significant differences at the p < .05 level in the AntIns for the three groups: in Cr level F (2, 
46) = 6.6, p < .01, η2 = .22 and in m-Ins level F (2, 46) = 4.34, p = .02, η2 = .16. Post-hoc 
comparisons using the Tukey HSD test indicated that the mean Cr level for OA group (M = 
10.18, SD = .94) was significantly higher than HC group (M = 8.92, SD = 1.03) with p < .01. 
Similarly, the mean m-Ins level was higher in OA group (M = 8.59, SD = 1.25) compared to 
HC group (M = 7.42, SD = 1.00) with p = .02. Furthermore, there was a trend towards 
significance (p = .07) at the level of Glu and Glx in the AntIns (FM > HC).  
 
There was a statistically significant difference in Thal in NAA level for the three groups: F (2, 
46) = 3.89, p = .03, η2 = .15. Post-hoc comparisons indicated that the mean NAA level for 
OA group (M = 10.37, SD = .60) was significantly lower than FM group (M = 10.94, SD 
= .75) with p = .03. No significant differences in any neurometabolite levels between the 
groups were found in ACC and PosIns.  
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 ACC  AntIns  PosIns  Thal 
  FM OA HC  FM OA HC  FM OA HC  FM OA HC 
NAA  10.11 9.29 9.65  11.00 11.00 10.68  10.41 9.93 10.44  10.94 10.37 10.84 
±SD  ±2.93 ±1.25 ±1.84  ±1.34 ±1.06 ±0.89  ±0.49 ±0.65 ±0.91  ±0.75 ±0.60 ±0.53 
Cho  2.39 2.37 2.43  2.15 2.23 1.98  1.74 1.84 1.79  2.15 2.13 2.19 
±SD  ±0.60 ±0.32 ±0.38  ±0.33 ±0.35 ±0.30  ±0.17 ±0.26 ±0.25  ±0.16 ±0.16 ±0.23 
Cr  10.33 10.60 10.36  9.36 10.18 8.92  9.00 9.48 9.25  8.76 9.01 8.85 
±SD  ±2.10 ±1.07 ±1.23  ±1.08 ±0.94 ±1.03  ±0.63 ±0.57 ±0.66  ±0.60 ±0.67 ±0.74 
m-Ins  9.40 8.88 8.57  7.82 8.59 7.42  6.81 7.27 6.78  5.72 5.86 5.85 
±SD  ±2.09 ±1.29 ±2.93  ±1.20 ±1.25 ±1.00  ±0.78 ±0.86 ±0.97  ±1.46 ±1.05 ±0.90 
Glu  14.22 13.23 13.93  13.74 12.45 11.61  11.46 10.99 11.14  12.11 10.94 10.95 
±SD  ±4.22 ±3.04 ±3.28  ±3.14 ±2.35 ±2.00  ±2.44 ±1.84 ±1.38  ±2.69 ±1.46 ±1.71 
Gln  2.86 3.11 3.12  3.10 2.79 2.84  3.01 2.57 2.47  3.09 3.07 3.01 
±SD  ±1.08 ±1.51 ±2.15  ±1.15 ±0.79 ±1.46  ±1.37 ±0.73 ±0.80  ±1.37 ±1.56 ±1.10 
Glx  17.08 16.34 17.05  16.84 15.24 14.45  14.47 13.56 13.61  15.30 14.10 14.05 
±SD  ±4.89 ±4.27 ±4.79  ±4.03 ±2.61 ±3.25  ±3.58 ±2.11 ±1.81  ±2.99 ±2.61 ±2.23 
 
Significant differences are shown in bold 
ACC – anterior cingulate cortex, AntIns – anterior insula, PosIns – posterior insula, Thal – thalamus, NAA – N-acetyl aspartate, Cho – Choline, 
Cr – Creatine, Glu – Glutamate, Gln – Glutamine, m-Ins – Myo-Inositol 
 
Table 8: Neurometabolite concentrations (Mm, relative to water) for each region in participants with fibromyalgia (FM), osteoarthritis (OA) 
and healthy controls (HC) 
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After adjusting for age with a one-way between-groups ANCOVA, there was no significant 
difference in the levels of Cr in AntIns between the groups, F (2, 45) = 1.77, p = .18, η2 = .07. 
Similarly, there was no significant difference in the levels of m-Ins in AntIns between the 
groups, F (2, 45) = 1.95, p = .15, η2 = .08, after controlling for age. There were no significant 
relationships between age and levels of Cr and levels of m-Ins in AntIns, while controlling 
for groups (η2 = .03 for Cr and .00 for m-Ins).  
 
However, there was still a significant difference in the levels of NAA in the Thal between the 
groups, F (2, 45) = 4.02, p = .03, η2 = .15, after controlling for age. There was no significant 
relationship between age and levels of NAA in the Thal, while controlling for groups (η2 
= .03).  
 
Also I ran an exploratory analysis (one-way between-groups ANOVA) of the tissue content 
(GM, WM, and CSF) in each region of interest and did not find a significant difference 
between the groups. 
 
Given the previously discussed consideration of NAA as a measure of neuronal viability, I 
analysed the observed levels of NAA data uncorrected for partial volumes together with the 
results from the tissue segmentation. This procedure was intended to determine whether 
lower levels of NAA correlated with a lower proportion of grey matter within the ROIs. No 
significant correlations were observed in ACC, AntIns or PosIns. A significant positive 
correlation was observed between the proportion of Thalamic grey matter and uncorrected 
NAA levels, Spearman’s rho = .19, p < .01.  
 
Finally, the relationships between the levels of neurometabolites and clinical measures were 
examined. Preliminary analyses were performed to ensure no violation of the assumptions of 
normality, linearity and homoscedasticity. Significant results for correlations between the 
levels of neurometabolites and PRS, DS, AS, and PD (r ranging from |0.49| to |0.75|) are 
presented in Table 9. FM showed negative correlations of Cr and m-Ins with DS and AS, 
NAA and Cho with PRS, and Glu and Glx with PD, while OA revealed positive correlations 
of Glu with PRS, and Gln and Glx with DS. It must be noted that comparisons between 
patients’ metabolite levels and 4 clinical measures were made. Applying a Bonferroni 
correction to these comparisons gives a p-value of .0125 for a significant difference. For the 
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FM patients the correlations between Cr levels in AntIns and both DS and AS achieved this 
level of significance. For FM, correlations between Cr in PosIns and DS, m-Ins in AntIns and 
DS, m-Ins in Ant Ins and AS, Cho in Thal and PRS and Glu in PosIns and PD approached the 
required level of significance. For OA patients the correlation between Gln in Thal and DS 
achieved this level of significance. Also for OA, Gln in PosIns and DS approached 
significance.
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Table 9: Significant results for correlations between levels of neurometabolites and pain rating scores 
(PRS), depression scores (DS), anxiety scores (AS), and pain duration (PD) 
 
My results demonstrated changes in OA patients (decreased NAA in Thal and increased Cr 
and m-Ins in AntIns), which were not observed in FM patients. Glu was found to correlate at 
a trend level with clinical measures associated with pain, but in differing ways between the 
two pain cohorts (with PD in FM, and with PRS in OA). After correcting for multiple 
Correlations Correlation 
Coefficient 
Significance 
Level 
Number of 
Cases 
Brain 
Region 
Pain 
Group 
Cr - DS - 0.62 p  = .01 17 AntIns FM 
 - 0.59 p = .017 17 PosIns FM 
 
Cr - AS - 0.75 p = .001 17 AntIns FM 
 
m-Ins - DS - 0.6 p = .014 17 AntIns FM 
 
m-Ins - AS - 0.61 p = .013 17 AntIns FM 
 
NAA - PRS - 0.53 p = .034 17 PosIns FM 
 
Cho - PRS - 0.59 p = .013 17 Thal FM 
 
Glu - PD - 0.6 p = .013 17 PosIns FM 
 
Glu – PRS   0.59 p = .013 
 
17 
 
PosIns 
 
OA 
Gln - DS   0.62 p = .008 17 ACC OA 
   0.57 p = .017 17 PosIns OA 
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comparisons, depression and anxiety scores were found to be negatively correlated with 
measures of Cr in FM. 
Discussion 
 
To my knowledge, this is the first MRS study of the effects of CLP (OA) on the brain in 
comparison with CWP (FM). My hypothesis of different central expression of chronic pain in 
CWP and CLP has been supported by my results, which indicate that these conditions have 
different neurochemical profiles in particular with regard to the relationship between clinical 
questionnaire measures and neurochemical levels. This is similar to a previous report, which 
studied trigeminal neuropathic pain (TNP) and temporomandibular disorder (TMD) (Gustin 
et al., 2011). Differences in some neurometabolite levels were seen in the raw data; however, 
only the NAA decrease within the Thal in OA group was found to be statistically significant 
after correcting for age. This finding is similar to what was reported in hip OA (Shigemura et 
al., 2012), and supports my hypothesis of reduced NAA in CLP although only in a single 
region. 
 
I did find the hypothesised elevation in Glu in CWP, however this was only at the trend level 
and must therefore discussion of this finding must be treated as speculative, pending further 
research. Further to this, an examination of the relationships between neurochemical profiles 
and clinical measures showed marked differences between the two patient groups. In 
particular, Glu levels were found to correlate at marginal significance with pain intensity in 
the PosIns in OA participants, but with duration of pain in FM. In addition, Cr showed a 
negative relationship with depression in FM (in both AntIns and PosIns), while in OA 
depression was found to correlate positively with Gln measures (in ACC and at a trend level 
in PosIns). These differing neurochemical profiles and relationships suggest that the neural 
mechanisms in FM are different from those found in OA. I will examine each of these 
findings individually. 
 
The first substantive finding that I report is the reduction of NAA in the Thal in OA. NAA is 
a marker of neuronal density and viability (Simmons et al., 1991), however, dynamic changes 
of NAA concentrations suggest that NAA levels may reflect neuronal dysfunction rather than 
loss (Govindaraju et al., 2000). Recovery of NAA levels has been detected in brain injury 
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(De Stefano, Matthews, & Arnold, 1995), reversible ischemia (Brulatout et al., 1996), 
multiple sclerosis (MS), AIDS, and temporal lobe epilepsy (Barker & Lin, 2006). Reduced 
NAA levels have also been observed with many neurodegenerative diseases such as 
leukodystrophies, hypoxic encephalopathy (Rosen & Lenkinski, 2007), and multiple sclerosis 
(Rosen & Lenkinski, 2007; Tsai & Coyle, 1995). My finding of NAA reduction in OA 
compared to HC suggests that long-term chronic pain from OA may lead to degeneration or 
dysfunction of central nervous system tissue. It would be informative to examine if NAA 
levels recover after knee surgery in OA patients. 
 
There are some similarities between this finding and previous MRS research in pain. A 
reduction of NAA has been found in patients with chronic back pain (CBP), although in 
different brain regions than in OA, specifically the dorsolateral prefrontal cortex (DLPFC) 
(Grachev et al., 2000), the AntIns, and the ACC (Gussew et al., 2011). Chronic regional pain 
syndrome (CRPS) has also shown reduced levels of NAA in bilateral DLPFC when 
compared with HC (Grachev et al., 2002). Taken together with my results in OA participants, 
it seems that NAA reduction is a common finding in CLP, although the location of these 
changes may differ, providing further support for the heterogeneity of neural involvement in 
different chronic pain conditions.  
 
Interestingly, there was also a positive correlation between uncorrected NAA levels and GM 
content in the Thalamus, but no other regions. Given that NAA is often reported to be at a 
higher level of concentration in GM compared to WM (Wang & Li, 1998), this is perhaps not 
entirely surprising.  However, given that GM levels did not vary between the three groups in 
the Thal, it is unlikely this relationship impacted on our findings of reduced NAA in the Thal 
in OA. 
 
In contrast to my finding of reduced NAA in the Thal in OA, Cr and m-Ins were found to be 
elevated in the AntIns in this patient group, although this finding did not survive correction 
for age This is not surprising given previous reports of increases in Cr and m-Ins with age 
(Chang et al., 1996; Christiansen et al., 1993; Haga et al., 2009; Saunders et al., 1999) and the 
fact that my OA group was older than two other groups. This suggests that the increase I 
observed in these two metabolites in this cohort may be related to the effects of aging rather 
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than disease. The effects of the difference in mean age of the participant groups will be 
considered in the limitations below. 
 
Providing a degree of support for my initial hypothesis, I did find a trend towards 
significance in Glu levels between the groups (FM > HC) using a one-way between-groups 
ANOVA. In post hoc analysis I found a Glu elevation in FM (M = 13.74, SD = 3.14) 
compared with HC (M = 11.61, SD = 2.00) using an independent-samples t-test: t (25.42) = 
2.29, p = .03 (two-tailed). This result is in line with previous research in FM (Fayed et al., 
2010; Harris et al., 2009; Valdés et al., 2010). In addition, I did find the differing 
relationships between Glu levels and clinical measures within PosIns in my two chronic pain 
cohorts. In contrast to AntIns, which is considered to play a role in the managing saliency of 
external stimuli and the direction of attention (Menon & Uddin, 2010), PosIns is considered 
to play a role in somatosensory representation and modulating response to painful stimuli 
(Sawamoto et al., 2000; Segerdahl, Mezue, Okell, Farrar, & Tracey, 2015). An alteration in 
levels of the excitatory neurotransmitter Glu may indicate increased activity within PosIns in 
response to pain. In my results Glu within PosIns was found to negatively correlate with 
duration of pain in FM, whereas in OA it was pain intensity that showed a strong positive 
relationship with Glu levels. This suggests that Glu levels in PosIns are higher at the onset of 
FM, and decrease in later stages of the condition; while in OA higher Glu levels in PosIns are 
linked to higher levels of reported pain on the day. 
 
Early reports of correlations between measures of Glu metabolites in cerebral spinal fluid and 
FM patients' pain ratings (Larson, Giovengo, Russell, & Michalek, 2000; Sarchielli, Di 
Filippo, Nardi, & Calabresi, 2007) support this suggestion. More recent evidence comes from 
reports of correlations between Glu in PosIns and evoked pain ratings in FM patients (Harris 
et al., 2009), and increased Glu in PosIns in FM patients compared to HC (Fayed et al., 2010). 
It would be beneficial for future studies to examine the correlation between neurometabolites 
and pain intensity in longitudinal studies to determine if levels of reported pain fluctuate with 
levels of neurometabolites.  
  
Within my study, differing relationships were observed between neurometabolite levels and 
clinical measures in FM and OA. As seen in Table 9 these differences are varied across 
metabolites and regions. The different relationships that exist between neurometabolite levels 
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and clinical measures within OA and within FM are an indication that different mechanisms 
are at work in these two conditions. 
 
It is informative to consider my results regarding relationships between neurochemicals and 
clinical measures in the light of previous, similar studies. A negative correlation between 
NAA and pain intensity was demonstrated recently, but in a different region – the thalamus – 
in patients with chronic neuropathic pain compared to patients without pain after spinal cord 
injury (Pattany et al., 2002). In contrast, another study showed a positive correlation between 
Cho/Cr and clinical pain in DLPFC in FM (Petrou et al., 2008), whereas my finding was a 
negative correlation between Cho and PRS in the Thal of FM participants. However, given a 
relationship between Cr and anxiety and depression scores, use of ratios to Cr as a 
concentration reference for neurometabolites is potentially problematic, as it can be difficult 
to determine whether the numerator or the denominator is changing. This issue was addressed 
in my study through the use of water as a reference in the calculation of neurometabolite 
concentrations. 
 
Similarly to my findings, other researchers have found that Cr was negatively correlated with 
depression, but in a different region (left thalamus in FM) (Valdés et al., 2010). However, 
they also report a positive relationship between Cho and duration of disease in right 
amygdala and right thalamus in FM patients, while I observed a negative correlation of 
duration of pain with another neurometabolite - Glu in a different region - PosIns. 
Unfortunately, differences in MRS acquisition strategies and field strength make it difficult to 
directly compare results, though further studies may be able to explain the physiological 
significance of these effects. 
 
Previous research (Harris et al., 2009) has demonstrated that FM patients have a negative 
correlation between elevated Glu and Glx levels and lower pain threshold within the PosIns, 
while in my research Glu was negatively correlated with duration of pain. It would therefore 
be interesting to examine how pain thresholds change over time in FM patients, as based on 
these two findings: one might expect lower pain thresholds at first presentation, with a 
gradual increase in these thresholds over time. Longitudinal studies investigating all factors, 
including pain thresholds, duration of pain, pain intensity, and Glu levels would be 
instructive in elucidating the nature of this relationship. 
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 Similarly, while others showed positive correlations between Glu/Cr in the left thalamus and 
pain intensity (VAS) and m-Ins/Cr in the right VLPFC and pain intensity in FM patients 
(Feraco et al., 2011), I showed that elevated Glu was related with higher pain level in PosIns 
in OA. This may reflect a basic role for Glu in pain response, a suggestion that is in 
agreement with acute pain studies that have shown an increase in Glu with painful stimulus 
administration (Gussew et al., 2009; Mullins et al., 2005). 
 
Limitations 
I am aware of some limitations within this study: participants were asked to refrain from 
using analgesic medication on the day of scanning whereas the washout period for some 
drugs is much longer. However, I felt that it would not be ethical to ask participants with 
chronic pain to refrain from taking analgesic drugs for a longer period.  
 
Age matching for the three groups presented a difficulty due to patients with OA typically 
being older. In order to obtain sufficiently sized participant groups it proved necessary to 
tolerate a mean age in the OA group that was significantly higher to the FM and HC groups. 
There was no significant difference in mean age between the FM and HC groups. 
Future studies should attempt to recruit older FM participants and ensure a closer match 
between the ages of patient groups and controls. To consider the potential effects of age 
differences within this study the literature was consulted to examine previous observations. 
The literature does not provide a definitive statement of the effects of aging on levels of brain 
metabolites. A systematic review (Haga et al., 2009) was consulted with several of the more 
relevant studies being examined in detail (Chang et al., 1996;  Maudsley et al., 2009; 
Saunders et al., 1999). Haga et al. reported that most studies had observed no significant 
change in levels of NAA, Cr, Cho and m-Ins with aging. A meta-analysis, conducted by Haga 
et al., of a subset (4) of the studies considered found a NAA decrease with age of borderline 
significance and significant increases of Cr and Cho with age. Haga et al. noted the difficulty 
of achieving a synthesis of the results of previous studies given the diversity of MRS and data 
analysis methods employed. It is instructive to note that the difference in mean ages between 
the (aggregated) groups for comparison in Haga et al.’s study was far larger than in my study. 
The overall groups used in Haga et al. had a mean age difference of 56.1 years, compared to a 
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maximum difference of 17.1 years in my study. Looking in detail at several studies showed 
that where changes in metabolites had been detected the changes were modest in size and not 
uniform across the brain. The overall consensus is that there may be a small decrease in levels 
of NAA and an increase in Cho, Cr, but this cannot be taken as a robust observation. In 
regard to my study this suggests that the ANOVA results are most likely unaffected by the 
difference in age between participant groups. However, a degree of caution is warranted 
given the literature’s suggestion of a possible increase in Cr with age and that the significance 
of the finding of increased Cr (between OA and HC) did not survive age-controlled analysis. 
Given the literature’s equivocal findings about the effects of age on NAA and that the 
significance of my observation of increased Thalamic NAA (between FM and OA), this 
observation can be considered robust. Further studies of the effects of aging on levels of brain 
metabolites are required, ideally with similar methods, to give a clear statement of the 
requirement to control for age differences between groups. Wherever possible, however, age 
matching of groups should be ensured to remove uncertainty in interpreting a study’s findings. 
 
As noted, I was unable to recruit sufficient numbers of participants to achieve the desired 
level of power within the study. An impairment to a study’s power level raises the possibility 
of type 2 errors occurring. This may have been a salient factor in this study as several 
correlation analyses were observed to be at the trend level of significance when corrected for 
multiple comparisons. Further studies that achieve a greater level of power may be able to 
offer confirmation of the validity of the correlations between metabolite levels and clinical 
measures presented above. 
 
I was also rather limited in exclusive female participation in this study, which precludes the 
investigation of possible gender effects. However, as FM patients are primarily female 
(Neumann & Buskila, 2003; Wolfe et al., 1995; Yunus, Masi, Calabro, Miller, & Feigenbaum, 
1981), it was decided to only recruit female participants for the other two groups, avoiding 
any potential gender bias effects. Future studies investigating both male and female 
participants may therefore be of use. 
Building on my results, I intend to investigate if a decrease of NAA in the Thal in OA is 
correlated with a decrease of grey matter volume in the same region and the same group since 
previous VBM studies have been equivocal on that matter (Baliki, Schnitzer, et al., 2011; 
Gwilym et al., 2010). Further to this, I intend to examine if decreased NAA levels in Thal of 
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OA patients recover after knee surgery as may be suggested from the post-operative recovery 
of grey matter volume as observed using VBM (Gwilym et al., 2010; Rodriguez-Raecke et al., 
2009). If this the case, it will suggest that low NAA level reflects dysfunction of the nervous 
system rather than degeneration, which might explain why drugs like NSAIDs and simple 
analgesics, and joint surgery work in OA. Additional investigation of the differences in the 
neural expression of chronic pain may also be of interest, in particular, studies comparing 
CWP and CLP to investigate differences in functional connectivity using fMRI. 
 
A potential methodological limitation was my use of the Cramer-Rao Lower Bound (CRLB) 
as a technique for setting a cut-off above which spectra would be excluded from analysis. As 
noted, CRLB is a technique, which gives an indication of the goodness of fit between a 
spectrum and a subsequently fitted model. The CRLB is the minimum possible level of error 
resulting from the fitting process, but should not be taken to indicate the level of error within 
the measured data itself (Kreis, 2016). CRLBs expressed as a percentage of the estimated 
value of error are generated by LC-Model and have been used in a large number of studies to 
establish a threshold above which spectra would be excluded from analysis (Choi & Frahm, 
1999; Choi et al., 2006; Träber et al., 2004; Tsai et al., 2007; Walaszek et al., 2012; Zaaraoui 
et al., 2007). As noted by Kreis, using CRLBs in this manner can distort MRS data since 
exclusion may apply unequally to groups of participants therefore creating a biased set of 
data for subsequent analysis. Caution must therefore be applied with the application of 
thresholds to ensure that the exclusion of data does not lead to erroneous conclusions. The 
CRLBs of all metabolites within my study, with the exception of Glutamine, were less than 
10%. Analysis of the standard deviations revealed that mean percentages were at least 5 
standard deviations from the cut-off of 20%. An inspection of these data revealed that no 
spectra were excluded from the analysis as a result of the 20% cut-off. The CRLB associated 
with Glutamine was 22% and therefore I decided to extend the cutoff to 30% rather than 
exclude more data than was necessary. An inspection of the data revealed that approximately 
one quarter of the spectra were excluded from analysis and therefore any findings related to 
Gln in this study must be treated with caution.  
 
In conclusion, I have demonstrated differences in the neurochemistry and relationships with 
clinical measures between two different types of chronic pain conditions, CWP and CLP. OA 
participants, my model for CLP, exhibited changes usually associated with degeneration 
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(decreased NAA in the Thal) and ageing (increased Cr and m-Ins in the AntIns), while FM, 
my CWP model, did not. In addition, Glu was found to correlate with clinical measures 
associated with pain, but in differing ways between the two pain cohorts, supporting again 
the existence of differing mechanisms between CLP and CWP. Furthermore, depression and 
anxiety were found to be negatively associated with measures of Cr and m-Ins in FM, 
suggesting that the use of Cr as a reference in studies of chronic pain may be problematic. 
Future MRS investigations of other chronic pain conditions would therefore benefit from 
using absolute measures of neurometabolites. 
 
Overall, the main difference between CLP and CWP was that in OA there were changes in 
neurometabolite levels, associated with anatomy and brain function, whereas in FM there 
were mainly changes in the relationships between neurometabolite levels and clinical 
measures (depression, anxiety, pain intensity), associated with mood and behavioural 
functional abilities. This might explain why OA patients give better response to physically 
targeted therapies (pain killers, anti-inflammatories, surgery, physiotherapy), whereas FM 
patients have a better response to behavioural therapies (CBT, meditation, hypnosis, yoga) 
and drugs working centrally such as amitriptyline, pregabalin, and duloxetine. Future MRS 
investigations of other chronic pain conditions would enable further elucidation of the true 
relationship between neurometabolites and clinical measures of pain, thus allowing better 
understanding of pain mechanisms in CLP and CWP. Gaining an understanding of the nature 
of chronic pain at all its levels is essential in developing novel therapies and the achievement 
of efficient pain management. 
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CHAPTER 3 - Functional connectivity in chronic pain 
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Introduction 
As previously mentioned, pain is “an unpleasant sensory or emotional experience associated 
with actual or potential tissue damage” and is classified as acute or chronic based on its 
duration (Merskey & Bogduk, 1994). Malinen et al. noted that acute pain has an important 
role in protecting the body, which is lost when pain becomes chronic. Further to this, chronic 
pain decreases quality of life and interferes with cognitive, affective, and physical function 
(Malinen et al., 2010). Chronic pain is classified as localised or widespread according to the 
extent of affected areas (Kamaleri, Natvig, Ihlebaek, & Bruusgaard, 2008). Fibromyalgia 
(FM) is an example of chronic widespread pain (CWP) and knee osteoarthritis (OA) is an 
example of chronic localised pain (CLP) (Chapter 2). OA is a common condition in the 
elderly, whereas FM can affect younger adults (Neumann & Buskila, 2003; Zhang & Jordan, 
2008). Both diseases have a financial impact on society through public spending on treatment 
and/or time lost from work (Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006). 
FM and OA are two common causes of chronic musculoskeletal pain with contrasting bodily 
representations. FM is characterised by widespread pain, poor sleep and fatigue with no 
obvious peripheral pathological cause. OA is a degenerative joint disease with obvious 
cartilage breakdown and bony deformity leading to dysfunction and pain in the affected area 
(Altman et al., 1986).  
 
Chronic pain has previously been associated with changes in brain activity: FM, chronic low 
back pain (CLBP), neuropathic pain, temporomandibular disorder (TMD), OA and other 
chronic pain conditions have all been investigated using fMRI (task-based and resting-state) 
(Baliki, Baria, & Apkarian, 2011; Baliki et al., 2012; Baliki, Geha, Apkarian, & Chialvo, 
2008; Cauda et al., 2010; Franco Cauda, Sacco, D’Agata, et al., 2009; Franco Cauda, Sacco, 
Duca, et al., 2009; Cifre et al., 2012; Geha et al., 2007; Gracely, Petzke, Wolf, & Clauw, 
2002; Ichesco et al., 2012; Jensen et al., 2013; Malinen et al., 2010; Napadow et al., 2010; 
Napadow, Kim, Clauw, & Harris, 2012; Parks et al., 2011). Whilst Giesecke et al. compared 
CLBP and FM brain responses using painful stimuli (Giesecke et al., 2004), there has not yet 
been a study that contrasts the effects of chronic localised and widespread pain  using resting-
state fMRI. Indeed, López-Solà et al., who used fMRI to assess brain response to auditory, 
visual and tactile-motor stimulation in FM patients, acknowledged the absence of a direct 
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comparison between the neural effects of two different chronic pain conditions as being a 
limitation of their study (López-Solà et al., 2014). 
 
One aspect of the effects of chronic pain on the central nervous system is altered functional 
connectivity (FC) within and between regions comprising identified brain networks (Baliki, 
Mansour, Baria, & Apkarian, 2014; Cauda et al., 2010; Cifre et al., 2012; Ichesco et al., 2012; 
Napadow et al., 2012). FC is a measure of the level of correlation of activity within two or 
more brain regions: strong positive correlations in fluctuations in the neural activity of brain 
regions are taken to represent a high level of FC (Fox et al., 2005). FC is assessed using 
resting-state fMRI, which measures the fluctuations in BOLD signal, taken to reflect changes 
in neural and metabolic activity, in a resting participant over a short period of time (Napadow 
et al., 2010). Studies of the effects of chronic pain on FC between brain regions have shown 
altered connectivity between elements of the default mode network (DMN) and areas 
associated with the processing of painful stimuli, such as the insula (Cifre et al., 2012; 
Ichesco et al., 2012; Napadow et al., 2012). Other studies have demonstrated altered FC 
within the DMN and between the DMN and attentional networks (Baliki, Mansour, Baria, & 
Apkarian, 2014; Cauda et al., 2010). I shall examine the nature of the DMN and attentional 
networks below, but given the attentional and cognitive disruption reported by chronic pain 
patients (Cifre et al., 2012) and the complementary nature of attentional and default mode 
networks it is reasonable to examine FC within and between these networks in the context of 
chronic pain conditions with differing aetiologies to gain a better understanding of their 
effects.   
 
The DMN (Greicius, Krasnow, Reiss, & Menon, 2003) comprises brain regions believed to 
be involved in self-referential thinking and includes brain areas such as the inferior parietal 
lobule, the posterior cingulate cortex (PCC) and precuneus (PC), the medial frontal gyri, the 
hippocampal formation, and lateral temporal cortex (Greicius, Krasnow, Reiss, & Menon, 
2003; Napadow et al., 2010). The PCC and PC are considered to constitute the “core hub” of 
the DMN and exercise influence on activity in the other regions of the network (Fransson & 
Marrelec, 2008; Utevsky, Smith, & Huettel, 2014). The DMN is more active at rest and 
“deactivated” during externally directed tasks (Napadow et al., 2010; Uddin, Kelly, Biswal, 
Castellanos, & Milham, 2009). This reduction in DMN activity during task-based fMRI is 
more pronounced in participants with chronic pain when compared to healthy controls (Baliki, 
75 
 
Geha, Apkarian, et al., 2008). Previous examinations of the effects of chronic pain on resting 
state FC in the DMN have found increased FC within the DMN (Baliki et al., 2014); 
increased FC between the DMN and areas associated with pain (Tagliazucchi, Balenzuela, 
Fraiman, & Chialvo, 2010); and it has been suggested (Loggia et al., 2013) that increased FC 
within the DMN encodes the intensity of pain experienced by chronic pain patients. Given 
these observations it is plausible to expect that a higher level of DMN FC would be expected 
in chronic pain patients when compared to healthy controls. 
 
The EAN (Posner & Dehaene, 1994), in contrast, consists of brain regions involved in 
cognitive processing of working memory and attention and includes the frontal and parietal 
lobe regions, specifically the dorsolateral prefrontal cortex (DLPC) and posterior parietal 
regions overlapping the superior parietal lobule (SPL) and intraparietal sulcus (Fan, 
McCandliss, Fossella, Flombaum, & Posner, 2005; Napadow et al., 2010). Of these areas, it 
has been suggested that the SPL plays a critical role in the transfer of attention between 
sources, the recruitment of other network regions and the establishment of attention 
(Behrmann, Geng, & Shomstein, 2004; Wolpert, Goodbody, & Husain, 1998). Behrmann et 
al. made the observation that whilst the SPL is pivotal in the establishment or alteration of 
attention it is not the primary EAN component required for maintenance of task-specific 
attention. Given that this study examined activity in the resting brain and considered 
‘spontaneous’ activity in brain networks, the SPL is an appropriate candidate for 
investigation since it is reasonable to expect activation in this area during a spontaneous shift 
of activity from the DMN to the EAN. The SPL’s role in establishing attention suggests that a 
strong anticorrelation of activity between the core hub of the DMN and the SPL would be 
expected in normal brain operation.  
 
The objective of this study was to investigate the degree of connectivity within and between 
three brain networks – the DMN, the left EAN (EANL) and the right EAN (EANR) – using 
resting-state fMRI in patients with chronic pain, comparing between FM, OA and healthy 
controls (HC). In addition, given previously noted differences in the experience of pain 
suffered by FM and OA patients (for example, Marques, Rhoden, de Oliveira Siqueira, & 
Joao, 2001)I compared how activity across these networks correlates with clinical measures 
taken from the McGill questionnaire (Melzack, 1975).  
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My hypotheses for this study were as follows: 
 
1. Since differences between CWP and CLP have been found in clinical measures and 
neurochemical profiles (Chapter 2), I hypothesized that there may be differences in 
the connectivity of the components of the DMN and EAN between the two chronic 
pain conditions. Given that the normal DMN response is usually disrupted during a 
state of chronic pain and cognitive deficits specific to working memory and attention 
are common in patients with chronic pain (Glass, 2009), I hypothesized that intrinsic 
connectivity between critical regions of DMN (PCC) and EAN (SPL) and the other 
regions within the networks would be altered in patients with CWP and CLP 
compared to HC.  
 
2. Given the previously observed effects on chronic pain conditions on the direction of 
attention and that this process entails interaction between core regions of the DMN 
and EANs, I was motivated to investigate FC between the EAN and DMN seed 
regions and components of the other network. I hypothesized that increased FC 
between the SPL and components of the DMN would be observed in CWP and CLP 
compared to HC. I similarly hypothesized that increased FC would be observed 
between the PC and regions of the EAN in CWP and CLP compared to HC. 
 
3. I hypothesized that these alterations in the FC observed in pain patients would be 
associated with altered clinical measures. Specifically, I hypothesised that there 
would be a correlation between clinical measures of patients’ pain and between-
network FC, and that observed correlations would differ between pain conditions. 
 
Methods and participants 
Participants 
All participants were females aged 31-65. FC data was collected from 9 participants with FM 
(mean +/- SD age 47 +/- 7.87 years), 14 participants with OA of the knee (mean +/- SD age 
62.07 +/- 3.12 years), and 12 HC (mean +/- SD age 44.5 +/- 11.04 years) for this study.  
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FM participants were classified using the American College of Rheumatology criteria (Wolfe 
et al., 1990) for the classification of FM, such that each subject fulfilled the following 
criteria: 1) widespread pain in all four quadrants of the body for at least 3 months; 
2) tenderness or pain to touch in at least 11 out of 18 specific anatomical sites described as 
tender points. FM participants were recruited from a district general hospital fibromyalgia 
clinic in North Wales. FM participants were excluded if they had knee OA. Participants with 
knee OA were recruited from the pre-operative arthroplasty clinic at Ysbyty Gwynedd, 
Bangor. Participants with rheumatoid arthritis and OA of other joints were excluded, as was 
anyone who also had a diagnosis of co-morbid FM. HC participants without chronic pain 
were recruited using the Bangor University’s School of Psychology’s community participant 
panel and local advertisements. All participants were asked to refrain from using analgesic 
medication on the day of the scan until after scanning was completed. Normal 
contraindications for MRI were also used as exclusion criteria (e.g. pacemakers, metal 
implants, claustrophobia). 
 
This study was approved by the Ethics Committee from the School of Psychology, Bangor 
University and North West Wales Research Ethics Committee (reference 10/WNo01/16). 
Research activities took place in Bangor Imaging Centre, Bangor University. All participants 
provided informed consent. 
Methods 
Functional connectivity (FC) was examined using the seed-based correlation method (Fox et 
al., 2005) within and between three brain networks: the default mode network (DMN), the 
executive attention network left (EANL), and the executive attention network right (EANR). 
Seeds (12 mm diameter spheres, as per Fox et al.within core regions of the networks of 
interest were selected in the posterior cingulate cortex for the DMN (ROI1), the left superior 
parietal lobule for EANL (ROI2), and the right superior parietal lobule for EANR (ROI3) 
(see Table 10).  
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Network (ROI) Seed region X      Y      Z 
DMN (ROI1) Posterior cingulate cortex 0      -48    30 
EANL (ROI2) 
 
Superior parietal lobule 
left 
-36   -62    50 
EANR (ROI3) Superior parietal lobule 
right 
36     -62   50 
 
ROI – Region of Interest 
DMN  – Default Mode Network 
EANL  – Executive Attention Network Left 
EANR  – Executive Attention Network Right 
 
Table 10: MNI coordinates for seed regions 
 
To enable analysis of the FC between the selected seed regions and the networks of interest, 
masks of the DMN, EANL and EANR were created. This was accomplished using WFU 
Pickatlas to combine templates of brain regions within the networks (Maldjian, Laurienti, 
Kraft, & Burdette, 2003). 
 
Functional Magnetic Resonance Imaging 
Resting state fMRI images were acquired using a single-shot echo-planar pulse sequence on a 
3 Tesla Phillips Achieva MRI system (Philips Health Care, Eindhoven, Netherlands). Each 
three-dimensional volume comprised 35 contiguous axial slices in an ascending order 
(TR/TE = 2000/30ms, flip angle 65 degrees, voxel size 3x3x3mm). During the 6-minute 
(~360 second) resting state fMRI acquisition period (175 scans), the subjects were asked to 
remain still with their eyes open. An anatomical, T1-weighted gradient echo data set (TR 
17ms, TE 6.5ms and 12.2ms, voxel size 0.7x0.7x0.7mm) was also acquired for each subject 
to assist with registration to standard stereotactic space. During the resting state data 
collection, 175 volumes were acquired. No volumes were discarded before analysis, as the 
Philips scanner automatically excluded T1 magnetisation equilibrium volumes. 
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Image Analysis 
Pre-processing of the data was carried out using Data Processing Assistant for Resting-State 
fMRI (DPARSF) (Yan and Zang, 2010) which is based on Statistical Parametric Mapping 
(SPM8) (http://www.fil.ion.ucl.ac.uk/spm) and Resting-State fMRI Data Analysis Toolkit 
(REST, (Song et al., 2011)). Data were slice timing corrected and realigned to the first 
volume. The anatomical image was coregistered to the mean functional image and then 
segmented using the ‘New Segment’ method into grey matter, white matter and cerebrospinal 
fluid (CSF). Functional data were then normalised to standard space and smoothed with a 9 
mm Gaussian kernel using DARTEL (Ashburner, 2007). A group-specific template for the 
entire data set was created for this purpose. 
Analysis of resting state FC 
For each of the defined seed regions the procedure described below was performed. The 
resting state time series of the seed region was correlated with resting state activity in each of 
the networks (DMN, EANL, EANR), for each group of participants (FM, OA, HC). Three 
one-way ANOVAs were performed to examine relative differences in FC between the seed 
region and each network between groups of participants. Thus, as an example, the first 
ANOVA examined differences in FC between the DMN seed region (the PCC) and the rest 
of the DMN across participant groups (i.e. an examination of FC differences within the 
DMN between participant groups); the second ANOVA examined differences in FC between 
the PCC and the EANL across participant groups (i.e. an examination of FC differences 
between the DMN seed and the EANL between participant groups); and the third ANOVA 
examined differences in FC between the PCC and the EANR across the participant groups 
(between the DMN seed and EANR between participant groups). The following planned 
comparisons were used within the ANOVAs: FM>HC, FM>OA, OA>HC, OA>FM, HC>FM, 
and HC>OA. Thresholds for significance were set at p < .05 and included an extent threshold 
of 100 voxels, which means that all clusters are significant at the family-wise corrected level. 
Regions showing significant differences in FC with the seed region between participant 
groups were labelled using the Automatic Anatomic Labelling toolbox (AAL) (Tzourio-
Mazoyer et al., 2002).  
FC between the seed regions of all pairs of networks (DMN-EANL, DMN-EANR, EANL-
EANR) was assessed using DPARSF to examine correlation between the activity of each 
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network’s seed region. The seed regions were taken to be representative of overall activity 
within the networks of interest, as discussed earlier. These levels of between-network FC 
were generated to enable correlations to be made between the patient groups’ clinical 
measures and the level of FC between the networks of interest. 
Analysis of correlations of FC with pain measures  
The McGill Pain Questionnaire was designed to provide quantitative measures of clinical 
pain. It consists of three classes of word descriptors, such as sensory, affective and evaluative, 
which are used by subjects to describe subjective pain experience. There are three major 
measures: the pain-rating index (PRI) – sum and rank, the number of words chosen (NWC), 
and the present pain intensity (PPI) (Melzack, 1975). In the present study PRI and NWC 
measures were collected. The measures were then compared between the patients groups (FM 
and OA) using an independent-samples t-test. 
 
The relationships between the McGill Pain Questionnaire’s measures and resting state FC 
between networks, as represented by the level of FC observed between each network’s seed 
voxel was performed. The relationships between these variables were investigated using 
Spearman’s Rank Order Correlation (rho) coefficient as the variables were related in non-
linear fashion.  
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Results 
I observed that functional connectivity (FC) between the DMN seed region (in the PCC) and 
the rest of the DMN during resting state was higher within areas of the DMN in both chronic 
pain conditions compared to HC (see Table 11). FC between the PCC and the left middle 
temporal gyrus was higher in FM when compared to OA (see Figure 4), and higher between 
the PCC and both middle temporal gyri in FM when compared to HC. FC between the PCC 
and the precuneus (left and right) was higher in OA when compared to HC. No areas of 
significantly different FC between the PCC and areas of the EANs were observed between 
participant groups. 
 
FC was lower between the EANL seed region (in the left SPL) and areas of the EANs in both 
pain conditions compared to HC (see Table 12). FC between the left SPL and the inferior and 
middle frontal gyri was lower in both pain conditions in comparison with HC (see Figures 5 
and 6). FC was lower in OA compared to HC between the EANR seed region (in the right 
SPL) and the left inferior and middle frontal gyri (see Table 13).  
 
FC between the EANL seed region (in the left SPL) and areas of the DMN was higher in both 
pain conditions compared to HC (see Table 12). FC between the left SPL and the precuneus 
(left and right) was higher in FM compared to HC. FC between the left SPL and right middle 
temporal gyrus was higher in OA compared to HC. I observed areas of higher FC between 
the EANR seed region (in the right SPL) and the precuneus (left and right) in the DMN in 
FM compared to HC (see Table 13). 
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rs-FC – resting-state functional connectivity 
FM – fibromyalgia 
OA – knee osteoarthritis 
DMN – default mode network 
 
Figure 4: Areas of significantly higher resting-state functional connectivity in fibromyalgia 
compared to knee osteoarthritis within the default mode network 
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Figure 5: Areas of significantly lower resting-state functional connectivity in fibromyalgia 
compared to healthy controls within the executive attention network left 
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Figure 6: Areas of significantly lower resting-state functional connectivity in knee 
osteoarthritis compared to healthy controls within the executive attention network left 
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Name of Brain Region PFWE -
corrected 
(Cluster 
Level) 
% Cluster Cluster 
Size  
(N of 
voxels) 
Z Score 
(Peak 
Value) 
MNI 
Coordinates 
X, Y, Z mm 
Contrast FM>OA, Masked by DMN  
MTGL 0.018 97.47 158 4.65 -51 -21 -9 
Contrast FM>HC, Masked by DMN  
MTGR 
MTGL 
0.011 
0.010 
94.71 
95.95 
170 
173 
3.85 
3.72 
 57  -9  -12 
-51 -21 -9 
Contrast OA>HC, Masked by DMN  
PR 
PL 
0.012 59.52 
37.50 
168 3.35 
3.21 
0 -54 54 
9 -39 51 
 
MTGL - Middle Temporal Gyrus Left 
MTGR - Middle Temporal Gyrus Right 
PR - Precuneus Right 
PL - Precuneus Left 
 
Table 11: Significant Results of Group Analysis with ROI1 – DMN 
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Name of Brain Region PFWE -
corrected 
(Cluster 
Level) 
% Cluster Cluster 
Size  
(N of 
voxels) 
Z Score 
(Peak 
Value) 
MNI 
Coordinates 
X, Y, Z mm 
Contrast FM>HC, Masked by DMN  
PL 
PR 
0.013 55.56 
39.87 
153 3.55 
3.29 
-6 -51 51 
 9 -39 51 
Contrast OA>HC, Masked by DMN  
MTGR 0.003 96.20 184 4.01 51 -42 9 
Contrast FM<HC, Masked by EANL 
IFGL, PT 
MFGL 
IFGL, PO 
0.000 30.96 
28.89 
12.38 
533 4.23 
4.16 
3.70 
-51 27 27 
-45 15 27 
-51 39 -9 
Contrast OA<HC, Masked by EANL 
IFGL, PT 
MFGL 
0.001 
 
63.94 
26.44 
208 
 
4.63 
4.16 
-51 21 27 
-51 36 15 
Contrast FM<HC, Masked by EANR 
MFGR 
IFGR, PT 
0.016 
 
54.36 
39.60 
149 
 
3.83 
3.23 
51 36 18 
51 33 30 
 
PL - Precuneus Left 
PR - Precuneus Right 
MTGR - Middle Temporal Gyrus Right 
IFGL, PT - Inferior Frontal Gyrus Left, Pars Triangularis 
MFGL - Middle Frontal Gyrus Left 
IFGL, PO - Inferior Frontal Gyrus Left, Pars Orbitalis 
MFGR - Middle Frontal Gyrus Right 
IFGR, PT - Inferior Frontal Gyrus Right, Pars Triangularis 
 
Table 12: Significant Results of Group Analysis with ROI2 – EANL 
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Name of Brain Region PFWE -
corrected 
(Cluster 
Level) 
% Cluster Cluster 
Size  
(N of 
voxels) 
Z Score 
(Peak 
Value) 
MNI 
Coordinates 
X, Y, Z mm 
Contrast FM>HC, Masked by DMN  
PL 
PR 
0.006 60.77 
33.15 
181 3.33 
3.30 
   3  -57 45 
-15 -66 60 
Contrast OA<HC, Masked by EANL  
IFGL, PT  
MFGL 
0.027 71.62 
12.84 
148 3.59 
3.13 
-45 30 18 
-51 24 30 
 
PL - Precuneus Left 
PR - Precuneus Right 
IFGL, PT - Inferior Frontal Gyrus Left, Pars Triangularis 
MFGL - Middle Frontal Gyrus Left 
 
Table 13: Significant Results of Group Analysis with ROI3 – EANR 
 
An independent-samples t-test was conducted to compare the McGill pain questionnaire’s 
measures for FM and OA. There was a significant difference in mean scores for evaluative 
rank of pain rating index (PRI) between FM (M=4.11, SD=1.45) and OA (M=2.93, 
SD=1.27); t (21) = 2.06, p < .05 (two-tailed). The magnitude of the differences in the means 
was large (eta squared = .18). The McGill Pain Questionnaire’s measures are presented in 
Table 14 (significant differences in bold).  
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 Patient   Mean (SD)   
Group S 
 
A E M T NWC 
 
FM 
 
24.67 
(7.11) 
 
6.11 
(3.48) 
 
4.11 
(1.45) 
 
9.00 
(4.09) 
 
43.89 
(13.68) 
 
15.89 
(3.48) 
 
OA 25.29 
(7.57) 
5.14 
(2.85) 
2.93 
(1.27) 
8.79 
(3.77) 
42.14 
(14.22) 
15.86 
(3.72) 
 
 
FM – fibromyalgia               OA – knee osteoarthritis 
S – sensory rank of pain rating index (PRI) 
A – affective rank of PRI 
E – evaluative rank of PRI 
M – miscellaneous rank of PRI 
T – total rank of PRI 
NWC – number of words chosen 
 
Table 14: The McGill Pain Questionnaire’s measures (mean scores) 
 
I examined the relationships between the McGill Questionnaire’s measures and resting state 
FC. Preliminary analyses were performed to ensure no violation of the assumptions of 
normality, linearity and homoscedasticity. Significant results for correlations between the 
McGill Questionnaire’s measures and resting state FC (r ranging from |0.54| to |0.84|) are 
presented in Table 15. FM showed positive correlations of affective rank of pain rating index 
(PRI) with FC between all three ROI (DMN-EANL, DMN-EANR, EANL-EANR) and PRI’s 
evaluative rank with FC between two ROI (DMN-EANL and EANL-EANR), whereas OA 
revealed a negative correlation of affective rank of PRI with FC between DMN and EANR. It 
must be noted that comparisons between patients’ FC and 7 clinical measures were made. 
Applying a Bonferroni correction to these comparisons gives a p-value of .007 for a 
significant difference. It can be seen that only the correlation between FM patients’ 
evaluative measure of their pain and FC between DMN and EANL achieved this level of 
significance: all other observations must be treated speculatively. 
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 Correlations Correlation 
Coefficient 
Significance 
Level 
Number of  
Cases 
FM    
A – DMN/EANL 0.66 p = .051 9 
A – DMN/EANR 0.72 p = .028 9 
A – EANL/EANR 0.77 p = .015 9 
E – DMN/EANL 0.84 p = .005 9 
E – EANL/EANR 0.78 p = .014 9 
OA    
A – DMN/EANR - 0.54 p = .048 14 
 
DMN  – Default Mode Network 
EANL  – Executive Attention Network Left 
EANR  – Executive Attention Network Right 
A – PRI (AR) – Pain Rating Index (Affective Rank) 
E  – PRI (ER) – Pain Rating Index (Evaluative Rank) 
 
Table 15: Significant correlations between McGill Scores and FC 
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Discussion 
Summary of results 
My hypothesis of altered FC between the core hub of the DMN (the PCC) and other areas of 
the network in chronic pain patients when compared to healthy controls was supported by the 
results. My hypothesis of altered FC in chronic pain patients between the SPL are other areas 
of the EANs was also supported. My hypothesis of rs-FC differences between CWP and CLP 
was supported by the observation of areas of higher connectivity between the PCC and the 
middle temporal gyrus left (MTGL) in CWP when compared to CLP. Additionally, the 
alterations observed in FC correlated with differing clinical measures in FM and OA.  
 
I observed greater FC in FM compared to OA in the MTGL within the DMN. Furthermore, 
higher FC in FM compared to HC was found in the MTGL and MTGR. In contrast, lower FC 
in FM compared to HC was found in the inferior frontal gyrus left (IFGL), pars triangularis 
(PT) and orbitalis (PO) and the middle frontal gyrus left (MFGL) within the EANL. Greater 
between-network FC was observed in FM compared to HC between the SPL in the EAN and 
the precuneus (left and right) in the DMN. 
 
OA participants showed higher FC compared to HC in the left and right precuneus (PL and 
PR) within the DMN. In contrast, lower FC in OA compared to HC was found in the IFGL, 
PT and the MFGL within the EANL. Greater between-network FC was observed in OA 
compared to HC between the SPLL in the EANL and the MTGR in the DMN. 
 
Finally, a correlation between the evaluative element of the McGill Questionnaire and resting 
state FC were found in FM. Other correlations were observed, but must be treated with 
caution given their failure to survive Bonferroni correction. 
What my findings within and between brain networks of interest tell us? 
My findings demonstrated increased FC between areas of the DMN and decreased FC 
between areas of the EANs in both chronic pain conditions when compared to healthy 
controls. There were also altered FC between areas of the DMN and EAN observed in the 
pain patients. These suggestions have parallels with observations in previous studies of the 
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effects of chronic pain on FC across brain networks. I will consider each of these findings in 
turn. 
Increased FC between areas of the DMN in pain patients 
Resting-state FC in areas of the DMN was increased in both chronic pain conditions in 
comparison with HC. It is instructive to consider what increased connectivity between the 
core of the DMN and other DMN regions may imply. Recent studies have shown that 
enhanced DMN FC has been associated with a range of adverse conditions. Gardini et al. 
demonstrated increased DMN FC in participants with mild cognitive impairment (Gardini et 
al., 2015); Cowdrey et al. observed an increased DMN FC in participants who had 
experienced anorexia nervosa (Cowdrey, Filippini, Park, Smith, & McCabe, 2014); Luo et al. 
demonstrated a link between higher levels of DMN FC and lower levels of happiness (Luo, 
Kong, Qi, You, & Huang, 2015); and McCormick et al. observed a link between impaired 
memory performance and increased DMN FC (McCormick et al., 2014). McCormick et al. 
specifically highlighted that abnormally high connectivity between the MTGs and the 
posterior DMN, including PCC, was associated with impaired episodic memory performance. 
I will consider these findings, as related to individual DMN regions, in detail in the following 
section, but it is noteworthy that increased FC within the DMN has been observed after a 
range of chronic conditions and has been associated with adverse outcomes. Adding to these 
findings, my observations suggest adaptation of brain connectivity in response to prolonged 
atypical experience: with a higher level of alteration in CWP than CLP as PCC-MTG FC 
connectivity was increased to a greater degree in FM than OA. 
 
This observation is in accord with previous studies, which found that supratentorial 
processing of neuropathic stimuli in chronic pain may alter FC at resting state. For example, 
it was reported that rs-FC was decreased between the thalamus and the cortex in diabetic 
neuropathic pain patients compared to HC (Cauda, Sacco, D’Agata, et al., 2009). Cifre et al. 
demonstrated a considerable imbalance of the FC within the pain network during rest in 
patients with FM, ‘suggesting that chronic pain may also lead to changes in brain activity 
during internally generated thought processes such as occur at rest’ (Cifre et al., 2012). 
Cifre’s observation is in agreement with the conclusion drawn by Luo that increased FC 
within areas of the DMN was associated with lower levels of happiness as the increased FC 
was strongly associated with internally generated ‘ruminative’ negative thought. 
92 
 
Decreased FC between areas of the EAN in pain patients 
I observed that FC in both chronic pain conditions was lower in areas of EANs compared to 
HC. Had the participants in this study been performing an externally directed task it would be 
reasonable to take this result as evidence of the disruption of the direction of attention 
associated with chronic pain (Dick & Rashiq, 2007). However given the nature of rs-FC, my 
participants were necessarily observed at rest and therefore it is challenging to interpret 
decreased FC in the EAN. No other studies have observed decreased FC in the EAN in either 
OA or FM in comparison to HC. A study by Napadow et al (2010) observed increased FC in 
areas of the EANR in FM patients at rest when compared to HC. Napadow et al interpreted 
this observation as suggesting that potentially indicative of pain causing the consumption of 
attentional resources that would be available for executive functioning during task 
performance i.e. the aberrant activity observed at rest would also be present during task 
related EAN activity and would therefore impair intended function. I did not observe any 
areas of increased FC in the EAN when comparing pain conditions to HC, however, it is 
possible that the areas of abnormally low FC I observed in the EAN of pain patients at rest 
may also have implications for the activity of this network during execution of a task. 
Disruption of directed attention in chronic pain is especially pronounced in FM patients as 
manifest in deficits of episodic memory and cognition (Glass, 2009). Given Luo’s (Luo et al., 
2015) observation about elevated levels of rumination in FM an investigation of the 
correlation between rumination and altered levels of FC in FM patients is warranted.  
Increased between-network FC in pain patients 
I observed greater FC between- areas of the DMN and EAN in both pain conditions when 
compared to HC. These observations are in broad agreement with those of previous 
researchers who have recorded increased FC between areas of both the DMN and EAN and 
other areas of other brain networks. Ichesco et al. revealed an increased FC between the left 
anterior insular cortex (IC) and pregenual anterior cingulate cortex (ACC) in TMD patients, 
during both resting state and the application of a painful stimulus to the face (Ichesco et al., 
2012). Napadow et al. showed that FM patients had greater connectivity within the DMN and 
greater connectivity between the DMN and the insular cortex, which is a brain region known 
to process evoked pain (Napadow et al., 2010). This observation is in accord with the 
findings of Martucci et al. (2015) observed increased functional connectivity within the DMN 
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and between the DMN and insula in chronic pelvic pain syndrome patients. Likewise, 
Malinen et al. showed altered spatial connectivity between insula and ACC in chronic pain 
patients using seed point-based correlation analysis (Malinen et al., 2010). It implies ‘both 
temporally and spatially aberrant activity of the affective pain processing areas in patients 
suffering from chronic pain’ (Malinen et al., 2010). These findings give support to the 
suggestion that chronic pain conditions disrupt the activity of the resting brain and, as 
suggested by Napadow et al., that abnormal inter-network activity ‘may also have broader 
implications for how subjective experiences such as pain arise from a complex interplay 
among multiple brain networks’ (Napadow et al., 2010).  
 
Taken together with my observations, these findings demonstrate alterations in FC within 
brain networks resulting from chronic pain, highlight that aberrant network activity alters a 
participant’s experience of acute stimuli and also affects ongoing interaction between brain 
networks. 
FC and clinical measures 
The only correlation between FC and patients’ clinical measures found to be significant after 
Bonferroni correction was the evaluative element of the McGill Questionnaire and FC 
between the DMN and EANL in FM. I noted previously that increased levels of between-
network FC may relate to cross-network activity entailed in spontaneous attention shifts 
towards pain, but it is challenging to suggest why this increased activity would correlate 
specifically with FM patients’ evaluation of their pain. It is possible that this is indicative of a 
more general set of relationships between clinical measures and between-network FC that my 
study was not sufficiently powerful to capture. I present below the other observed 
correlations, which did not survive Bonferroni correction as speculative observations, which 
may inform future studies with greater power. 
 
A positive correlation was observed between affective rank of pain rating index (PRI) and 
with between-network FC using all seed regions for the FM group. Higher affective ranks of 
PRI in FM were associated with higher levels of FC between seed regions (i.e. between the 
DMN and EANs). Given the typically anticorrelated activity of the DMN and EAN, the 
increased FC between network regions in FM may indicate dyscoordination of network based 
brain activity. That is, the transitions between DMN and EAN activity represented by 
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anticorrelation between these networks are impaired in FM and thus increased cross-network 
activity between DMN and EANs can be observed.  
 
It has been observed that the affective component of experienced pain increases in FM 
(Gracely et al., 2004).This observation, coupled with the increased FC in the DMN may 
suggest the presence of a feedback loop where patients concentrate on their pain, increasing 
their awareness of this sensation, which in turn increases the focus of their concentration on 
their condition.  
 
In contrast, the OA patients showed a negative correlation of affective rank of PRI with FC 
between DMN and EANR. This might suggest that the affective component of pain is less 
pronounced in OA compared to FM. However, a comparison of affective ranks of PRI 
between FM and OA did not show a significant difference. Further research in revealing 
different components of pain between the two chronic pain conditions is needed. 
  
What my findings within specific brain regions tell us? 
It is also informative to consider brain regions with altered FC within and between DMN and 
EAN in the context of their function. Within the DMN, FC in FM was higher compared to 
OA and HC between PCC and precuneus left and right, PCC and medial temporal gyrus left 
and right, PCC and medial frontal gyrus left and right. 
 
The precuneus, a part of the medial posterior parietal cortex, is engaged in reflective, self-
related processing (Kjaer, Nowak, & Lou, 2002; Lou et al., 2004). It is plausible to suggest 
that, given its role, the precuneus may be active with rumination in FM, and therefore may be 
increasing the level of patients’ experienced pain. The precuneus is also involved in 
awareness and conscious information processing (Kjaer, Nowak, Kjaer, Lou, & Lou, 2001; 
Vogt & Laureys, 2005), episodic memory (Dörfel, Werner, Schaefer, Von Kummer, & Karl, 
2009; Lundstrom et al., 2003; Lundstrom, Ingvar, & Petersson, 2005), and visuospatial 
processing (Kawashima, Roland, & O’Sullivan, 1995; Wenderoth, Debaere, Sunaert, & 
Swinnen, 2005), as well as showing greater activity during resting as compared to responding 
to an external task (Cavanna & Trimble, 2006; Cavanna, 2007; Fransson & Marrelec, 2008; 
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Zhang & Li, 2012). Future fMRI research looking at the involvement of the precuneus in 
ruminative processes in FM would therefore be of interest. 
 
The middle (medial) temporal gyrus is involved in a number of cognitive processes, 
including semantic memory processing, language processes, and integrating information from 
different senses (Calvert, Campbell, & Brammer, 2000; Squire & Zola-Morgan, 1991). 
Together with the inferior temporal gyrus, it has been implicated in recognising and 
interpreting information about faces. Both structures are a part of the ventral visual pathway, 
which identifies “what” things are. The inferior temporal gyrus also participates in visual 
perception and some forms of mental imagery (Eskandar, Richmond, & Optican, 1992; 
Andrea Mechelli, Price, Friston, & Ishai, 2004). The medial temporal gyrus has been 
connected with processes as different as contemplating distance, recognition of known faces, 
and accessing word meaning while reading (Acheson & Hagoort, 2013). Kirkham (2010) 
observed marked differences between the responses of FM and OA patients when asked to 
draw their pain (see Figure 7). Despite the differences in the distribution of physical sources 
of the patients’ pain, it is worth considering the role played by the MTGL and the 
involvement of mental imagery in the patients’ experience of their condition. Differences 
within FC in the MTGL between pain conditions may suggest a differing use of mental 
imagery by patients in relation to their condition. Further research is warranted to uncover the 
links between activity within the MTGL and patients’ use of self-referential or external 
imagery in relation to their experience of pain. 
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Figure 7: Differences between FM and OA patients in drawing their pain 
 
The left inferior frontal gyrus left (IFGL) has consistently been associated with both 
phonologic and semantic operations in functional neuroimaging studies (Costafreda et al., 
2006; Katzev, Tuscher, Hennig, Weiller, & Kaller, 2013). There is growing interest regarding 
the role of the inferior frontal gyrus right (IFGR) during a particular form of executive 
control referred to as response inhibition (Hampshire, Chamberlain, Monti, Duncan, & Owen, 
2010). 
 
Inferior frontal gyrus, pars triangularis, is a part of Broca’s area, which is involved in 
semantic tasks. Inferior frontal gyrus, pars orbitalis, is associated with controlled semantic 
retrieval (Sabb, Bilder, Chou, & Bookheimer, 2007) and processing the semantic aspects of a 
sentence (Dapretto & Bookheimer, 1999). 
 
Overall, from analysing the functions of brain areas involved in DMN and EAN, it may be 
suggested that those brain networks intersect morphologically and functionally. Both brain 
networks are altered in chronic pain. For example, the increased FC in the FM cohort may 
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indicate increased emotional processing (ACC), increased monitoring of sensory input and an 
attempt to make sense of it (MTG), as well as increased rumination and reflective self-
referential processing of that input (precuneus). 
 
There are some limitations to my study, the biggest being the age difference and small 
populations. A plausible suggestion of the age difference may be that greater FC in FM 
compared to OA could be a result of OA group being older than FM. However, FC in OA is 
greater than in HC (being older as well), where aging usually results in a decrease, not an 
increase of rs-FC (Damoiseaux et al., 2008). Larger participant groups may have led to more 
powerful results, but numbers of participants between 16-32 have also been suggested to be 
useful in imaging studies (Friston, 2012). As a preliminary exploration of the effects of 
chronic pain on brain networks connectivity at rest my results have shown interesting 
alterations in FC that may suggest more directed research questions for future studies. 
 
The broader implications of my study suggest that differences between resting-state FC 
measures in chronic pain conditions support the use of differing pain therapies in different 
conditions, especially when considering behavioural based therapies addressing the affective 
component of pain. Alterations in FC in chronic pain may also serve as biomarkers for 
chronic pain, but further research of FC in various and larger clinical pain populations is 
needed. However, differences in FC in various chronic pain conditions may provide another 
index for the development of individualized pain management. 
 
In conclusion, I have presented the first study to compare resting-state FC in two different 
chronic pain conditions. Differences in FC between CWP and CLP were found, such as an 
increased FC in FM participants compared to OA within DMN (PCC – MTGL). Furthermore, 
I observed a suggestion of differing correlations between FC and clinical measures in FM and 
OA, though only a single correlation achieved robust significance. The other correlations 
observed may be suggestive of both affective and evaluative clinical measures showing a 
greater role in predicting FC in FM, compared to the affective measure in OA, though a 
further study of greater power would be required to confirm this suggestion. This suggestion 
fits with an increased attention to pain in FM, consistent with increased rumination, 
suggesting FM patients concentrate on their pain, increasing their awareness of it, which 
further increases their attention to it in a feedback loop. FC in DMN in chronic pain was 
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increased compared to HC, with a greater effect in FM. In contrast, FC in EAN in chronic 
pain was decreased in comparison with HC. Both these results are in line with my hypotheses. 
These results showing changes within the brain in chronic pain also provide some 
justification for the use of central painkillers in chronic pain as well as suggesting that some 
cognitive therapies, which have also been shown to alter FC, may be useful as treatments for 
chronic pain, especially in FM. 
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CHAPTER 4 -VBM in chronic pain: differences and similarities 
between widespread and local pain 
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Introduction 
Chronic pain is defined as pain that lasts longer than 3 months (Merskey & Bogduk, 1994). 
This is a highly prevalent condition that has adverse effects across many areas of patient 
health including sleep, cognition, mental health and general quality of life (Fine, 2011). The 
effects of chronic pain can be exacerbated by the development of increasingly complex 
pathophysiology that renders effective treatment challenging (Fine, 2011). The far reaching 
effects of chronic pain mean that many patients suffer serious economic consequences (Fine, 
2011). 
 
Osteoarthritis (OA) and fibromyalgia (FM) are chronic pain conditions with different bodily 
representation: osteoarthritis is a local pain condition whereas fibromyalgia is a widespread 
pain condition. Fibromyalgia and knee osteoarthritis are described in detail in Chapter 2.  
 
The neurobiology and pathophysiology of chronic pain have been studied using several 
neuroimaging techniques: voxel-based morphometry (VBM) - which examines brain 
morphology, fMRI and resting-state functional connectivity (FC) - which examines brain 
function, and magnetic resonance spectroscopy (MRS) - which reveals differences in brain 
neurochemistry (Bandettini, 2009). In earlier chapters, I looked at the differences between 
chronic local and widespread pain in neurochemistry (Chapter 2) and brain function (Chapter 
3). I found differences between the two chronic pain conditions using MRS: NAA level in the 
thalamus of OA participants was significantly lower than in FM. Furthermore, there were 
differences in the relationship of neurometabolites and clinical measures between OA and 
FM (Chapter 2). I additionally found differences in resting-state FC between the two chronic 
pain conditions. The relationships between FC and clinical measures (McGill questionnaire) 
were also different between local and widespread chronic pain (Chapter 3). These differences 
suggest that these two chronic pain conditions may benefit from different therapeutic 
approaches (Chapters 2 and 3).  
 
In this study I further examine the differences in the brain representation of chronic pain, 
specifically the differences in brain morphology between chronic widespread pain (FM) and 
chronic local pain (knee OA), relative to healthy controls using VBM. VBM is a 
neuroimaging technique, which involves a voxel-wise comparison of the relative amounts of 
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each tissue type (grey matter – GM and white matter - WM) in a region of interest between 
two or more groups of subjects (Mechelli, Price, Friston, & Ashburner, 2005). VBM provides 
high sensitivity to regional differences in grey or white matter using the estimation of smooth, 
low frequency deformation fields (Mechelli et al., 2005). VBM is a simple and pragmatic 
approach for localising small scale changes, which is feasible for most research groups 
(Ashburner & Friston, 2000). 
 
There are relatively few VBM studies in chronic pain. In the studies published reductions in 
grey matter volume (GMV) in the thalamus have been found: in chronic back pain (Apkarian 
et al., 2004); in FM (Schmidt-Wilcke et al., 2007); in hip OA (Gwilym et al., 2010); and in 
trigeminal neuropathy (Gustin et al., 2011). Apkarian et al. suggested there are at least two 
types of decrease in the thalamic GMV. One possible explanation is tissue shrinkage due to 
changes in microvascular volume and extracellular space without impacting neurons 
substantially (Apkarian et al., 2004). This type of decrease in most cases is reversible after 
appropriate treatment (Apkarian et al., 2004). In contrast, the other type of decrease – atrophy 
- is irreversible. Thalamic atrophy in chronic pain was suggested to be due to 
neurodegeneration caused by changes in glial numbers and microglial activity and apoptosis 
of thalamic interneurons (Apkarian et al., 2004). A decrease in the brain GMV in chronic 
pain may be result of a change in cell size, shrinkage or atrophy of neurons or glia, and 
synaptic loss (May, 2008; May & Gaser, 2006). 
 
One research group found a thalamic GMV decrease and a reduction of thalamic NAA level 
in trigeminal neuropathy patients compared to trigeminal neuralgia patients (Gustin et al., 
2011). As was shown in Chapter 2, there is a decrease in the level of NAA in the left 
thalamus of OA patients compared to FM. Since NAA is a marker of neuronal density and 
viability (Govindaraju et al., 2000; Simmons et al., 1991) it would be expected that GMV of 
the thalamus would be decreased in OA compared to FM. Therefore I propose that OA 
patients would have a reduction of thalamic GMV positively correlated to the decreased 
NAA level in the thalamus. 
 
Another research group compared chronic back pain, complex regional pain syndrome 
(CRPS) and knee OA, relative to healthy controls (Baliki, Schnitzer, et al., 2011). They found 
that different chronic pain conditions reveal distinctive anatomical ‘brain signatures’ (Baliki, 
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Schnitzer, et al., 2011). I likewise propose that the brain morphology will be different 
between the two chronic pain conditions. As these two chronic pain conditions have different 
bodily representation (Chapter 2) I propose that structural reorganization of the brain would 
be different as well between FM and OA participants. I would expect a decrease of GMV in 
FM participants in the anterior cingulate cortex – ACC (Burgmer et al., 2009; Jensen et al., 
2013; Kuchinad et al., 2007; Robinson, Craggs, Price, Perlstein, & Staud, 2011; Wood, 
Glabus, Simpson, & Patterson, 2009), posterior cingulate cortex – PCC (Kuchinad et al., 
2007; Robinson et al., 2011; Wood, Glabus, et al., 2009), the prefrontal cortex - PFC 
(Burgmer et al., 2009; Kuchinad et al., 2007), insula (Robinson et al., 2011), thalamus 
(Schmidt-Wilcke et al., 2007), left precuneus (Fallon et al., 2013), the pons (brainstem) 
(Fallon et al., 2013), and parahippocampal gyri (Kuchinad et al., 2007; Wood, Glabus, et al., 
2009). In OA participants I would expect a decrease of GMV in primary and secondary 
somatosensory cortex, insula, ACC, DLPFC, brainstem and motor cortex (Davis & Moayedi, 
2012; May, 2011; Rodriguez-Raecke et al., 2009), and the thalamus (Gwilym et al., 2010).  
 
In this study I compared grey matter volume (GMV) of FM and OA participants, relative to 
healthy controls. I hypothesised that reductions in GMV would be seen when the patient 
groups were compared to healthy controls. Furthermore, I hypothesised that different brain 
areas would be affected (a decrease in GMV) when FM and OA participants compared to 
each other and healthy controls. Moreover, since NAA levels were reduced in the thalamus of 
OA patients (Chapter 2), I additionally hypothesised that there would be a positive 
relationship between the thalamus GMV and the thalamus NAA in OA participants compared 
to FM and HC.  
Methods 
Participants 
A review of 8 previous VBM studies of chronic pain (7 FM, 1 OA) revealed a mean group 
size of 20.5 participants. These studies had, except in one case, made a comparison between 
grey matter volumes in a single patient group and healthy controls and therefore had a mean 
total participant group size of 41. As per the previous analysis (Chapter 2) a total participant 
group size of 42 would be required to achieve an 80% power level in detecting a large effect 
size (Cohen’s d = 0.8) therefore these studies were adequately powered. Since it was my 
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intention to make a 3-way comparison between two groups of chronic pain patients and a 
group of healthy controls I was able to reuse the previous analysis to determine the group 
sizes that would be required to achieve a power level similar to previous experiments using 
an ANOVA. To achieve 80% power in detecting a large effect size (Cohen’s f = 0.4) three 
groups of 22 participants would be required and therefore I aimed to recruit a total of 66 
participants. It was possible to recruit 50 participants for this study, thus achieving a power of 
approximately 70%. The achieved power level was lower than ideal and therefore raised the 
possibility of type 2 errors. 
 
All participants were females aged 31-65. There were 17 participants with FM (mean +/- SD 
age 47.88 +/- 8.15 years), 17 participants with OA of the knee (mean +/- SD age 61.65 +/- 
3.06 years), and 16 HC (mean +/- SD age 44.25 +/- 11.32 years) for this study. 
FM participants were classified using the American College of Rheumatology criteria (Wolfe 
et al., 1990) for the classification of FM, such that each subject fulfilled the following 
criteria: widespread pain in all four quadrants of the body for at least 3 months and 
tenderness or pain to touch in at least 11 out of 18 specific anatomical sites described as 
tender points. FM participants were recruited from a district general hospital fibromyalgia 
clinic in North Wales. FM participants were excluded if they had knee OA. Participants with 
knee OA were recruited from the pre-operative arthroplasty clinic at Ysbyty Gwynedd, 
Bangor. Participants with rheumatoid arthritis and OA of other joints were excluded, as was 
anyone who also had a diagnosis of co-morbid FM. HC participants without chronic pain 
were recruited using Bangor University School of Psychology’s community participant panel 
and local advertisements. All participants were asked to refrain from using analgesic 
medication on the day of the scan until after scanning was completed. Normal 
contraindications for MRI were also used as exclusion criteria (e.g. pacemakers, metal 
implants, claustrophobia). 
 
This study was approved by the Ethics Committee from the School of Psychology, Bangor 
University and North West Wales Research Ethics Committee (reference 10/WNo01/16). 
Research activities took place in Bangor Imaging Centre, Bangor University. All participants 
provided informed consent. 
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Magnetic resonance imaging (MRI) and analysis 
MRI was performed on a Phillips Achieva MRI system (Philips Health Care, Eindhoven, 
Netherlands), operating at 3.0 Tesla. For each subject a T1 weighted gradient echo MP-
RAGE sequence (TE = 3.5, 5.1, 6.8, 8.5, 10.2 ms, TR = 12 ms, TI = 1150 ms, 3D acquisition, 
FOV = 240 mm X 220 mm X 130 mm, voxel dimensions = 0.7 X 0.7 X 0.7 mm3) was 
acquired. The T1 MR-images showed no morphological abnormalities or artefacts across any 
of the groups. 
The aim of VBM is to identify differences in the local composition of brain tissue, while 
discounting large-scale differences in gross anatomy and position (Mechelli et al., 2005). 
This is achieved by spatially normalising all the structural images to the same stereotactic 
space, segmenting the normalised images into grey and white matter, smoothing the grey and 
white matter images and finally performing a statistical analysis to localise significant 
differences between the groups (Mechelli et al., 2005). 
 
The analysis in VBM included the following steps: 
 
1) High-resolution MR images from all subjects were spatially normalised to the same 
stereotaxic space, which was achieved by registering each image to the same template. 
 
2) The spatially normalised images were then segmented into grey and white matter 
using the segmentation technique ‘New segment’ (Ashburner & Friston, 2005; 
Ashburner, 2007). 
 
3) Next grey matter images were smoothed by convolving with an isotropic Gaussian 
kernel. The use of Gaussian smoothing makes the subsequent voxel by voxel analysis 
comparable to a region of interest approach, because each voxel in the smoothed 
images contains the average amount of grey matter from around the voxel. The region 
around the voxel is defined by the form of the smoothing kernel (Ashburner & Friston, 
2000, 2001). 
 
4) Following pre-processing, the next step was to perform a voxel-wise parametric 
statistical analysis (a one-way between-groups ANOVA), which compare the 
smoothed GM images from the groups (FM, OA, and HC). Corrections for multiple 
105 
 
comparisons were made using the theory of Gaussian random fields (Ashburner & 
Friston, 2000, 2001). The output from the method is a statistical parametric map 
(SPM) showing regions where grey matter concentration differs significantly between 
the groups. A whole-brain search for significant clusters (extent threshold=1000 
voxels) was performed using a voxel-wise threshold of p < .05 corrected for multiple 
comparison using family-wise error (Hsu et al., 2009; Kuchinad et al., 2007; Schmidt-
Wilcke et al., 2006, 2007). Then a whole-brain search for significant clusters was 
performed using independent-samples t-tests with contrasts of interest as relevant to 
the hypotheses (HC>FM+OA, HC<FM+OA, FM>OA, and FM<OA). A voxel-wise 
threshold of p < .05 corrected for multiple comparison using family-wise error was 
applied. In addition, a ROI-based search using a mask, which was specially created, 
using WFU Pickatlas by combining templates of brain regions within the left 
thalamus was conducted (Maldjian et al., 2003). For the ROI-based search, all clusters 
with an uncorrected voxel-level p < .001 and those with a voxel-level p < .05 
(corrected for small volume and family-wise error) were considered significant (Brett, 
Anton, Valabregue, & Poline, 2002; Hsu et al., 2009). The contrasts of interest were 
again HC>FM+OA, HC<FM+OA, FM>OA, and FM<OA. 
 
5) Finally, mean voxel values for any significant clusters inside the left thalamus mask 
were extracted from each subject for a correlation analysis with NAA levels. The 
correlation analysis was planned to be performed using SPSS, version 14.0 (SPSS Inc., 
Chicago, IL). Between-group differences were planned to test using a one-way 
ANOVA, with a significance threshold of p < .05. For any significant clusters, the 
standardized residuals from a linear regression between mean voxel value - dependent 
and total intracranial volume (TIV) - independent were calculated (Hsu et al., 2009). 
The relationships between the left thalamus GMV and the left thalamus NAA in all 
three groups were planned to investigate using Spearman’s Rank Order Correlation 
(rho) coefficient.  
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Results 
The initial whole-brain analysis of revealed no clusters (above the threshold of 1000 voxels) 
of significantly different GMV between the three groups of participants when the results had 
been corrected for multiple comparisons. The results of the whole-brain analysis between the 
3 groups are therefore not presented in detail. 
 
Using the whole-brain search approach with the planned contrasts of interest (t-tests), the 
main effect of group revealed the following clusters of significantly different GMV between 
patient groups. The FM<OA contrast revealed clusters of difference within the left brainstem 
– midbrain, the left brainstem – pons, and the posterior cingulate (p < .05, corrected). The 
FM>OA contrast (p < .05, corrected) showed differences in the left precentral gyrus 
(Brodmann areas 4 and 6) and the left postcentral gyrus (BA 40). There were no significant 
alterations in any other brain areas. There were no significant GMV changes in patient groups 
compared to HC. These results are shown in detail (i.e. peak coordinates, T-values, Z-values, 
and cluster sizes) in Table 16. Figures 8 and 9 demonstrate areas of significant decrease in 
grey matter volume in FM and OA patient groups compared to each other. 
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 Cluster 
Location 
MNI coordinates  
of highest peaks 
within cluster 
X, Y, Z mm 
Peak t value Uncorrected  
p value 
FWE corrected  
p value 
Cluster Size  
(N of Voxels) 
                                                           Contrast FM < OA   
Left Brainstem 
(Midbrain)                                                                                                                                                                                
-9 -27 -20 5.02    
Left Brainstem 
(Pons) 
-2 -36 -30 
 
5.01 < .0001 .003 2088 
Posterior 
Cingulate 
 0 -37   7 4.89    
Contrast OA < FM 
Left Middle 
Frontal Gyrus 
(BA 6) 
-45   2  37 4.88    
Left 
Suprmarginal 
Gyrus (BA 40) 
-42 -25 46 4.21 .002 .012 1482 
Left Precentral 
Gyrus (BA 4) 
-39 -19 57 3.97    
 
 
FM – fibromyalgia; OA – osteoarthritis; BA – Brodmann area 
P < 0.001, uncorrected; Extent threshold k = 1000 voxels 
 
Table 16: Areas of significant decrease in grey matter volume 
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Figure 8: Areas of significant decrease in grey matter volume in fibromyalgia compared to 
knee osteoarthritis (FM<OA) 
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Figure 9: Areas of significant decrease in grey matter volume in knee osteoarthritis 
compared to fibromyalgia (OA<FM) 
 
 
Using the ROI-based search approach, applying the left thalamus mask, the main effect of 
group revealed no clusters of significantly different GMV between the three groups (a one-
way between-groups ANOVA), uncorrected and small-volume corrected. In addition, using 6 
contrasts of interest and the left thalamus mask in the ROI-based search approach did not 
reveal any clusters of significantly different GMV between the groups (independent-samples 
t-tests), uncorrected and small-volume corrected. Despite the absence of the expected 
decrease in GMV in the left thalamus of OA patients, a correlation analysis was performed 
between left thalamus GMV and thalamic NAA. No significant correlation was found 
between thalamic GMV and corrected NAA levels in any of the participant groups. However, 
as mentioned in chapter 2, a positive correlation was found between the uncorrected NAA 
and grey matter levels.  This contrasting result indicates that our partial volume correction 
110 
 
procedures were effective and suggests that the NAA differences seen are not a result of 
tissue content changes, but may instead reflect alterations in neuronal viability in OA. 
Discussion 
My most notable finding was a decrease of GMV in FM patients compared to OA in the left 
brainstem (midbrain and pons) and the posterior cingulate. In contrast, in OA patients GMV 
was decreased compared to FM in the left precentral (BA 4), middle frontal (BA 6) and the 
postcentral gyri (BA 40). No significant GMV changes in either patient group compared to 
HC were found. No decrease of thalamic GMV in OA patients was found. No correlation 
between thalamic GMV and NAA levels were found in OA patients. I will analyse each of 
these findings individually.  
 
1) FM < OA: left brainstem – midbrain and pons 
The midbrain, particularly periaqueductal grey (PAG) and reticular formation, is involved in 
the pain desensitization pathway (Zambreanu, Wise, Brooks, Iannetti, & Tracey, 2005). 
Decrease of GMV in the midbrain of FM patients may inhibit pain desensitization function in 
these chronic pain patients, which may explain hypersensitivity in FM. This dysfunction (or 
incoordination) of the pain desensitization pathway may result in central sensitization being 
more prominent in FM patients than in OA patients.  
 
The pons, on the other hand, carries sensory signals to the thalamus. So, decrease of GMV in 
the pons of FM patients may interrupt the spinothalamic tract’s function, which in turn may 
cause a disruption in the pain sensitivity control of those patients. This may result in FM 
patients having some sensory incoordination, which may explain the existence of 
paraesthesias in FM patients.  
   
The spinothalamic tract for pain sensation passes through the brainstem. Brainstem has 
integrative functions within cardiovascular system control, respiratory system control, pain 
sensitivity control, consciousness and the sleep cycle (Nicholls & Paton, 2009). Given the 
brainstem’s involvement in this range of functions, a decrease of GMV in this region in FM 
may provide an explanation for the diversity of the symptoms of FM: widespread pain, 
fatigue, nonrestorative sleep, morning stiffness, headache, cognitive disturbance, anxiety, and 
paraesthesias, in addition to chronic pain. 
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 My finding is in agreement with previous research by Fallon et al. (Fallon et al., 2013) who 
also reported a decrease in GMV within the brainstem (pons) in FM patients. Fallon et al. 
suggested that brainstem GMV loss may contribute to sensitivity to pressure pain in FM 
patients, as they noted the role of brainstem areas within descending nociceptive control. 
 
Another research group suggested that a decrease of GMV in the brainstem may promote the 
chronification of back pain (Schmidt-Wilcke et al., 2006). A correlation between the grey 
matter decrease in the brainstem and pain intensity and unpleasantness at the time of 
scanning was demonstrated, which was suggested to account for the level of impaired 
antinociception at that time (Schmidt-Wilcke et al., 2006). My finding of both a reduction in 
brainstem GMV and increased pain intensity in FM patients adds support to the conclusions 
of Schmidt-Wilcke et al. 
 
2) FM < OA: posterior cingulate 
Posterior cingulate cortex (PCC) has a well-documented role in cognitive function (working 
memory and episodic memory retrieval) (Shimizu et al., 2007). Working memory is a key 
component of effective cognition and has a major bearing on problem solving (Baddeley & 
Hitch, 1974). Fibromyalgia affects patients’ cognition, especially memory and ability to 
focus and express their thoughts clearly, which is often referred to as “fibro fog” (Arnold et 
al., 2008). Decrease of GMV in the PCC of FM patients compared to OA may suggest that 
cognitive function is more affected in FM compared to OA.  
 
Hypofunction of the PCC has been found to be associated with cognitive decline (Shimizu et 
al., 2007). It was suggested that a decreased NAA/Cr in the PCC has a contribution to the 
pathophysiology of chronic schizophrenia with cognitive deficit (Shimizu et al., 2007). In 
addition, a relationship between the NAA/Cr in the PCC and verbal memory was found and it 
was suggested that the NAA/Cr in the PCC might be associated with episodic memory 
function (Shimizu et al., 2007). Previous PET studies also have shown the usage of PCC in 
episodic memory (Andreasen et al., 1995; Desgranges, Baron, & Eustache, 1998; Nyberg et 
al., 1996; Shallice et al., 1994). Furthermore, a role of the PCC in cognitive impairment 
(learning and memory) was demonstrated in Alzheimer’s disease (Minoshima et al., 1997; 
Minoshima, Foster, & Kuhl, 1994).  
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 In addition, involvement of the PCC in working memory has been shown in fMRI studies 
(Hampson, Driesen, Skudlarski, Gore, & Constable, 2006). In particular, the PCC was 
activated during standardized and autobiographical memory retrieval, allowing concluding 
about an important role of the PCC in successful memory retrieval (Maddock, Garrett, & 
Buonocore, 2001). Furthermore, it was proved that PCC plays a key role in the default mode 
network (DMN), which was investigated to link intrinsic connectivity to cognition (Fransson 
& Marrelec, 2008). Also, abnormal connectivity in the PCC and hippocampus was 
demonstrated in early Alzheimer disease and mild cognitive impairment (Zhou et al., 2008). 
 
Thus, my finding of decreased GMV in the PCC of FM patients compared to OA and 
cognitive impairments in those patients (Glass, 2009; Reyes Del Paso, Pulgar, Duschek, & 
Garrido, 2012; Suhr, 2003) give additional evidence for the role of PCC in cognitive function.  
 
In addition to the involvement of the PCC in cognition, it was demonstrated the PCC has a 
role in pain (Bromm, 2001; Hsieh, Belfrage, Stone-Elander, Hansson, & Ingvar, 1995; 
Lekander, Fredrikson, & Wik, 2000; Nielsen, Balslev, & Hansen, 2005; Vogt et al., 1996; 
Willoch et al., 2000). A PET study showed the activation of the PCC in neuropathic pain 
patients (Hsieh et al., 1995). Another PET study correlated regional cerebral blood flow to 
immune function in fibromyalgia: activity in the PCC was negatively correlated with natural 
killer cell activity (Lekander et al., 2000). Furthermore, activations in the PCC were 
positively correlated to phantom limb pain sensations (Willoch et al., 2000). Thus, my 
finding of decreased GMV in the PCC in FM gives additional support to the role of this 
region in pain.  
 
Bromm noted that, given the position of the PCC within a network involving amygdala and 
widespread areas of temporal and parietal cortex, there is support for pain-related activation 
in the PCC representing the “emotional-aversive component of pain” (Bromm, 2001). I found 
a GMV reduction in the PCC in FM patients and higher evaluative rank of pain rating index 
(PRI) in FM compared to OA (see McGill Questionnaire in Chapter 3). My findings are in 
accord with Bromm’s suggestion that the PCC plays a key role in providing the “emotional-
aversive component of pain” (Bromm, 2001). 
 
113 
 
 3) OA < FM: BA 4 and BA 6 – primary motor cortex and premotor cortex 
Brodmann areas 4 (left precentral gyrus) and 6 (middle frontal gyrus) are primary motor 
cortex (motor execution) and premotor cortex areas (motor planning and execution) 
respectively (Hanakawa, Dimyan, & Hallett, 2008; Rizzolatti & Luppino, 2001). I found a 
decrease in GMV in those areas in OA patients compared to FM. This suggests the possibility 
that changes to brain structure in OA may contribute to, or arise from, the motor dysfunction 
and consequent disability observed in this condition. 
 
My finding is in agreement with previous research. Motor cortex stimulation was used for 
central and neuropathic facial pain. 88% of pain relief was demonstrated postoperatively and 
75% after 10 months. It was suggested that motor cortex stimulation alters cortical plasticity 
and inhibits thalamic hyperactivity (Brown & Pilitsis, 2005). Pain relief and improvement of 
daily functioning was observed after applying transcranial direct current stimulation (tDCS) 
over primary motor cortex in FM patients (Fagerlund, Hansen, & Aslaksen, 2015). Many 
studies have reported significant pain relief by repetitive transcranial magnetic stimulation 
over primary motor cortex in central and peripheral neuropathic pain, fibromyalgia, CRPS, 
low back pain, irritable bowel syndrome, and postoperative pain syndrome (Galhardoni et al., 
2015). My finding of decreased GMV in motor cortex in OA invites the question if 
stimulation over the primary motor cortex would have the same analgesic effect in patients 
with OA of the knee.  
 
4) OA < FM: BA 40 – supramarginal gyrus 
Supramarginal gyrus (BA 40) is a component within the somatosensory system, which plays 
an important role in proprioception (De Ridder, Van Laere, Dupont, Menovsky, & Van de 
Heyning, 2007; Filimon, Nelson, Huang, & Sereno, 2009; Goble et al., 2011; Shimada, 
Hiraki, & Oda, 2005). Proprioception is awareness of the body’s disposition and the position 
of its components relative to each other, including joint static position and movement 
(Sharma, 1999). Proprioception is mediated by the central nervous system, and depends upon 
input from the somatosensory system (proprioceptive input), as well from the visual and the 
vestibular systems (Lephart, Pincivero, & Rozzi, 1998). It has previously been demonstrated 
that proprioception is impaired in OA of the knee (Sharma, 1999; Sharma, Pai, Holtkamp, & 
Rymer, 1997). I found a decrease in GMV in the supramarginal gyrus in OA patients 
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compared to FM. My suggestion is that a decrease in GMV of the supramarginal gyrus is 
related to the proprioceptive impairment in knee OA. Whether this is cause or consequence is 
difficult to say at this stage. Further research on OA of the knee and other joints is needed. 
Furthermore, it would be of interest to investigate whether a decrease in GMV in the 
supramarginal gyrus reverses after a total knee replacement as it was shown that 
proprioception was more accurate in replaced knees than in osteoarthritic knees (Barrett, 
Cobb, & Bentley, 1991; Gauchard, Vançon, Meyer, Mainard, & Perrin, 2010; Isaac et al., 
2007; Reider et al., 2003; Swanik, Lephart, & Rubash, 2004). 
 
5) No significant differences in GMV between patients groups and HC 
I did not find significant GMV changes in patients groups when compared to HC. Most 
previous VBM studies of the effects of chronic pain have made a comparison between a 
single group of patients and HC rather than between pain groups (see Smallwood et al. 
(2013) for review). The failure to detect changes between patients and healthy controls may 
be due in part to this study’s relatively small sample size (as can be seen in comparison to the 
studies listed by Smallwood et al.) and the difference in mean ages between the groups (as 
discussed as limitations below). Those differences were detected between the patient groups 
rather than with HC suggest that the pain conditions can create opposing alterations in GMV 
in affected areas rather than being solely responsible for reduction in GMV. This suggestion 
is supported to an extent by the findings of Smallwood et al. who observe that several studies 
recorded GMV increases in chronic pain patients when compared to HC. The suggestion of 
opposing effects on brain areas by CLP and CWP is worthy of further study as greater 
understanding of the mechanisms underlying these changes may lead to better-targeted 
treatments.  
 
6) No decrease of GMV in the thalamus of OA patients 
In my previous MRS study (Chapter 2) I found a decrease of the thalamus NAA levels in OA 
patients. NAA is a marker of neuronal density and viability (Govindaraju et al., 2000; 
Simmons et al., 1991). Reduced NAA levels have been observed with many 
neurodegenerative diseases such as leukodystrophies, hypoxic encephalopathy (Rosen & 
Lenkinski, 2007), and multiple sclerosis (Rosen & Lenkinski, 2007; Tsai & Coyle, 1995). 
Because of my previous finding of thalamic NAA reduction in OA I suggested that long-term 
chronic pain from OA might lead to degeneration or dysfunction of central nervous system 
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tissue (Chapter 2). In this study I hypothesised a reduction of GMV in the thalamus of OA 
patients. However, I did not find the expected decrease in GMV in this region. This may 
suggest that the neurochemical changes seen are related to functional rather than structural 
(morphological) effects.  
   
Furthermore, dynamic changes of NAA concentrations suggest that NAA levels may reflect 
neuronal dysfunction rather than loss (Govindaraju et al., 2000). Recovery of NAA levels has 
been detected in brain injury (De Stefano et al., 1995), reversible ischemia (Brulatout et al., 
1996), multiple sclerosis, AIDS, and temporal lobe epilepsy (Barker & Lin, 2006). My 
findings of a reduction in NAA level in the thalamus, but not a reduction of GMV supports 
possible functional, but not structural changes in the thalamus of OA patients.  
 
7) No correlation between thalamic GMV and NAA levels in OA patients 
Despite the absence of the hypothesised reduction in thalamic GMV in OA patients, the data 
were analysed to determine if a relationship could be observed between NAA levels and 
thalamic GMV. No significant correlations between these values were observed for any of 
the participant groups. This finding, taken with the lack of thalamic atrophy in OA adds 
further support to the suggestion that reduced NAA levels in this region are indicative of 
functional rather than structural alterations in response to chronic pain. A degree of caution 
must be exercised in the synthesis of data from the MRS study described in Chapter 2 and the 
current VBM study. The data used to form the correlations with GMV had been corrected for 
partial volumes and relaxation effects therefore the relationship between GMV and 
metabolite levels may be obscured. 
 
There are some limitations of this study. The OA group is older than FM and HC groups, the 
numbers of participants in each group were smaller than would have been ideal, and only 
female participants were recruited. I will consider each of these limitations in turn.  
 
It is possible that the age difference between participant groups may have introduced 
confounding factors given the effects of age on brain morphology. I examined the literature 
to consider the effects that an older participant group may have had on the results derived by 
VBM. A review conducted by Matsuda (2013) of 12 previous VBM studies of the healthy, 
aging brain revealed a broad consensus of cortical GMV reduction in older subjects. The 
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observed reduction was most marked in frontal and insular areas of the cortex. In contrast, 
non-cortical structures, including the thalamus, were largely unaffected. Examination of 
studies outside the scope of Matsuda’s review (Callaert, Ribbens, Maes, Swinnen, & 
Wenderoth, 2014; Crivello, Tzourio-Mazoyer, Tzourio, & Mazoyer, 2014; Riello et al., 2005; 
Van Laere & Dierckx, 2001) were broadly in agreement with Matsuda’s observations, with 
Crivello et al. demonstrating GMV loss in the frontal and parietal cortices, middle occipital 
gyri, temporal cortex and hippocampus in healthy older adults (65-82 years). Given these 
findings it is possible that OA participants had reduced GMV compared to other groups as a 
result of age, which may have obscured findings in the FM < OA contrast. The one 
significant finding from this contrast was a reduction of brainstem GMV in FM, which 
occurred in an area not noted by previous studies as affected by age-related GMV reduction. 
The observation of GMV reductions in the younger FM cohort is interesting, as it would 
appear to be in the opposite direction to healthy aging related changes. It is possible that 
GMV decrease in FM patients relates to premature aging in FM (Hassett, Clauw, & Williams, 
2015; Kuchinad et al., 2007).  I found one significant result in the OA < FM contrast, namely 
a cluster of GMV reduction across the middle frontal, supramarginal, and precentral gyri. 
These are cortical areas in which age-related GMV reductions have been observed, therefore 
it is possible that age may be a contributing factor to these results. A further study with more 
closely matched participant groups may determine if this is the case. 
 
As noted previously, I was unable to recruit sufficient numbers of participants to achieve the 
desired level of experimental power. It is possible that existing differences in GMV between 
the chronic pain conditions were not detected by this experiment. The original intention for 
recruitment to this study was to form participant groups of sufficient size to achieve 80% 
power. Logistical constraints enable the recruitment of only 50 participants, which reduced 
the sensitivity of my experiment.  
 
Additionally, as I only recruited female participants, possible gender effects may limit the 
generalizability of my findings (for detailed consideration of the limitations of my studies the 
reader is referred to Chapter 5). Certain methodological limitations of VBM have been noted, 
for instance in normalisation and segmentation confounds, accuracy of localisation and the 
interpretation of results (Mechelli et al., 2005). However, as Whitwell reported, there is a 
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growing body of literature that provides validation of VBM as a technique for assessing 
structural changes in the brain (Whitwell, 2009).  
 
My results suggest future research to perform a longitudinal study with OA patients being 
scanned before and after a total knee replacement. There is some evidence that brain 
morphology is reversible in chronic pain (Gwilym et al., 2010; Rodriguez-Raecke et al., 
2009; Seminowicz et al., 2011). For example, Rodriguez-Raecke et al. have shown reversible 
alterations of GMV in the ACC, DLPFC, amygdala, brainstem and right insula in patients 
with hip OA before and after endoprosthetic joint replacement (Rodriguez-Raecke et al., 
2009). Gwilym et al., likewise, have demonstrated reversible GMV changes in the left 
thalamus of hip OA patients before and after arthroplasty (Gwilym et al., 2010). Reversibility 
of brain changes has also been shown in chronic low back pain with increased cortical 
thickness in the left DLPFC, primary motor cortex, and right anterior insula in CLBP patients 
after spine surgery or facet joint injections (Seminowicz et al., 2011). Furthermore, another 
research group has concluded that CLBP due to lumbar disk herniation can induce structural 
brain alterations, which are potentially reversible after microsurgical lumbar discectomy 
(Luchtmann et al., 2015). Thus I expect that GMV of the left precentral gyrus (BA 4 and 6) 
and the left postcentral gyrus (BA 40) would increase (normalise) after a total knee 
replacement in OA patients.  
 
Subsequently, it would be interesting to evaluate whether non-surgical treatment of FM 
patients (CBT, acupuncture) would have the same effect i.e. normalising brain morphology. 
Possible future research is to investigate the influence of cognitive behavioural therapy 
(CBT) on FM patients. I speculate that GMV of the posterior cingulate in FM would recover 
to normal levels after the treatment. There is evidence that CBT is an effective method in FM 
(Ang et al., 2010; Bennett & Nelson, 2006; Glombiewski et al., 2010; Goldenberg et al., 
1994), which improves cognitive function, especially attention, and reduces nociceptive 
responding in FM (Ang et al., 2010).  
 
In conclusion, different brain areas were affected in two chronic pain conditions: in FM there 
were brain areas more associated with cognition, whereas in OA the areas were implicated in 
motor function. These findings suggest that the two chronic pain conditions would benefit 
from different therapeutic strategies: for FM patients an accentuation on CBT, psychotherapy 
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and relaxation techniques and for OA patients emphasis on movement therapies and 
physiotherapy. Further VBM studies of a wider range of chronic pain conditions would allow 
better comprehension of pain mechanisms in CLP and CWP. Gaining an understanding of the 
nature of different chronic pain conditions is essential in the development of targeted 
therapies and the achievement of efficient pain management.  
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CHAPTER 5 - General Discussion 
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This programme of research sought to determine whether differences can be identified in the 
effects of chronic widespread and chronic localised pain on the human brain. I selected 
osteoarthritis (OA) as an example of chronic localised pain (CLP) and fibromyalgia (FM) as 
representative of chronic widespread pain (CWP) to make a comparison with each other and 
with healthy controls (HC). My investigations used a range of neuroimaging techniques to 
examine the brains of participants at rest. It is my intention in this chapter to bring together 
the results of these investigations and consider what these results can tell us about the effects 
of chronic pain on the human brain. 
Summary of the investigations and key findings 
My research used Magnetic Resonance Spectroscopy (MRS), Voxel-based Morphometry 
(VBM) and Functional Connectivity (FC) to examine tissue composition (neurochemistry), 
relative size of brain regions (structure), or correlations between activity (function) in the 
brains of chronic pain patients and healthy controls. In this section I will summarise the 
investigations that were performed and their main findings. 
 
I used MRS to determine the levels of seven neurochemicals in four brain regions that have 
been found to be relevant to chronic pain conditions. My most notable finding was a 
reduction of N-acetyl aspartate (NAA) in the thalamus of OA patients compared to FM 
patients.  
 
I used VBM to compare the relative amounts of tissue types present across the brain. Further 
motivation for this investigation was provided by the results of the preceding study: since 
NAA levels are taken to be indicative of neuronal viability, I considered it plausible that the 
observed reduction may suggest loss of neurons in the thalamus of OA patients. Contrary to 
expectations, I did not find a reduction of grey matter volume (GMV) in the thalamus of OA 
patients. I did observe a reduction in GMV in OA in the left middle frontal and supramarginal 
gyri. I also observed a reduction of GMV in FM patients in the brainstem (primarily midbrain 
and pons) and in the posterior cingulate cortex (PCC). 
 
I used FC to examine the effects of chronic pain conditions on the level of correlated activity 
in networks of regions in the participants’ brains. Given that an altered level of NAA in the 
thalamus without corresponding neuronal loss was observed, it was considered plausible that 
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the differing effects of CLP and CWP on patients’ brains may be functional rather than 
structural. I noted a higher level of FC between areas of the Default Mode Network (DMN) 
in FM when compared to OA. I also noted that FC in both chronic pain conditions was 
greater compared to HC between selected regions within the networks and the precuneus in 
the DMN. In contrast, I noted that FC in both chronic pain conditions was lower than in HC 
between SPLs and the inferior frontal gyri (IFGs) and the middle frontal gyri (MFGs) within 
the Executive Attention Network (EAN). I will consider now what these results tell us about 
the differences and similarities of the effects of CWP and CLP on the human brain. 
Differences between CWP and CLP: summary and discussion of 
main research findings 
My main hypothesis of the existence of observable differences in the effects of patients’ 
brains of CWP and CLP was supported by the following findings across the clinical measures 
(questionnaires) and neuroimaging techniques: 
 
1) A significant decrease in the level of NAA in the thalamus of CLP (OA) patients 
compared to CWP (FM) group (MRS). 
 
Reduced levels of thalamic NAA have been observed in a range of conditions. Gustin et al. 
(2014, 2011) found that this reduction could be used to draw a distinction between groups of 
trigeminal neuropathy and spinal injury patients who experienced neuropathic pain and those 
who did not. Shigemura et al. (2012) observed a similar reduction of thalamic NAA in hip 
OA patients. Other instances of reduced thalamic NAA have been observed in schizophrenia, 
multiple sclerosis, epilepsy, essential tremor, ecstasy use, cocaine tolerance and alcoholism 
(Bernasconi et al., 2003; De Win et al., 2008; Jagannathan, Desai, & Raghunathan, 1996; Li, 
Wang, Pankiewicz, & Stein, 1999; Wylezinska et al., 2003). The thalamus acts as a hub for 
information directed to the cortex and plays a role in managing the direction of consciousness 
and arousal through oscillatory, inhibitory circuits (Steriade & Llinás, 1988). Since reduced 
levels of NAA levels are taken to indicate neuronal dysfunction (Tsai & Coyle, 1995) it is 
clear that the thalamus is vulnerable to damage by a range of factors. It is interesting to note 
that abnormal and, in some cases, prolonged input to the brain is present in several of these 
cases. In CLP this may suggest that chronic nociceptive input causes damage to the thalamus, 
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which disrupts inhibitory thalamocortical circuits. Thalamocortical dysrhythmia has been 
implicated as a factor in which central mechanisms maintain the experience of pain (Llinás, 
Ribary, Jeanmonod, Kronberg, & Mitra, 1999). The absence of a similar effect in CWP may 
indicate that abnormal input from the periphery is not the primary factor in the generation of 
pain i.e. thalamic damage does not occur in FM since central rather than peripheral factors 
are primarily responsible for pathogenesis. 
 
2) A significant decrease in grey matter volume (GMV) in the left brainstem and PCC of 
the CWP group compared to CLP (VBM). 
 
The brainstem plays a key role in facilitating descending pain modulation and desensitisation, 
signal integration and in a range of the brain’s fundamental functions (Nicholls & Paton, 
2009). The GMV loss observed in FM patients in my study may indicate damage to the 
structures fulfilling these functions. This finding may suggest a neurological basis for FM 
patients’ paraesthesias (due to disruption of sensory integration), hypersensitivity (due to 
impairment of the descending pain desensitization pathway) and the spectrum of additional 
symptoms experienced by FM patients (due to dyscoordination of the integrative control 
functions of the brainstem). My observation of reduced brainstem GMV is agreement with 
Fallon et al. (2013) who observed a reduction accompanied by brainstem shape alteration. 
Further analysis of my data may add to our understanding if volume change or structural 
distortion is the main component of functional loss. 
 
It is interesting to note that these findings are relatively novel: prior studies that have noted 
GMV reduction in pain patients have compared the brains of CLP patients with healthy 
controls (Rodriguez-Raecke et al., 2009; Schmidt-Wilcke et al., 2005). Rodriguez-Raecke et 
al. examined the effects on GMV associated with hip OA and found GMV reduction in the 
patient group, which was reversible after treatment of the affected joint. Rather than 
suggesting a different mechanism of action between hip and knee OA it is more plausible to 
consider the difference in CLP findings between my studies to be due to the larger sample 
size (roughly twice as many in each group) and the closer match that Rodriguez-Raecke were 
able to achieve in the ages of their participant groups. 
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My finding of reduced GMV in the PCC in CWP is in agreement with the observation made 
by Kuchinad et al. (2007) and suggests a neurological basis for the cognitive symptoms 
experienced by FM. As noted, the PCC plays a role in working memory and cognitive control 
therefore a loss of GMV in this region may impair these functions in FM patients. The PCC 
has also been suggested as a key component of the pain representation system, particularly in 
the “emotional-aversive component of pain” (Bromm, 2001). This finding adds support to the 
division of the pain system into two component systems: a lateral somatosensory system and 
a medial emotional-aversive system, of which the PCC forms a part. No studies have been 
published which indicate GMV loss in the PCC associated with OA. Neuronal loss or damage 
to the PCC may therefore contribute to the higher level of emotional symptoms experienced 
by FM patients when compared to OA. It must be noted, however, that a reduction in GMV 
in PCC (and ACC) was noted by Gerstner et al. (2011) in patients with myofascial-type 
temporomandibular disorders. This latter observation suggests that whilst a division may 
exist in the impact of OA and FM on the medial and lateral pain systems, caution should be 
used when looking to separate the effects of all CWP and CLP conditions. 
 
3) A significant decrease in GMV in the left precentral (BA 4), middle frontal (BA 6) 
and supramarginal (BA 40) gyri of the CLP patients compared to CWP (VBM). 
 
The decrease of GMV in the motor cortex suggests that changes to brain structure are 
associated with the motor dysfunction and consequent disability. However, a clear statement 
cannot yet be made of the direction of any causal relationship. Reorganisation of the motor 
cortex has been observed in OA (Shanahan, Hodges, Wrigley, Bennell, & Farrell, 2015) 
therefore it is not surprising to observe structural changes to these areas. Increases in the 
GMV of these areas has been observed in OA patients who have received treatment 
(Tetreault et al., 2015), which suggests that as per the findings of Rodriguez-Raecke et al. 
GMV alterations associated with OA are reversible in some cases, suggesting neuronal 
damage rather than loss.  
 
Whilst alterations to the motor cortex in OA may primarily result from an adjustment to a 
patient’s use of the affected limb, there is evidence to suggest that some reorganisation may 
be driven by alterations to the mechanisms that support motor imagery and anticipation 
(Stanton et al., 2012). An effect on motor imagery has been discovered in complex regional 
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pain syndrome: another CLP (Moseley et al., 2008). It has also been observed that 
stimulation of the motor cortex has an analgesic effect on some chronic pain conditions 
(Brown & Pilitsis, 2005; Fagerlund, Hansen, & Aslaksen, 2015). Taken together, this 
suggests a more complex role for the motor cortex in CLP than was previously appreciated.  
 
A reduction in GMV was found in the supramarginal gyrus (BA 40) within the 
somatosensory association cortex in OA patients. This finding is novel as I am not aware of 
any other studies that have observed GMV alterations in this area in OA (or FM). Gerstner et 
al. (Gerstner et al., 2011) observed an increase in white matter volume in the supramarginal 
gyrus, but no significant difference in GMV in patients with temporomandibular pain (a CLP 
condition). Impaired proprioception has been observed in OA patients (Sharma, 1999; 
Sharma et al., 1997). The impairment observed being generalised rather than relating to the 
joint or limb affected by OA. This finding taken with my observation of GMV reduction in 
OA may suggest a neurological basis for the impaired general proprioception in OA. 
 
4) A significant increase in FC within DMN between PCC and MTGL in the CWP 
group compared to CLP. Increased DMN FC in CWP. 
 
It is challenging to interpret this result in the context of the hypothesis that increased FC 
would be observed in the DMN in pain conditions that in healthy controls. No difference was 
found between the pain conditions and healthy controls, but a higher level of FC was 
observed between the seed region of the DMN and a component of the DMN in FM when 
compared to OA. The MTG is believed to play a role in language and memory (Binder et al., 
1997; Squire & Zola-Morgan, 1991). The different effects may reflect the move cognitive 
elements of FM, but this cannot be stated confidently. Further research is required to 
investigate whether opposing effects on the DMN FC of the MTGL can show significantly 
differences between the pain conditions and healthy controls. It would be instructive to rerun 
this study with larger and more closely matched participant groups. 
 
It is interesting to consider the observation of increased DMN FC in FM with the previous 
finding of decreased GMV within the PCC in FM compared to OA. Taken together, this 
suggests a somewhat counterintuitive situation entailing increased network cohesion being 
generated by a region experiencing neuronal damage or loss. Further research is required to 
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determine the underlying nature of the reduction of GMV and whether increased FC can 
cause neuronal loss or FC increases as a result of neuronal damage. 
  
5) Significant differences between CWP and CLP in relationships between the clinical 
measures (questionnaires) and the measures from neuroimaging techniques. 
 
FM patients showed positive correlations of affective rank of pain rating index (PRI) with FC 
between DMN and the EANs. OA, on the other hand, revealed a negative correlation of 
affective rank of PRI with FC between DMN and the right EAN. Activity in the DMN and 
EANs is anticorrelated under normal conditions. The observation of opposing shifts in 
correlation between the patients’ experience of CWP or CLP and FC between the networks is 
illustrative of the greater emotional component of FM. This observation aligns with the 
suggestion made by Gracely et al. (2004) of a ruminative feedback loop within FM, where 
patients’ reflection on their pain enhances their awareness and this effects their emotional 
state in relation to their condition. Increased FC across DMN and EANs accompanying FM 
was observed by Napadow et al. (2010). Increased FC between the networks may indicate 
that the intrusion of pain into a patient’s resting state causes attention shifts entailing 
switching between DMN and EAN. Within FM these shifts may contribute to the direction of 
attention to pain, rumination and the enhancement of the affective component of the patient’s 
condition. A role for the insula in the shifting of activity between DMN and EAN has been 
demonstrated (Menon & Uddin, 2010). The insula is also a component of the pain 
neuromatrix (Melzack, 1990). It would be instructive to review the activity of the insula in 
conjunction with the DMN and EAN in FM patients to determine if further understanding can 
be gained of the interaction of the insula’s role in both pain processing and the co-ordination 
of shifting activity between networks. 
 
6) A significant difference in mean scores for evaluative rank of pain rating index (PRI) 
was observed between CWP and CLP (McGill Questionnaire). 
 
The observation of significantly increased evaluative PRI in FM was anticipated given prior 
research that has emphasised the cognitive and affective component of the condition. This 
finding emphasised that patients’ experience of CWP and CLP can vary not only in the 
location of pain, but also disruption to other psychological and physical systems. This finding 
126 
 
is closely related to the catastrophisation of their condition expressed by some FM patients 
(Gracely et al., 2004), which marks a significant difference in the subjective experience of 
this group with than of OA patients. Whilst this finding is not novel it is informative to 
consider in the context of the other differences observed between CLP and CWP particularly 
with a view towards determining new methods for managing the conditions. The correlation 
found between the increased between network FC and PRI in FM, coupled with the higher 
evaluative component of FM suggests that working with FM patients to reappraise their 
experience and attempt to manage their reaction to the intrusion of pain may be appropriate in 
this condition. 
 
I will consider now the findings from my studies that indicated similarities between CWP and 
CLP. Additionally, I will discuss the findings where the pain conditions shared a difference 
between themselves and HC. 
Similarities between CWP and CLP: summary and discussion of 
main research findings 
 
1) Increased FC in the DMN in both chronic pain conditions compared to HC. Increased 
FC between the seed regions (SPLL, SPLR and PCC) and the precuneus. 
 
Both chronic pain conditions were associated with increased levels of FC within the DMN 
when compared to healthy controls. Previous research has indicated that enhanced DMN FC 
is associated with a range of adverse effects including mild cognitive impairment, lower 
levels of happiness and impaired episodic memory performance (Gardini et al., 2015; Luo, 
Kong, Qi, You, & Huang, 2015; McCormick et al., 2014). My findings are in accord with the 
work of the other research groups, but they leave questions unanswered to whether increased 
FC is caused by the pain conditions and why enhanced DMN FC should be associated with 
adverse effects. I recommend a further study to compare areas of enhanced DMN FC with the 
behavioural and emotional effects presented in OA and FM: whilst the cognitive effects of 
FM are well-documented (“fibro fog” etc.) less is known about the effects of OA on 
cognition. It would be informative to know whether a link can be drawn between enhanced 
DMN FC in OA and impaired cognition. 
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Increased FC between the precuneus and areas between and within my networks of interest 
was noted in both pain conditions when compared to healthy controls. In Chapter 3 I 
considered the role of the precuneus and noted its extensive connectivity with areas of the 
brain believed to support a wide range of behaviours. Activity in the precuneus has been 
associated with awareness, self-reflection, episodic memory and rumination (Kjaer, Nowak, 
& Lou, 2002; Lou et al., 2004; Kjaer, Nowak, Kjaer, Lou, & Lou, 2001; Vogt & Laureys, 
2005; Dörfel, Werner, Schaefer, Von Kummer, & Karl, 2009; Lundstrom et al., 2003; 
Lundstrom, Ingvar, & Petersson, 2005). The pronounced atypicality of FC between the 
precuneus and other brain areas and, as noted, the proposed role of the precuneus as a core 
hub of the DMN, gives plausibility that the abnormal FC observed in chronic pain patients is 
a key factor in the effects of their condition: both sensory and beyond.  
 
It was noted that increased FC between the seed regions of both the DMN and the EANs and 
the precuneus was observed. An increase in between network FC (i.e. between the precuneus 
of the DMN and the EAN seed regions) may be indicative of pain-driven activity shifts 
between the networks (as discussed above). Given the previously identified role of the insula 
in between network activity shifts, it would be informative to examine FC between the 
precuneus and insula to determine if FC is increased between these areas in pain conditions. 
It is recommended that further studies of the disruptive effects of chronic pain examine the 
role of the precuneus and insula. 
 
2) A significant decrease in FC in both chronic pain conditions compared to HC between 
SPLs and IFGs and MFGs within and between EANs. 
 
I observed that network coherence within (and between) the EANs was decreased in both 
pain conditions when compared to healthy controls. As noted, EAN activity corresponds with 
externally directed, goal oriented cognition (Seeley et al., 2007). This network incoherence 
adds further support for the suggestion that the effects of chronic pain are not limited to 
sensory discomfort, but also result from the disruption of coordinated activity that supports 
other functions (e.g. Dick & Rashiq, 2007; Luo et al., 2015). My observations revealed 
shared differences between the pain conditions and healthy controls. These observations 
suggest a level of overlap in the effects of these conditions on the brain, but also invite 
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further questions to why similar neurological effects can be associated with differing levels of 
behavioural dysfunction. 
Limitations 
I am aware of several limitations of my investigation, both as a whole and within the 
individual studies. I shall consider these in turn. 
General Limitations 
I chose two conditions to represent CLP and CWP and to generalise from them, rather than 
select participants from a range of CLP and CWP conditions. My patient population was 
small, but well-defined, and represents two common pain conditions. I selected knee OA as 
an example of CLP because of its prevalence in adult population. However, it would be 
difficult to make a generalisation about other CLP conditions, as the changes in the brain 
might be different from those I found. An investigation of other CLP conditions is required in 
future studies.  
 
The selection of FM as a ‘typical’ CWP condition is worthy of further consideration. Our 
understanding of the underlying organic condition that drives FM is still somewhat limited 
(Chinn, Caldwell, & Gritsenko, 2016), indeed it is possible that this investigation’s FM group 
may comprise a set of individuals with different underlying problems that share only a 
common set of symptoms. This may have had the effect of diluting the ‘purity’ of my CWP 
sample and may account for the absence of some of the expected findings. Future studies 
may be guided by increased knowledge of the underlying causes of FM or may select other 
conditions as exemplars of CWP.  
 
For logistical reasons I formed participants groups whose mean age differed according to 
condition. It is the case that OA is more common in older people and that the mean age of 
onset of FM is much younger and therefore recruiting age-matched participants is 
challenging. It is important to try to match age, because of the effects of age on the brain 
chemicals, brain volume and functional connectivity. Future researchers may benefit from 
either selecting a CLP condition with an earlier mean onset age, or/and a CWP condition with 
a later mean onset age. It is possible that researchers with access to a larger group of patients 
may be able to select FM patients of a more comparable age to those with OA, but this may 
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come at the price of introducing another possible confound to the study in an increased 
number of years that one of the conditions has been experienced. 
 
I included only female participation in my studies, which precluded the investigation of 
possible gender effects. However, as FM patients are primarily female (Neumann & Buskila, 
2003; Wolfe et al., 1995; Yunus et al., 1981), it was decided to only recruit female 
participants for all groups to avoid any potential gender bias effects. Studying females is 
important as females generally report a greater level of chronic pain (Andersson, Ejlertsson, 
Leden, & Rosenberg, 1993). However, future studies investigating both male and female 
participants may provide further knowledge. 
 
Potential limitations of individual experiments 
MRS is a relatively less well-known technique in the neuroimaging of pain, which has 
evolved rapidly over recent years. As such, there is not yet full agreement regarding elements 
of the methodology of MRS and the conclusions that can be drawn using this technique. As 
an example, there is still discussion about appropriate peak referencing and calibration 
(Jansen, Backes, Nicolay, & Kooi, 2006), although in recent years a consensus have 
developed around the use of water as a concentration reference. 
 
The conclusions drawn from MRS are reliant on an accurate assessment of neurochemicals 
present within the subjects’ brains on the day of scanning. Neurochemical levels can, 
however, be affected by a variety of factors in addition to a pain condition including age, 
fitness, vascular health, diet and drug usage (e.g. Yeo et al., 2012). The participants were 
asked to refrain from using analgesic medication on the day of scanning whereas the washout 
period for some drugs is much longer. It was felt, however, that it would not be ethical to ask 
participants with chronic pain to refrain from taking analgesic drugs for a longer period.  
 
Potential methodological vulnerabilities of VBM have been noted, for instance in 
normalisation and segmentation confounds, inaccuracy of localisation and potential 
misinterpretation of results (Mechelli et al., 2005). It has been suggested that VBM may 
produce type 1 errors if the possibility of systematic misregistration of participants’ brain 
images is not controlled (Ashburner & Friston, 2001). Systematic differences between 
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scanning parameters, or the movement or positioning of a subject group within the scanner 
may produce artefacts that manifest as observed differences between-group grey matter 
volumes that do not reflect the morphometry of the participants’ brains. Within my study I 
controlled for this possibility by ensuring that images were generated using identical 
scanning parameters within the same scanning unit. I further ensured that all participants 
were positioned identically in the scanner and all image sequences were analysed for motion 
artefacts. 
  
Other potential limitations of VBM have related to the introduction of artefacts due to the 
pre-processing of images of atypical brains (Mechelli et al., 2005). Mechelli et al. found that 
apparent differences in grey matter volume may be produced by the presence of pathological 
features within participants’ brains (e.g. tumours or abnormal artero-venous structures) that 
are not accounted for in the template employed for normalisation and segmentation. To 
control for this possibility, high-resolution anatomical scans of each participant were 
obtained and the absence of significant atypicality was confirmed. I am confident that my use 
of VBM was in accordance with appropriate methodological recommendations and I note, as 
per Whitwell (2009), the presence of a growing body of literature that provides validation of 
VBM as a technique for assessing structural changes in the brain.  
 
FC requires a relatively lengthy scanning sequence during which the participant is instructed 
to rest. These requirements lead to the potential impairment of this technique through the 
introduction of head motion and to differences in participant response to the “Rest” 
instruction (Buckner, Krienen, & Yeo, 2013). The interpretation of FC results has been found 
to be vulnerable to observation of spurious correlations resulting from head motion (van Dijk, 
Sabuncu, & Buckner, 2012). I believe that I accounted for the possibility of head motion 
artefacts through regression and realigning. I acknowledge, however, that the possibility of 
performance differences in response to the “Rest” instruction is more difficult to control. 
Whilst each participant was briefed as to the response required during the FC scanning 
sequence and emphasis was placed on the need for an absence of directed thought, I cannot 
be fully confident that the participants’ responses to the instruction were uniform. I believe 
that there is no reason to suspect a systematic difference in the responses between groups 
within my experiment, but I cannot exclude this possibility. 
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A further methodological consideration is specific to the form of FC that was used within my 
study. Seed-based component analysis examines the FC between a selected group of voxels 
and the rest of the brain. Whilst there are several advantages associated with this method 
(Cole, Smith, & Beckmann, 2010), the drawing of correct inferences from results derived 
from this method is entirely dependent on the selection of a well-defined seed that is 
appropriate for the research question being answered. As noted earlier, I believe I selected 
appropriate seed voxels based on prior knowledge of the networks of interest and a review of 
the literature. 
 
Another possible limitation of the FC study is that I only examined resting state when 
considering attention – it is possible that differences in EAN need the participants to be 
engaged in a suitable task to reveal themselves. I am also mindful that the power of my FC 
experiment may have been limited due to the size of the available participant groups. Friston 
(2012) recommended groups of between 16 and 32 participants to reduce the possibility of 
type 2 errors. The groups in my study were, however, limited by access to suitable patients. I 
would suggest that the results of this experiment be considered a preliminary exploration of 
the effects of chronic pain on brain networks’ connectivity at rest. I also suggest that my 
results have shown interesting alterations in FC that may help directed research questions for 
future studies with larger participant groups. I will consider now clinical implications and 
applications of the results. 
Clinical Implications and Applications 
 
The differences discovered in the neurological presentation of chronic pain between CWP 
and CLP give us grounds to consider differential therapy and management of the two 
conditions. For example, the MRS study identified differences between the two chronic pain 
conditions: OA gave changes in neurochemical levels, associated with anatomy and brain 
function, whereas FM presented with changes in the relationships between neurochemical 
levels and clinical measures (depression, anxiety, pain intensity), associated with mood and 
behavioural functional abilities. This gives us a basis for using physically targeted therapies 
(pain killers, anti-inflammatories, surgery, physiotherapy) in OA patients, whereas FM 
patients may derive more benefit from behavioural therapies (CBT, meditation, hypnosis, 
yoga) and drugs working centrally such as amitriptyline, pregabalin, and duloxetine. Findings 
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from the VBM study also suggest that the two chronic pain conditions would benefit from 
different therapeutic strategies: for FM patients an emphasis on CBT, psychotherapy and 
relaxation techniques (changes in the brain area involved in cognition) and for OA patients a 
focus on movement therapies and physiotherapy (changes in the brain areas involved in 
movement). Differences found between CWP and CLP within the FC study also suggested 
that cognitive and behavioural therapies would be more effective in FM than in OA. I found 
an increase in FC between PCC and MTGL (within DMN) in FM compared to OA. The PCC, 
especially within the precuneus, has been found to be active in rumination in FM, and 
therefore may play a role in increasing the level of patients’ experienced pain. Thus, FM 
patients would benefit from hypnosis, rational emotive behaviour therapy and group 
psychotherapy. MTGL is involved in a number of cognitive processes and increased FC 
between PCC and MTGL of FM patients suggests that CBT would be more effective in FM 
compared to OA. The observation of the differing emotional relationship to patients’ pain 
conditions suggests that FM suffers may derive more benefit from therapies that examine 
their subjective experience of pain and aim to control rumination. However, further research 
is required to understand the atypical FC that is observed within this condition to determine 
whether this has an effect in reinforcing rumination and would therefore work against re-
evaluative therapies. 
Future plans 
 
My future plans include scanning OA patients after knee surgery to see whether the brain 
changes that I observed are reversible. Also I am planning to scan FM patients after a full 
course of CBT to investigate if CBT can improve cognitive performance of FM patients and 
play a role in altering the effects of this condition on the brain.  
 
In future studies I am planning to make sure that participants are age-matched and also to 
include male participants as well. My future research would include larger population groups 
to have more powerful results. Additionally, I intend to investigate differences in brain 
presentation of chronic pain between other chronic pain conditions: chronic low back pain, 
hip osteoarthritis, CRPS, chronic pelvic pain syndrome to determine whether my results can 
be generalised. 
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Conclusion 
 
These investigations have provided additional evidence to enhance our understanding of the 
effects of CLP and CWP on the human brain. Differences were observed in the effects of FM 
on the medial cognitive-emotional elements of the pain system and of OA on the lateral 
somatosensory pain systems. The differences observed via neuroimaging are in good 
alignment with previous research and with patients’ own reports of their experience of these 
conditions. The correlation between the FM patients’ evaluation of their condition and the 
observation of alterations to components of the cognitive-emotional pain system suggest a 
neural basis for this part of their experience. I believe that the evidence provided by my 
investigations on the separation of affected brain areas may assist in the search for brain 
biomarkers, which would be particularly useful if the case of FM.   
 
Of further value in my investigations has been the addition of evidence that may assist in 
understanding the mechanisms through which reorganisation of the brain becomes a factor in 
CLP. My observation of functional alteration in OA (and not in FM) is in accord with 
previous research that highlighted the vulnerability of the thalamus to prolonged abnormal 
input from the periphery. The alignment of my findings with this previous work and the 
known role of the thalamus in thalamocortical oscillatory, inhibitory circuits (which are in 
turn known to play a role in managing the descending pain modulation pathways), suggests 
that thalamic disruption may lead to dysfunction of pain modulation and to the prolongation 
of CLP through central mechanisms. 
 
My investigations have also provided evidence for the role of the precuneus in the activity of 
brain networks in patients experiencing chronic pain. The increased FC observed in pain 
conditions between the precuneus and areas within the DMN and EANs suggests a role for 
the precuneus in between-network co-ordination in these conditions. As noted, a detailed 
investigation of FC between the precuneus and insula of CLP and CWP patients would be of 
great value. 
 
In conclusion, my studies have demonstrated differences in the effects of CLP and CWP on 
the pain system and provided additional understanding of the neural substrates of these 
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conditions. I have also demonstrated where the conditions overlap in their effects on the 
human brain and given an indication of shared mechanisms. I believe the results of my 
investigations have added to our knowledge of these conditions and may be useful in the 
development of further treatment.  
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